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Testicular development is a tightly regulated and complex process in which
Sertoli cell functional maturation plays a pivotal role. Reported increases in the
incidence of male reproductive abnormalities in humans and other wildlife have
been linked to increased levels of oestrogen and oestrogen-like chemicals in the
environment. The function of oestrogen in male reproduction in particular
during testicular development and maturation has been investigated.
Oestrogen administration during postnatal testis development indirectly
modifies Sertoli cell maturation. The recent discovery of oestrogen receptor-
beta (ER(3) expression in Sertoli cells has provided a direct route for oestrogenic
action in Sertoli cells. The aims of the present studies were firstly to examine the
ontogeny of gene expression during normal prepubertal development of the rat
testis at both mRNA and protein levels focusing on expression patterns of novel
markers of Sertoli cell functional maturation. Secondly Sertoli cell gene
expression patterns were investigated following exposure to oestrogen or
testosterone in vivo or in vitro.
In the first part of the thesis changes in the temporal and spatial expression of
Sertoli cell mRNA and proteins were investigated in the postnatal rat testis.
Novel results regarding ER[3 expression during this time of development were
reported. In addition patterns of Musashi-1, GATA-1 and GATA-4 Sertoli cell
expression were described including new information demonstrating changes in
Musashi-1 and GATA-1 protein localisation in the Sertoli cell during the
transition from proliferating cells to mature differentiated Sertoli cells.
Artificially elevated levels of oestrogen in the neonatal testis delayed Sertoli cell
maturation and subsequently delayed expression of GATA-1 protein
demonstrating the restriction of GATA-1 protein expression to non-proliferating
Sertoli cells which has not previously been described. A primary rat Sertoli cell
culture system was established in which Sertoli cells retained hormonal
sensitivity consistent with the expression of androgen receptor and ER{3
proteins. New preliminary data describing upregulation of ER(3 protein levels
by oestrogen in cultured rat Sertoli cells are reported. Steroid regulation of
x
GATA-4 expression in cultured rat Sertoli cells was not detected in the present
study at the level of either mRNA or protein. Problems obtaining sufficient
numbers of Sertoli cells in culture during this investigation were overcome by
employing an immortalised mouse Sertoli cell line from the H-2Kb-tsA58
transgenic mouse and confirmation of results obtained using primary cultures
of rat Sertoli cells was carried out.
In conclusion, the studies outlined in this thesis have described expression
patterns of markers of Sertoli cell functional maturation and preliminary data
regarding their steroid regulation. Such new data can be employed in future
studies to further evaluate direct effects of oestrogen and oestrogen-like
chemicals on Sertoli cell behaviour in the postnatal rat testis with a view to
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Review of the Literature
1.1. Introduction
The impact of endogenous oestrogens, or exogenous ligands with oestrogenic
activity, on the formation of the male reproductive system, and on
reproductive function in adulthood, remain the subject of intensive research
activity and debate (see reviews by (Sharpe, 1998; Sharpe et ah, 1998; Toppari et
ah, 1996). Testosterone was always viewed as the 'male' hormone and
conversely oestrogen was seen as the 'female' hormone a distinction that now
appears simplistic. In males oestrogens are synthesised from androgens by the
aromatase enzyme both within the brain and testes and levels within the male
reproductive tract are generally higher than in the general circulation
(reviewed in (Hess et ah, 1997). Oestrogen action is mediated via high affinity
receptors which are shifted to a transcriptionally active state after ligand
binding. Two forms of oestrogen receptor commonly known as alpha (ERa,
((Green et al., 1986) and beta (ER(3, (Kuiper et al., 1996) have been cloned and
although they exhibit significant sequence homology within both their DNA
and ligand binding domains (reviewed in (Saunders et al., 1998) they are
encoded on different chromosomes (Enmark et al., 1997). Within rat testes
expression of both ER isoforms has been demonstrated (Dorrington and Khan,
1993; Fisher et ah, 1997; Saunders et ah, 1998; van Pelt et al., 1999).
Postnatal development of the testis is a highly complex and tightly regulated
process involving a number of paracrine interactions. Sertoli cells play a pivotal
role in these processes. In the postnatal rat testis, modification of Sertoli cell
differentiation causes a delay in the onset spermatogenesis (De Franca et al.,
1995) and prevents the differentiation of mature Leydig cells (Papadopoulos et
al., 1987). Oestrogens have been proposed to have both direct, and indirect
effects on functional maturation of Sertoli cells (Sharpe et ah, 1998; Sharpe et al.,
1995; Sharpe et al., 2000) and neonatal treatment with oestrogens in vivo has
recently been shown to affect the numbers of spermatozoa produced in adult
rats (Sharpe et ah, 1995).
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At the time that these studies were initiated it had been proposed that
oestrogens played an essential role in male fertility (Eddy et al., 1996) however
exposure to elevated levels of oestrogen or chemicals with oestrogen-like
activity during fetal or neonatal life had been shown to alter gene expression
within the testis (Majdic et al., 1997; Majdic et al.r 1995). The aim of the work
described in this thesis was to increase our knowledge of the action(s) of
oestrogen(s) in the postnatal testis focusing in particular on the proposal that
oestrogens can have direct effects on Sertoli cell differentiation. To provide a
background to these studies this chapter will firstly, briefly review the
structural organisation of the mature testis. Postnatal development of the testis
in the rat is reviewed in detail with particular reference to Sertoli cell
maturation and the factors involved in this process. The final section reviews
evidence and hypotheses surrounding effects of oestrogen on male testis
development.
1.2. Organisation of the Adult Testis
The testis is a complex organ that is divided into two main compartments, the
seminiferous tubule and the interstitial space. The seminiferous tubules contain
Sertoli cells and germ cells. In adulthood the Sertoli cells provide both
structural and metabolic support to the germ cells as they differentiate into
mature spermatozoa and are released into the tubule lumen. Peritubular
myoid cells surround the circumference of the tubule and provide support and
contractile activity. The interstitial space is located between seminiferous
tubules and is composed of Leydig cells, macrophages, blood vessels,
lymphatics, fibroblasts, nerve fibres and fibrinonectin rich connective tissue.
Leydig cells synthesise and secrete testosterone which is transported to the rest
of the body via the adjacent vasculature. In the mature testis, the seminiferous
tubules produce mature sperm which is in part dependent on the production of
testosterone by the Leydig cells.
1.2.1. Seminiferous Epithelium
The seminiferous tubule consists of a seminiferous epithelium, basement
membrane and peritubular cells (see Figure 1.1). The seminiferous epithelium
is separated into two compartments by the inter-Sertoli cell junctions. Firstly,
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the basal compartment between the inter-Sertoli cell junctions and the
basement membrane which contains spermatogonia and secondly, the
adluminal compartment above the tight junctions that contains all other germ
cell types. Germ cells are arranged in a highly organised manner in close
contact with Sertoli cells. In the seminiferous epithelium of the rat for example
there is a fixed complement of 4-5 germ cell types, the associations of which
have been divided into fourteen separate stages which make up the
spermatogenic cycle (Leblond and Clermont, 1952). In humans the
spermatogenic cycle comprises of six recognisable stages (see Figure 1.2). In
the human, up to three different stages can be observed in a single cross section
and the arrangement of stages appears to be helical (Schulze and Rehder.,
1984). In contrast, in the rat and most other species the asegmental
arrangement of stages along the epithelium results in a single stage observed
per cross section (reviewed in (Sharpe, 1994).
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Figure 1.1: A schematic illustration of a Sertoli cell and its associated germ
cells at stage VII of the spermatogenic cycle. Figure shows the cellular
associations of a seminiferous tubule at stage VII of the spermatogenic cycle
and the interstitial space with which it is in contact. (Adapted from (Sharpe,
1994).
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Figure 1.2: The spermatogenic cycles of the rat and human. The figure shows
the different stages of the spermatogenic cycle in the rat (14 stages) and in the
human (6 stages). The germ cells associated with Sertoli cells at each stage of
the cycle are shown Ai-A4, In and B = A, intermediate and B type
spermatogonia; PI, L, Z and P = preleptotene, leptotene, zygotene and
pachytene spermatocytes; 1-19 = round and elongating spermatids. (Adapted
from (Sharpe, 1994).
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1.2.1.1. Spermatogenesis
Spermatogenesis is the process whereby a diploid type A spermatogonium
undergoes a series of cellular events to become a haploid spermatozoa. In the
rat each germ cell passes through the fourteen stages of the cycle 4.5 times
prior to its release into the seminiferous lumen as a mature spermatozoon
whilst in the human the cycle is repeated 5.5 times (see figure 1.2). The whole
process of germ cell development, from the mitosis of spermatogonial stem
cells to the release of spermatids takes 56 days in the rat (Clermont and
Harvey, 1965) and approximately 70 days in humans.
The process of spermatogenesis can be considered as falling into three main
phases; firstly, proliferation of spermatogonia, secondly, meiosis to produce
haploid round spermatids and finally, spermiogenesis where round spermatids
differentiate into fully mature spermatozoa. During the first phase, a
spermatogonial stem cell divides into two cells, one enters the spermatogenic
process and the other remains a stem cell. In the rat the stem cell entering
spermatogenesis (A0 spermatogonia) undergoes six further mitotic divisions at
specific time points giving rise to Alr A2, A3, A4 and B type spermatogonia
(Clermont, 1962). The progeny of each division remain connected by
cytoplasmic bridges throughout proliferation and differentiation into
spermatozoa (Dym and Fawcett, 1971). In man the type A spermatogonia do
not undergo as many mitotic divisions as in the rat and this is believed to partly
explain the reduced efficiency of spermatogenesis observed in humans
(Paniagua et al, 1987). B type spermatogonia undergo a final mitotic division
then enter a lengthy meiotic phase as primary spermatocytes differentiating
through preleptotene, leptotene, zygotene, pachytene and diplotene phases,
consecutively. This is followed by two meiotic divisions which results in the
formation of four haploid spermatids for each original A0 spermatogonia,
assuming no germ cell degeneration has occurred (Monesi et al., 1978).
The third phase, spermiogenesis, involves the structural remodelling of the
haploid spermatid and requires acrosome development, nuclear condensation
and elongation followed by elimination of the cytoplasm (Parvinen and
Ruokonen, 1982). Reduction of cytoplasmic volume is accomplished mainly by
the elimination of water from the cell via membrane pumps (Sprando and
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Russell, 1987). Specialised structures formed between the Sertoli cells and the
head region of late spermatids (tubular lobular complexes) are known to play a
role in cytoplasmic elimination.
1.2.1.2. Sertoli Cells
Sertoli cells are the only somatic cellular component of the seminiferous
epithelium. In the adult testis Sertoli cells are tall, columnar and stellate in
appearance with their base attached to the basement membrane of the
seminiferous epithelium and their apex reaching to the tubular lumen. Mature
Sertoli cells provide both physical and nutritive support to developing germ
cells via the numerous lateral and apical veil like processes extending between
and around every germ cell (Russell, 1993b). Germ cells are dependent on
lactate from the Sertoli cells for energy metabolism as they are unable to utilise
glucose directly (Jutte et al., 1982). The low levels of rough endoplasmic
reticulum and storage granules within their cytoplasm appear contradictory to
the secretory role of Sertoli cells. However Bardin (1994) (Bardin et al., 1994)
has proposed that this is because Sertoli cell proteins are secreted immediately
following synthesis rather than being stored in vesicles.
Sertoli cells carry out a number of important functions within the seminiferous
tubule. Due to the presence of tight junctions between adjacent Sertoli cells (the
blood testis barrier see section 1.2.1.3) the meiotic germ cells located within the
adluminal compartment are totally dependent on factors produced or
transported by the Sertoli cells. The seminiferous tubule fluid (STF) produced
by Sertoli cells is involved in the transport of nutrients and chemical
messengers to the germ cells and spermatozoa in the adluminal compartment.
STF also enables cell-cell communication to occur within the seminiferous
epithelium and is responsible for the transport of spermatozoa into the
epididymis (for review see (Russell, 1993a). Sertoli cells are also actively
involved in the release of spermatozoa from the seminiferous epithelium.
Following disengagement of the spermatid head from the specialised
tubolobulbar complexes of the Sertoli cell, the surplus cytoplasm or residual
body is retained in the adluminal compartment and phagocytosed by the
Sertoli cell (for review see (Russell, 1993a). Sertoli cells also produce numerous
proteases which may be involved in tissue remodelling during germ cell
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movement in the seminiferous epithelium and growth factors such as
transforming growth factor (3 (TGF(3) and insulin like growth factor-1 (IGF-1)
which are known to be involved in germ cell proliferation and development
(Parvinen, 1993). Thus it is generally accepted that germ cells rely on Sertoli
cells for all their requirements for growth and differentiation. This has been
further illustrated by in vitro studies that show the poor survival of
spermatogenic cells when cultured in the absence of Sertoli cells (Tres and
Kierszenbaum, 1983).
1.2.1.3. Blood Testis Barrier
Both physiological (Vitale et al.r 1973) and morphological studies (Dym and
Fawcett, 1970) have documented the presence of a permeability barrier
surrounding seminiferous tubules of mature mammalian testis. The most
effective component of the barrier are tight junctions or desmosome like
structures present between adjacent Sertoli cells (Dym and Fawcett, 1970).
Penetration of electron dense markers from the blood vasculature into the
seminiferous tubules is partly retarded by peritubular myoid cells (de Kretser
and Kerr, 1994) and endothelial linings of blood vessels and lymphatics provide
a further partial barrier (Holash et al., 1993; Ploen and Setchell, 1992). The fluid
composition in the seminiferous tubules is dramatically different from that in
testicular lymph and blood. Free movement of proteins into the testis is
restricted by the blood testis barrier and the majority of the proteins in the
tubule fluid are secreted by the Sertoli cells (Mather et al., 1983).
The barrier also maintains a gradient of ions, small molecules and proteins
between blood and tubular fluid and sequesters the immunogenic germ cells
from the body's immune system ensuring a unique environment for the
developing germ cells (Setchell, 1980; Setchell et al., 1994). The exclusion of
small molecules from the seminiferous tubule by the blood testis barrier
protects the developing germ cells from mutagenic agents (Bardin et al., 1994).
The production of seminiferous tubule fluid (STF) also facilitates sperm
transport along the tubules towards the epididymis (Saez, 1994). The presence
of inter-Sertoli cell junctions plays an important role in maintaining the STF
filled tubular lumen of the seminiferous tubule.
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1.2.2. Interstitium
The organisation of the interstitial space is consistent with its main endocrine
function; a rich vascular supply is in close association with steroid producing
Leydig cells allowing the passage of steroids into the general circulation.
1.2.2.1. Leydig Cells
There are approximately 22 million Leydig cells /adult rat testis (Mendis-
Handagama et al, 1987) organised into continuous strings or sheets of cells
which surround the seminiferous tubules and blood vessels (Clark, 1976). They
have numerous surface projections which enable them to interact with
neighbouring Leydig cells and macrophages. The Leydig cell cytoplasm
contains a high proportion of smooth endoplasmic reticulum which together
with the numerous coated pits and vesicles found on their surface are
characteristic of a highly active steroid-producing and secreting cell (Russell,
1996). Androgens are the principal steroids secreted by the Leydig cell and
testosterone is the most important of these androgens (Saez, 1994).
1.2.2.2. Macrophages
Testicular macrophages are in close physical association with Leydig cells.
Cytoplasmic digitations extend from Leydig cells into membrane invaginations
of macrophages which suggests that these cells are functionally related
(Hutson, 1994; Miller et al., 1983). Degenerating Leydig cells are engulfed and
phagocytosed by neighbouring macrophages (Kerr et al., 1985). The latter cell
type also metabolises steroids secreted by Leydig cells (Miller et al., 1983). It is
estimated that there is one macrophage to every four Leydig cells in the rodent
testis (Hutson, 1994) and approximately 14-16% of interstitial cells are
macrophages (Niemi et al., 1986).
1.2.2.3. Vasculature
Blood vessels within the testis are the main route for transport of nutrients,
secretory products and oxygen into the testis, as well as the removal of waste
products and the transport of testicular secretory products to the rest of the
body. Testicular capillaries show differences in permeability when compared to
blood vessels in other organs. This difference in permeability is due to the
continuous unfenestrated endothelium covering the outside of the capillaries
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(Damber and Bergh, 1992a). Testicular blood flow needs to be tightly
controlled as the oxygen levels within the testes are close to those that occur
during hypoxia. Testosterone is thought to play an important role in the
control of blood flow as a positive correlation exists between testicular blood
flow and testosterone secretion (Damber and Bergh, 1992a; Setchell, 1990).
Capillaries within the testis show rhythmical variations in blood flow and this is
termed 'vasomotion' (Bergh and Damber, 1993). Testosterone effects on
testicular capillary vasomotion may be modulated via androgen receptors
expressed on blood vessel walls (Damber and Bergh, 1992b).
1.3. Hypothalamo-Pituitary-Gonadal axis
Regulation of testicular function in the adult male is under the control of the
hypothalamic-pituitary-gonadal axis comprising a classical negative feedback
system combined with local feedback loops involving paracrine and autocrine
interactions. The endocrine interactions between the pituitary and testis are
summarised in Fig 1.3. Briefly, the positive drive for the system comes from
gonadotropin-releasing-hormone (GnRH) which is secreted from the terminals
of the hypothalamic GnRH neurones. Binding of GnRH to GnRH receptors on
gonadotrophs in the anterior pituitary stimulates the release of follicle
stimulating hormone (FSH) and luteinising hormone (LH) into the circulation.
FSH and LH are members of the glycoprotein hormone family and are
heterodimeric, sharing a common a subunit but different hormone specific fi
subunits. LH interacts with specific LH receptors present on Leydig cells and
stimulates the production of testosterone (Klinefelter and Kelce, 1996). FSH
interacts with specific receptors located on Sertoli cells and there is some debate
as to whether spermatogonia also express functional receptors for FSH (FSHR)
(Baccetti et al., 1998; Rannikko et al., 1996). Ligand activation of FSHR stimulates
the production of inhibin B (Byrd et al., 1998) by Sertoli cells. Testosterone and
inhibin B diffuse into the general circulation where testosterone acts as a
negative regulator for the system by inhibiting the secretion of GnRH from the
hypothalamus which subsequently reduces production of LH by the
gonadotrophs. In addition, increased inhibin B levels in the general circulation
specifically inhibit FSH production by the anterior
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pituitary. Testosterone has also been shown to negatively regulate FSH





Figure 1.3: Endocrine interactions within the male reproductive axis.
Seminiferous tubules are represented by yellow circles and interstitial cells are
represented by orange octagons.
1.4. Fetal Development of the Testis
In mammals, the genetic sex of the embryo is determined at fertilisation, with
the inheritance of either an X or Y chromosome from the father. A female
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containing an X chromosome whilst a male phenotype develops following
fertilisation with a Y carrying sperm. Phenotypic sex is not established until the
gonads have started to develop and this occurs around midgestation in rodents
(Kaufman, 1992) whilst in humans it is observed during the first trimester
(Gustafson and Donahoe, 1994).
Gonads form within the developing urogenital system which is divided into
the pronephros, mesonephros and the metanephros. Gonadal ridges arise
from a thickening of the ventrolateral surface of each mesonephros and are
first visible on postcoital day 11.5-12.0 in the mouse, day 13-13.5 in the rat and
day 28-42 in the human (Bogan and Page, 1994; Gustafson and Donahoe, 1994;
Kaufman, 1992). Both male and female gonads are morphologically identical
and bipotential at this point of development. However a day later in the male
gonad epithelial strands extend into the underlying mesenchyme forming
rudimentary testicular cords, which later differentiate into the seminiferous
tubules. This occurs around postcoital day 13 in the mouse (Kaufman, 1992),
day 14 in the rat (Mittwoch et al., 1969) and day 42 in the human (Gustafson and
Donahoe, 1994). Within newly formed testicular cords, epithelial cells derived
from the coelomic epithelium (Karl and Capel, 1998) begin to surround the
primordial germ cells that have migrated from the wall of the yolk sac
(Chiquoine, 1954; Witschi, 1948). Almost immediately the epithelial cells begin
to express anti-Mullerian hormone (AMH) and are now recognised as Sertoli
cells (Gustafson and Donahoe, 1994). Within the next few days mesenchymal
cells between the testicular cords differentiate into steroid producing Leydig
cells (Saez, 1994). Testosterone is first detectable in fetal mouse testis on
postcoital day 14-14.5, in the rat testis on day 15.5 and in the human on day 50-
55 (Siiteri and Wilson, 1974; Warren et al., 1972; Warren et al., 1975).
Two of the somatic cell lineages present in the undifferentiated gonad have a
bipotential cell fate which is dependent on the sex of the organ formed: the
supporting cell lineage will differentiate into Sertoli cells in the male or
granulosa cells in the female, and the connective cell lineage will develop into
peritubular myoid cells or stomal cells in the male and female, respectively. It is
suggested that the sex determining gene (SRY), located on the Y chromosome,
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triggers cell fate and differentiation of Sertoli cells which in turn directs the
differentiation of other cell lineages within the gonad, along the male pathway.
1.5. Prepubertal Development of the Testis
Postnatal testicular development in mammals varies considerably between
species and is dependent upon the maturity of testis at birth and on the length
of time between birth and the acquisition of sexual maturity. In the rat
preparation of the testis for puberty commences almost immediately after
birth. In contrast, human testes change little in appearance between birth and
7-9 years of age when the spermatogenic process begins and spermatozoa are
released around 11-13 years of age (Muller and Skakkebaek, 1983).
1.5.1. Germ Cells
In the prenatal rat testis gonocytes proliferate between fetal day 14 and 16
(Hilscher et al., 1974), afterwhich cell division ceases and prespermatogonia are
held in the G1 mitotic phase (Byskov, 1986; Vergouwen et al., 1991). Mitosis of
prespermatogonia resumes around postnatal day 3 and germ cells contact the
basal lamina a day later (postnatal day 4). At the onset of spermatogenesis,
prespermatogonia differentiate into type A and type B spermatogonia and then
enter meiosis (Clermont and Perey, 1957; Vergouwen et al., 1991). A high rate
of selective degeneration of dividing germ cells occurs during the first wave of
the spermatogenic process (Russell et al., 1987) and it has been suggested that
this is related to the "inexperience" of the Sertoli cell at this time. The cell types
most usually observed to be undergoing degeneration within the pubertal
seminiferous cords are generally those cell types that are most
developmentally advanced (Russell et al., 1987).
FSH plays an important role in the initiation of spermatogenesis particularly in
the differentiation of type A spermatogonia into preleptotene spermatocytes.
Rats treated from birth with FSH antiserum have reduced numbers of
preleptotene spermatocytes and step 7-8 spermatids whilst type A
spermatogonia numbers remain unchanged (Chemes et al., 1979). Experiments
show that both FSH and LH are required for quantitatively normal
spermatogenesis (Chemes et al., 1979; Dym and Raj, 1977; Raj and Dym, 1976).
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The gonadotropins work synergistically (Russell et al, 1987), LH by stimulating
increased Leydig cell testosterone production and FSH through its direct and
indirect action on both Sertoli (for review see (Sharpe, 1994) and Leydig cells
(Kerr and Sharpe, 1985), respectively. It has been proposed that between days
20 and 40 the regulation in Sertoli cell function changes from one controlled by
FSH to one controlled by testosterone (Sharpe, 1994). Nonetheless, these
factors are thought to be required for quantitative spermatogenesis to occur in
the pubertal rat (Russell et al., 1987; Sharpe, 1994).
1.5.2. Sertoli Cells
1.5.2.1. Proliferation of Sertoli Cells
The number of Sertoli cells that proliferate during prepubertal development is
critical to the ultimate spermatogenic potential of the adult testis due to the fact
that Sertoli cells can only support a finite number of germ cells as they progress
through the spermatogenic cycle (Russell and Peterson , 1984; Russell et al.,
1990). Using cytosine arabinoside, an antimitotic drug, Orth et al. (1988)
significantly reduced the level of Sertoli cell proliferation in neonatal rats. As a
result of treatment Sertoli cell numbers were reduced by 54% and they
observed that the number of round spermatids was reduced by 55% in the
seminiferous tubules of the treated rats after puberty. However, the number
of spermatids per Sertoli cell was identical to that in controls providing
powerful evidence that the production of normal numbers of germ cells in the
adult rat depended, in part, on the size of the Sertoli cell population that was
established during the perinatal period of life.
In the rat, Sertoli cells begin to proliferate in the testis on fetal day 16. Orth
(1982) observed that maximum Sertoli cell proliferation rates were reached by
fetal day 20 after which the percentage of Sertoli cells which incorporated 3H-
thymidine steadily decreased until day 21 and after this point dividing Sertoli
cells were no longer detectable. Therefore the greatest expansion in Sertoli cell
numbers occurs just prior to birth and proliferation is then on the decline.
Steinberger and Steinberger (1971) and Clermont and Perey (1957) found
similar results and reported that the sharpest drop in proliferation occurred
after day 10 and that no labelled Sertoli cells were observed after day 16. These
Chapter One Literature Review 15
results were further supported by work from Meachem, (1996) who observed
that incorporation of bromodeoxyuridine (BrDU) into rat Sertoli cells sharply
declined after the first 10 days of life. Cultured Sertoli cells removed from day
16 rats have been shown to incorporate tritiated thymidine but this was not
observed in vivo (Steinberger and Steinberger, 1971). In the rat the number of
Sertoli cells increases from 1.5 million/testis at birth to 30 million/testis at day
20 (Zhengwei et al, 1990).
In the rat once Sertoli cell division ceases on, or about day 16 numbers are fixed
and remain so throughout adultlife (Clermont and Perey, 1957; Steinberger and
Steinberger, 1971; Wang et al., 1989). Similar observations have been made in a
number of mammals including the mouse where Sertoli cell proliferation stops
on about day 12 with thymidine incorporation declining 100 fold between day 6
and day 12 (Kluin et al., 1984), although there are some studies which state low
levels of Sertoli cell proliferation take place in the rat as late as 5-7 weeks after
birth (Nagy, 1972).
1.5.2.2. Regulation of Sertoli Cell Number
The regulation of postnatal Sertoli cell proliferation and maturation is primarily
controlled by FSH, and thyroid hormones, respectively. Following
hemicastration of rats compensatory Sertoli cell proliferation can be observed
in the remaining testis. (Cunningham et al., 1978; Orth, 1984; Ultee-van Gessel et
al., 1985). Hemicastration is accompanied by elevated FSH levels in the blood
(Cunningham et al., 1978) and coadministration of antibodies against FSH
prevents compensatory proliferation occurring. However, if hemicastration is
carried out after the main period of Sertoli cell proliferation there is no further
increase in Sertoli cell number (Orth, 1984). Meachem et al., 1996 examined the
effect of recombinant FSH on postnatal Sertoli cell proliferation and reported
that a significant increase in Sertoli cell number occurred following neonatal
FSH administration. However the duration of proliferative activity was
unaffected by FSH. In vitro studies show that administration of FSH to Sertoli
cells increases mitotic activity and incorporation of 3H thymidine. The response
to FSH is greatest in cells removed from day 10 or younger rats (Griswold et al.,
1977; Solari and Fritz, 1978). FSH receptors are first detectable in fetal rat
Sertoli cells on fetal day 17.5 and reach maximal levels by fetal day 20-21, a time
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when Sertoli cell proliferation is at its maximal rate (Warren et al., 1984). FSH
receptor levels in the testis remain constant during the period of Sertoli cell
mitosis and the number of receptors increases with subsequent Sertoli cell
maturation (Bortolussi et al., 1990).
Thyroid hormones have been shown to play a critical role in 'kick-starting' the
onset of Sertoli cell maturation and this in turn affects the duration of Sertoli cell
proliferation. Neonatal hypothyroidism induced by the administration of 6-N-
propyl-2-thiouracil (PTU) causes retardation of functional and morphological
differentiation of Sertoli cell and prolongs the period of Sertoli cell replication.
The net result is a significant increase in the number of Sertoli cells and
consequently macroorchidism. (Hess and Cooke, 1992; Kirby et al., 1992; van
Haaster et al., 1992). The reverse situation occurs with neonatal administration
of triidothyronine (T3) which causes hyperthyroidism. Van Haaster and
coworkers (1993) treated newborn rats with T3 for 16 days. By the end of the
first week of life Sertoli cell proliferation had sharply decreased and on day 12
mitosis had stopped completely. This resulted in a 50% decrease in Sertoli
numbers when compared to controls. Thyroid hormones are believed to act
directly on Sertoli cells via receptors which are expressed at high levels during
fetal and neonatal life. Receptor levels then decline during Sertoli cell
maturation (van Haaster et al., 1993). Thyroid hormones have been shown to
stimulate functional maturation of Sertoli cells in culture (Palmero et al., 1989;
Palmero et al., 1990). Therefore low T3 levels delay Sertoli differentiation and
extend the period of proliferation whilst high T3 levels accelerate the process of
maturation. Thyroid hormones have been shown to increase metabolic
processes in isolated immature Sertoli cells and it has been suggested that T3
simply increases the metabolic activity of Sertoli cells in preparation for the
onset of spermatogenesis (Ulisse et al., 1992).
A number of growth factors have been shown to influence Sertoli cell
proliferation. Epidermal growth factor (EGF), fibroblast growth factor (FGF),
insulin and insulin like growth factor-1 (IGF-1) have mitogenic effects on
immature porcine Sertoli cells (Jaillard et al., 1987). Glial cell line derived
neurotropic factor (GDNF) is highly expressed in the testis during postpuberal
development. Coadministration of GDNF with FSH causes a dramatic increase
Chapter One Literature Review 2 7
in the rate of replication of immature rat Sertoli cells (Hu et al, 1999). FSH also
works synergistically with activin to increase proliferation of Sertoli cells
removed from day 9 rats. However this effect did not occur in cells recovered
from day 18 rats (Boitani et al., 1995). Inhibin B on the other hand is thought to
have a negative autocrine effect on Sertoli cell replication via an inhibitory
action on pituitary FSH secretion. FSH stimulates the secretion of inhibin B by
Sertoli cells and intratesticular inhibin levels are maximal during the period
when Sertoli cells are mitotically active; levels decrease thereafter (for review
see (Sharpe, 1994).
The opiate peptide (3-endorphin has also been shown to have a proliferative
effect on Sertoli cells. Administration of opiate antagonists to immature testis
had a suppressive effect on replicating Sertoli cells and their function (Kilpatrick
and Rosenthal, 1986; Orth, 1986; Orth and Boehm, 1990). This is thought to be
mediated by a direct action on opiate receptors expressed by Sertoli cells
(Fabbri et al., 1985). (3-endorphin is secreted by Leydig cells (Fabbri et al., 1988)
and in vitro studies have shown a tropic effect of Leydig cells when cocultured
with immature porcine Sertoli cells (Reventos et al., 1989). It has therefore been
suggested that Leydig cell secretion of (^-endorphin can act as a paracrine
regulator of Sertoli cell proliferation during the neonatal period.
A number of other genes have been proposed as being involved in Sertoli cell
replication. For example, the fragile X mental retardation gene (FMR-1) which
is silenced in patients with fragile X syndrome is associated with development
of macroorchidism. In studies on mice Slegenhorst-Eegdeman et al. (1998)
found that the FMR-1 gene acted as a 'brake' on the rate of Sertoli cell
proliferation. Notably, Fmr-1 knock out mice had an increased rate of Sertoli
cell proliferation and this was not associated with an increase in FSH or FSHR
levels. Chubb (1992) suggested that there are at least two other autosomal
testis-size determining genes which control testis size by regulating Sertoli cell
numbers.
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1.5.2.3. Maturation of Sertoli Cells
During postnatal development Sertoli cells undergo structural and functional
changes some of which are related to general cellular maturation, other
changes are transitional and restricted to prepubertal Sertoli cells only. As
development progresses the volume of the individual Sertoli cell increases:
between day 19 and day 26 rat Sertoli cell volume is doubled and this is
associated with a significant increase in cell surface area. In the human testis
there is an eight fold increase in cell volume during postnatal development.
This increase in volume is mainly due to a large expansion in cytoplasmic
volume which is accompanied by extensive development of smooth
endoplasmic reticulum, golgi apparatus and mitochondria. Sertoli cells become
elongated and develop finger like cytoplasmic extensions. Concurrent with the
onset of spermatogenesis these elaborate cytoplasmic processes are further
developed until they extend from the tubule base to the lumen thus enabling
Sertoli cells to reach the increasing layers of germ cells. Cytoplasmic processes
also extend to contact neighbouring Sertoli cells allowing communication to
occur between adjacent cells. Once Sertoli cells have ceased dividing, the
nuclear volume and nuclear surface area significantly increased as the Sertoli
cells continue to mature (Gondos and Berndston, 1994). An associated rise in
RNA:DNA ratio is observed in Sertoli nuclei between days 19 and 26 (Lamb et
al., 1982). At the same time there is an increase in cellular protein:DNA ratio
and this again is indicative of a maturing Sertoli cell (Sanborn et al., 1986).
1.5.2.4. Formation of the Blood-Testes Barrier
Another indicator of Sertoli cell maturation is the establishment of occluding
tight junctions between Sertoli cells. These inter Sertoli cell junctions are major
contributors to the blood-testes barrier and appear between adjacent Sertoli
cells near to the basal lamina. In different species the timing of inter-Sertoli cell
junction formation is dependent upon the onset of puberty. Thus in humans it
occurs between 11 and 14 years (Nistal and Paniagua, 1983; Schukze, 1984)
whilst in the rat there is gradual restricted penetration of tracers into the
tubular lumen between day 16 to 19. Inter-Sertoli cell junction formation in the
rat therefore occurs at the same time as Sertoli cell maturation begins (Hinton
and Setchell, 1993; Russell et al., 1989).
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Tight junction formation begins once Sertoli cells have ceased dividing and
have started the process of differentiation. If maturation is delayed as happens
during hypothyroidism, occluding junction formation is also delayed and the
blood testis barrier is not formed until Sertoli cells have ceased proliferating
around day 30 (van Haaster et al., 1992). The reverse situation occurs during
hyperthyroidism where the formation of the blood testis barrier is observed as
early as day 12 and this is in association with the early onset of
spermatogenesis and cessation of Sertoli cell mitosis (van Haaster et al., 1993).
The appearance of the tubule lumen occurs at around the same time as
formation of inter-Sertoli cell junctions. Lumen formation is dependent upon
seminiferous tubule fluid (STF) secretion by the Sertoli cell. STF is essential for
normal spermatogenesis as it represents the main route by which nutrients and
information are passed to the developing germ cells from the Sertoli cell and
the basal compartment (Hinton and Setchell, 1993). Increasing testosterone
levels and the appearance of elongate spermatids are believed to play a role in
increasing STF production (Jegou et al., 1984; Sharpe, 1989) but it has also been
suggested that increased STF secretion simply reflects the increased activity of
Sertoli cells during puberty (Sharpe, 1994).
Associated with Sertoli cell maturation is a down regulation in functions linked
to the fetal/neonatal period of life including a decrease in AMH production and
aromatisation of testosterone into oestrogen (Kuroda et al., 1990; Rosselli and
Skinner, 1992) coupled with an upregulation in functions predominantly
associated with Sertoli cells in adulthood e.g. secretion of STF (Jegou et al.,
1983). These changes are concurrent with a progressive switch from mainly
FSH modulation to mainly testosterone modulation. The control of this
process is not fully understood. However increased numbers of germ cells
have been shown to reduce the responsiveness of Sertoli cells to FSH in vitro
(le Magueresse and Jegou, 1988) and FSH has been shown to increase
expression of AR (Blok et al., 1992; Verhoeven and Caillaeu, 1988).
1.5.3. Leydig Cells
It is generally accepted that Leydig cell differentiation in the rodent testis
involves differentiation of both fetal- and adult-type Leydig cells. Fetal type
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Leydig cells are responsible for masculinisation of primary sexual characteristics
during fetal and neonatal life and the adult type population is responsible for
pubertal masculinisation. The pig and human male have triphasic patterns of
Leydig cell differentiation which comprise of fetal, pubertal and adult type
Leydig cell populations (Prince, 1990; Whitehead, 1905).
In the rat, fetal type Leydig cells originate from somatic mesenchymal cells
which start to differentiate and produce testosterone around fetal day 15.5.
After birth a few fetal type Leydig cells may persist as a stable population
through postnatal life (Mendis-Handagama et al, 1987). However the relative
number and cell volume of fetal type cells is reduced in the first two weeks of
postnatal development.
Adult type Leydig cells differentiate from peritubular mesenchymal cells
(Ariyaratne et al., 2000) and Leydig cell progenitors are first seen in the
postnatal testis of the rat around day 10 (Saez, 1994). Thereafter they undergo
rapid proliferation which begins to slow down on postnatal day 14. At this
time Hardy et al (1989) observed the start of morphological and functional
differentiation of Leydig cell progenitors into adult type Leydig cells. This
process occurred between postnatal days 14-28 and was linked to increased
cellular production of steroidogenic enzymes and LH receptors. After day 28
Leydig cells become morphologically indistinguishable from adult type cells.
Both thyroid hormone and androgens play critical roles in the differentiation,
but not the proliferation of Leydig cell precursors into mature type Leydig cells
(for review see(Ge et al., 1996) whilst LH delays the onset of mesenchymal cell
differentiation into Leydig cells (Ariyaratne et al., 2000).
Oestrogen has been shown to have an inhibitory effect on both neonatal
Leydig cell proliferation and development (Abney and Carswell, 1986; Abney
and Myers, 1991). Both precursor and mature Leydig cells express oestrogen
receptor alpha (ERa) mRNA. However between days 10 and 21
ERa mRNA levels in the progenitor Leydig cells are greatly reduced. This
decline occurs at the same time as a decline in oestrogen production by Sertoli
cells and it has been proposed that this decrease in oestrogen production allows
precursor Leydig cells to undergo proliferation and differentiation (Zhai et al.,
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1996). Adult type Leydig cells synthesise oestrogen which may prevent further
proliferation and limit Leydig cell population growth in the adult testis (Sharpe,
1993).
1.5.4. Other Interstitial Cells and Vasculature
1.5.4.1. Macrophages
Macrophages are first detected in the fetal rat interstitium on day 19 (Hutson,
1990). After birth their rate of proliferation increases resulting in a large
expansion in macrophage number and volume by the third week of life. A
further rise in cell division and an increase in cell size results in a 15-20 fold
increase in macrophage volume by day 47 (Hardy et al., 1989; Hutson, 1990;
Mendis-Handagama et al., 1987). Raburn et al. (1991) have proposed that the
postnatal increase in macrophage proliferation is induced by LH.
1.5.4.2. Peritubular Myoid Cells
The majority of myoid cell proliferation takes place in the fetal testes and the
rate of proliferation gradually declines during the first four weeks of life.
Before birth, myoid cells are in contact with the basal lamina of the
seminiferous cords and the myoid cells become elongated along the basal
membrane during postnatal life. As cytodifferentiation takes place, myoid cells
become flatter with an expanded cytoplasm and a squamous appearance
resulting in an increase in the peritubular surface (Palombi et al., 1992;
Vergouwen et al., 1991). Palombi et al (1992), have suggested that myoid cell
maturation occurs early during postnatal life with the expression of known
contractile cell markers and changes in cytoarchitecture finalised by the third
week of life in rats. It is thought that differentiation of myoid cells is in part due
to androgen action (Skinner, 1991).
1.5.4.3. Vasculature
In the fetal testis the majority of the vasculature consists of small blood vessels.
As development progresses larger blood vessels begin to develop associated
with an increase in the proliferation of endothelial, perivascular and vascular
muscle cells during the first two weeks of postnatal development (Mendis-
Handagama et al., 1987; Vergouwen et al., 1991). As a result, the absolute
volume of vasculature in the mature testis is 100 fold greater than at birth. At
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puberty, capillaries in the rat testis develop a high level of alkaline phosphotase
activity, express receptors for IGF-1 and around day 30 there is a large increase
in capillary permeability to albumin and y-globulin (Setchell et al., 1994). Both
connective tissue and lymphatic endothelial cells within the interstitium follow a
similar pattern of development (Mendis-Handagama et al., 1987; Vergouwen et
al., 1991).
1.5.5. Paracrine Interactions in the Prepubertal Testis
During prepubertal development numerous paracrine interactions occur
between all cell types in the testis. For example, Sertoli cells mediate the effects
of FSH on Leydig cell differentiation (Kerr and Sharpe, 1985) as well as
functionally enhancing Leydig cell responses to LFI (Chen et al., 1976; Chen et
al., 1977). Some of the paracrine interactions between Sertoli and Leydig cells
have been documented. For example, DNA synthesis in Leydig cell
progenitors is stimulated by a 30kDa protein secreted by immature Sertoli cells
following stimulation with FSH and testosterone (Ojeifo et al., 1990). In
addition, Mendis-Handagama et al. (1998) and Teerds et al. (1998) have shown
that thyroid hormones trigger the differentiation of mesenchymal cells into
progenitor/immature Leydig cells. Thyroid hormone receptors have been
detected in Sertoli cells but not in Leydig cells during neonatal development
suggesting that the observed effects are indirect and that they could be
mediated via the Sertoli cells.
FSH also appears to upregulate the steroidogenic activity of Leydig cells by
stimulating the production of paracrine factors by Sertoli cells. For example,
FSH increases LH receptor numbers and testosterone production (Kerr and
Sharpe, 1985; Vinko et al., 1991) through an increase in the activity of various
steroidogenic enzymes (O'Shaughnessy et al., 1992). These effects may in part
be mediated via insulin like growth factor (IGF-1) as FSH has been shown to
increase the production of IGF by Sertoli cells and levels of IGF-1 receptors in
Leydig cells increase following exposure to LH. In addition, IGF-1 increases LH
receptor numbers in Leydig cells and further upregulates steroidogenic
enzyme levels (Saez, 1994). Immature Leydig cells cocultured with different
quantities of Sertoli cells show a 'dose dependent' upregulation in testosterone
synthesis (Perrard-Sapori et al., 1987). Both tissue inhibitor of
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metalloproteinase-1 (TIMP-1) and CP-2 have been isolated from FSH
conditioned Sertoli cell media and shown to stimulate testosterone production
in cocultured Leydig cells (Boujrad et al., 1995).
Conversely, Leydig cells have a trophic effect on cultured immature Sertoli cells
which could be via paracrine factors (Reventos et al., 1989). In addition
peritubular myoid cells have been shown to secrete factors which stimulate
transferrin secretion by cultured immature Sertoli cells (Norton and Skinner,
1989). Peritubular myoid cells also regulate Sertoli cell morphology by the
secretion of extracellular matrix factors (Anthony and Skinner, 1989). Different
germ cell types also alter Sertoli cell function in vitro. Sertoli cell secretion of
plasminogen activator is upregulated in the presence of preleptotene
spermatocytes and secretion levels are maximal with the onset of meiotic
activity (Vihko et al., 1986). Sertoli cells isolated from day 20 rats have increased
androgen binding protein secretion following stimulation by various germ cell
types (le Magueresse et al., 1986) and FSH stimulated oestrogen secretion by
immature rat Sertoli cells in culture is inhibited by cocultured germ cells (le
Magueresse and Jegou, 1988).
Thus the developing postnatal testis is a very dynamic organ requiring tight
regulation of maturation in which the proliferating and differentiating Sertoli
cell plays a vital role in Leydig cell differentiation and 'preparation' of the testis
for the onset of spermatogenesis.
1.5.6. Steroid Production in the Prepubertal Testis
1.5.6.1. Testosterone
In the testis, Leydig cells are the main and probably the only site of androgen
synthesis. The first step in androgen biosynthesis is the conversion of
cholesterol into pregnenolone which is carried out by the enzyme cytochrome
P450 cholesterol side chain cleavage (P450scc) (see Figure 1.4). This is the rate
limiting step of testosterone production and takes place on the inner
membrane of mitochondria. Cholesterol can either be obtained by de novo
synthesis from acetate or can be transported into the Leydig cell by lipoprotein
and is then ferried to the outer mitochondrial membrane by the sterol carrier
protein (SCP2) (Saez, 1994; Stocco and Clark, 1994). Rapid transfer of
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cholesterol from the outer to the inner mitochondrial membrane is carried out
by the steroidogenic acute regulatory protein (StAR) (Clark et al., 1994).
Pregnenolone is then metabolised by 3(3-hydroxysteroid dehydrogenase (3(3-
HSD) and cytochrome P450 17a- hydroxylase (P450cl7) in the smooth
endoplasmic reticulum to form the C19 steroids. Androstenedione is converted
into testosterone by 17(3 hydroxysteroid dehydrogenase (17(3 HSD).
Testosterone can be transformed into the more potent androgen, DHT by
5a-reductase or converted into oestrogen by aromatisation utilising
cytochrome P450 aromatase (P450arom) which is located in the microsomes of
Leydig cells and neonatal Sertoli cell cytoplasm (Payne and O'Shaughnessy,
1996; Saez, 1994).

















Figure 1.4: Steroid biosynthetic pathways in Leydig cells. 313-HSD, 312-
hydroxysteroid dehydrogenase; 17KSR, 17R-HSD; 5a-RED, 5a reductase.
(Adapted from (Payne and O'Shaughnessy, 1996).
During postnatal development the predominant androgens secreted by the
Leydig cells are 5a-androstene-3a, 17(1 -diol and androsterone with levels 5-8
times greater than testosterone. This is due to increased production of 5a-
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reductase by differentiating Leydig cells between days 15 and 32. Testosterone
becomes the predominant androgen secreted by the testis after day 45
(Dorrington and Khan, 1993; Moger, 1977). Isolated seminiferous tubules from
rats at all stages of development contain 5a-reductase and have the ability to
convert testosterone into DHT which can be metabolised to 5a-androstanediols
and further to androsterone. 5a-Reductase and hydroxysteroid
dehydrogenase activity have been shown to be significantly higher in tubules
from immature rats than adult rats (Dorrington and Fritz, 1975).
The synthesis of androgens by Leydig cells is regulated by LH. Receptors for
LH are coupled to adenylate cyclase and are located on the plasma membrane
of Leydig cells. An acute response to LH results in an increase in the amount of
cholesterol transported to the inner mitochondrial membrane purportedly via
an increase in levels of StAR protein (Luo et al., 1998). LH also upregulates the
activity and levels of P450cl7 (Klinefelter and Kelce, 1996). Decreased LH
levels result in atrophy of Leydig cells, a decrease in LH receptor numbers and
a loss of the ability to secrete testosterone (Saez, 1994).
A short-loop negative feedback mechanism is known to exist within the testis
such that testosterone can inhibit its own biosynthesis. Darney et al (1996)
(Darney et al., 1996) demonstrated specific, competitive binding of testosterone
to the active site of P450cl7. Negative regulation of P450cl7 by testosterone is
also mediated through the androgen receptor (Hales et al., 1987). Oestrogens
are known to suppress gonadotropin release from the pituitary which results in
a subsequent decrease in testosterone biosynthesis by the Leydig cells (Kalla et
al., 1980). Oestrogen also has a direct inhibitory affect on Leydig cell
steroidogenesis via the reduction in LH receptor levels (Saez et al., 1978) and
competitive inhibition of P450cl7 and 17J3HSD activity (Brinkman et al., 1980;
Kalla et al., 1980; Samuels et al., 1964). The oestrogen concentrations used in
these studies were nonphysiological: therefore further studies are required to
determine if physiological levels of oestrogen have a direct effect on Leydig
cell steroidogenesis.
In Sertoli cells, androgens induce a rapid but transient (15 minutes) increase in
RNA polymerase II activity followed by a further and more prolonged increase
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3 to 6 hours later. Isolated Sertoli cells that are deprived of testosterone
undergo morphological changes in nuclear and mitochondria as well as an
increase in lipid droplets and decreases in smooth endoplasmic reticulum (Dym
and Raj, 1977). In vivo, the effects of testosterone are dependent upon the
stage of Sertoli cell differentiation (Bardin et al.r 1994) and Sertoli cells have been
shown to become more responsive to testosterone with increasing cell
maturation. For example, production of STF is under the control of
testosterone in the adult rat whereas in the prepubertal testis it is under the
control of FSH. A similar change in responsiveness is true for the secretion of
androgen binding protein and the control of other Sertoli cell functions (Sharpe,
1994).
1.5.6.2. Oestrogen
The microsomal enzyme cytochrome P450 aromatase (P450arom) catalyses the
conversion of androgens to oestrogens (see Figure 1.5). The substrate for
aromatase can be either testosterone or androstenedione. Aromatase activity
can be detected in the smooth endoplasmic reticulum of cells in the liver,
kidney, brain, fat and skeletal tissue (Carreau et ah, 1999). In the testis,
expression has been observed in the Leydig cells, Sertoli cells and germ cells. In
the neonatal testes of rats and mice Sertoli cells are the main site of testosterone
aromatisation. However during puberty this role switches to Leydig cells
where the majority of aromatase activity remains thereafter (Papadopoulos et
al., 1986; Tsai-Morris et ah, 1985).









Figure 1.5: The aromatase pathway. Diagram showing conversion pathway for
aromatisation of testosterone into oestradiol. (Adapted from (Sundaram and
Kumar, 1996).
The synthesis of oestrogens in the immature Sertoli cell is primarily regulated
by FSH. In vitro studies show that in isolated rat Sertoli cells, FSH stimulated
aromatase activity decreases with increasing age. FSH induced aromatase
activity is highest in Sertoli cells from rats aged day. However by day 30 only
low levels of oestrogen are synthesised by the Sertoli cells even in the presence
of FSH (Dorrington and Armstrong, 1979). In adult rats the expression of
aromatase in Leydig cells is induced by LH. Leydig cells isolated from day 15
rats exhibit constitutive aromatase activity which becomes LH inducible by day
25 (Sundaram and Kumar, 1996).
Androgens can influence aromatase activity by serving as a substrate for
oestrogen synthesis, by inhibiting basal and FSH induced aromatase activity in
Sertoli cells (Verhoeven and Cailleau, 1988a), and by increasing P-Mod-S
activity and secretion of a 50-100 kDa protein from peritubular cells which have
both been shown to inhibit aromatase activity in Sertoli cells (Rosselli and
Skinner, 1992; Verhoeven and Cailleau, 1988b). Conditioned media from
spermatocytes, spermatids and stage VII-VIII seminiferous tubules also inhibits
Sertoli cell aromatase activity (Magueresse and Jegou, 1988).
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The physiological significance of oestrogen production in the immature testis
has remained obscure. A marked drop in plasma and testicular testosterone
concentrations is reported following 24 hour oestradiol benzoate treatment.
However, LH levels remain unchanged. Thus it has been proposed that direct
inhibition of testosterone production in Leydig cells by oestradiol is taking
place. It is possible that the release of oestradiol from Sertoli cells prior to the
onset of puberty serves to suppress the synthesis of androgens by Leydig cells
thus holding back the onset of spermatogenesis until Sertoli cells are
undergoing maturation (Dorrington and Khan, 1993).
A direct correlation between oestrogen concentrations and Sertoli cell mitotic
activity has been demonstrated and it is notable that oestrogen stimulates DNA
synthesis in cultured granulosa cells from immature rats. Oestradiol is thought
to stimulate the production of TGF-(3 which interacts with FSH to promote the
progression of the granulosa cells through the G1 phase of the cell cycle. FSH
and TGF-P act synergistically in isolated Sertoli cells from day 10 rats to increase
DNA synthesis and oestrogen is known to increase Sertoli cell secretion of TGF-
(3 in immature pigs. It has been proposed that in the immature animal FSH acts
to stimulate the synthesis of oestradiol via increased aromatase levels in Sertoli
cells. Increased levels of oestradiol in turn stimulate secretion of TGF-(3 which
together with FSH upregulates the mitotic activity of Sertoli cells. The decline
in Sertoli cell responsiveness to FSH parallels a decrease in aromatase activity
and oestrogen secretion is associated with a decline in TGF-p production and a
consequent decline in mitotic activity of Sertoli cells (Dorrington and Khan,
1993).
Female mice deficient in aromatase (ArKO) due to targeted disruption of the
aromatase gene are infertile. However male ArKO mice are fully fertile and
have markedly elevated testosterone levels; the number of Sertoli cells has not
been determined (Fisher et al., 1998a).
1.5.7. Steroid Receptors in the Prepubertal Sertoli Cell
Modulation of cell function by steroids is mediated via specific intracellular
receptors which are expressed in steroid target tissues (Carson-Jurnica et al.,
1990; Evans, 1988). All members of the steroid receptor superfamily share a
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common arrangement of five structure-function domains (A-F) (reviewed by
(Evans, 1988). The highly conserved DNA binding domain (C) is involved in
DNA binding and receptor dimerisation, a less well conserved ligand binding
domain (E) contains regions involved in ligand binding, receptor dimerisation,
nuclear localisation and also interacts with transcription cofactors, the A/B and
F domains at the N and C termini respectively, are involved in transactivation
and the D region acts as a hinge contributing to the flexibility of the receptor
and influencing DNA binding. Following ligand binding, steroid receptors
form dimers. The steroid-ligand dimer regulates gene transcription through
binding to specific sequences in the regulatory regions of target genes. These
specific sequences are called response elements (reviewed in (Carson-Jurnica et
al., 1990; Evans, 1988).
1.5.7.1. Androgen Receptor (AR)
Androgen action is carried out in target tissues via binding to a specific AR
encoded by a single gene on the X-chromosome (Chang et al., 1988; Lubahn et al.,
1988). Immunoexpression of AR in the testis is restricted to nuclei of Sertoli
cells and interstitial cells which include peritubular myoid cells, Leydig cells and
vascular endothelial cells (Bremner et al., 1994). It is generally agreed that germ
cells do not immunoexpress AR protein. AR is first expressed in the fetal rat
testis and is immunolocalised to interstitial cells however significant nuclear
staining is not seen in Leydig or Sertoli cells during fetal life (Majdic et al., 1995).
In immature rats, peritubular myoid cell immunostaining is abundant in day 5
testis, AR immunoexpression is also detected in Sertoli cells at this age and the
intensity of staining increases with increasing age. AR immunoexpression in
Sertoli cells becomes stage dependent between days 21 and 35. Thus stage
specificity is acquired during normal development as spermatogenesis matures
(Bremner et al., 1994).
The distribution of AR in the seminiferous tubule as determined by
immunocytochemistry is in agreement with ligand binding measurements of
AR and with in vivo studies where AR has been detected in isolated Sertoli cells,
peritubular myoid cells and Leydig cells. Levels of AR are higher in Sertoli cells
cultured from day 35 rat testis than Sertoli cells obtained from day 15 rats (Sar
etal, 1993).
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Concentrations of AR in cultured Sertoli cells from day 19 rat testis increase 3-4
fold following FSH and testosterone administration. The effects of testosterone
and FSH are additive. FSH also increases the abundance of AR mRNA and
increases AR protein levels in the immature testis (for review see (Sar et ah,
1993). Androgen stimulates AR levels in immature Leydig cells but is without
effect in adult Leydig cells. Conversely, AR levels in adult Sertoli cells are
upregulated in response to androgen stimulation but levels remain unchanged
in immature Sertoli cells (Shan et al., 1997). Following rat neonatal
oestrogenisation, Sertoli cell expression levels of both AR mRNA and protein
are reduced (Sharpe et al., 1998; Tena-Sempere et al., 2000). These changes are
not solely caused by decreases in gonadotropin levels suggesting that
oestrogen has a direct inhibitory effect on Sertoli cell AR expression in the
prepubertal rat testis. Alteration of normal germ cell complement in the
mature rat testis does not modify levels of AR protein detected by
immunohistochemistry (Bremner et al., 1994).
1.5.7.2. Oestrogen receptor beta (ER(3)
There are two subtypes of oestrogen receptor (ER), alpha (ERa) and beta
(ERP). The classical ERa first discovered in 1958 and cloned in 1986 (Green et al.,
1986) was for many years believed to be the only ER to existence. However in
1996 a second ER (ERP, (Kuiper et al., 1996)) was cloned from rat prostate. In
mammals, both receptors have the greatest homology in the DNA binding
domain (97% amino acid identity) and the ligand binding domain (59% amino
acid identity) (Enmark et al., 1997; Kuiper et al., 1996). Overall the degree of
homology between the two receptors is quite low apart from within the DNA
binding domain and they are encoded on separate chromosomes (Enmark et al.,
1997). In the rat additional mRNA splice variants of ERP have been found
which contain an insertion in the ligand binding domain (ERP2) (Chu and
Fuller, 1997; Peterson et al., 1998).
In vitro studies have shown both receptor subtypes have similar affinities for a
wide range of ligands including some synthetic oestrogens. However
Scatchard analysis indicates that ERP has a lower affinity for oestradiol than
ERa. In contrast ERP binds the 'environmental oestrogens' methoxychlor and
bisphenol A in addition to the phytoestrogens genistein and coumestrol with
Chapter One Literature Review 32
considerably higher affinity than ERa (Kuiper et al., 1998). If both subtypes of
ER are present in a single cell type following interaction with the ligand it is
possible that receptors form homodimers (ERa-ERa or ERP-ERP) or
heterodimers (ERa-ER(3) (Cowley et al., 1997). The two homodimers, when
complexed with oestradiol or certain anti-oestrogens, may signal in opposite
ways following interaction with Fos and Jun proteins which modulate gene
activation via an AP-1 site. Studies in vitro have shown that ERa, and
17P oestradiol activate transcription of a reporter construct whereas ER(3 and
17(l-oestradiol inhibit transcription. Moreover the antioestrogens tamoxifen,
raloxifene and ICI164384 are potent transcriptional activators with ERP at API
sites (Paech et al., 1997).
ERP mRNA has been detected by reverse transcription PCR analysis in a range
of rat tissues including the testis, pituitary, ovary, uterus, bladder, brain, lung,
thymus and heart (Kuiper et al., 1997). ERR mRNA has also been detected in
adult male rat efferent ducts, prostate, vas deferens and all regions of the
epididymis. Immunohistochemical studies have shown that ERR protein is
widely expressed in a number of tissues, although highest levels appear to be in
granulosa cells of the ovary (Saunders et al., 1997). In the adult rat testis ERR is
immunoexpressed in Sertoli cells, Leydig cells and some germ cells types
(spermatocytes and spermatogonia) (Saunders et al., 1998; van Pelt et al., 1999).
Pelletier et al., (2000) found ERR expression restricted to Sertoli cell nuclei in
adult rat testis. In addition ERa expression was localised to the nuclei of mature
Leydig cells, round spermatocytes and spermatids. This is in disagreement
with other studies where testicular ERa protein expression is restricted to
interstitial cells in the rat (Fisher et al., 1997).
When this study was started ERP had only recently been cloned and therefore
very little information regarding expression and regulation of ERP during
development was known. Studies within the Unit demonstrated that ERR was
expressed in fetal gonocytes (Saunders et al., 1998) and this was confirmed by
van Pelt et al., (1999) who detected ERR mRNA and protein in gonocytes and
Sertoli cells in day 4 rat testis. In neonatal and immature rat testes ERR protein
has been detected in Sertoli cells, Leydig cells, peritubular cells and
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spermatogonia (Saunders et al., 1998; van Pelt et ai, 1999). This pattern of ERfi
expression indicates that oestrogens can directly affect germ cells during
testicular development and the first wave of spermatogenesis. In mice ER(1
mRNA levels in testis have been reported to peak by day 12 and then decrease
to undetectable levels by day 26 and ER(3 protein has only been
immunolocalised to neonatal spermatocytes (Jefferson et al., 2000).
Neonatal exposure to oestrogen differentially alters testicular expression of
ERa and ER(3 mRNA levels in the developing rat. ERa mRNA levels are
significantly reduced following oestradiol benzoate administration whereas
expression levels of ER(3 mRNA directly increase during postnatal/prepubertal
development following neonatal oestrogen benzoate exposure (Tena-Sempere
et al., 2000). These changes in oestrogen receptor expression levels are not
solely attributable to oestrogen-induced decreases in gonadotropin secretion
during the critical period of neonatal differentiation (Tena-Sempere et al., 2000).
This work strongly suggests that neonatal oestrogen administration causes an
increase in ER(1 mRNA levels by acting directly on the developing testis.
Transgenic male mice with targeted disruption of the ERa gene (ERKO) are
infertile indicating that ERa plays an essential role in the regulation of male
reproduction. Adult ERKO mice have significantly fewer epididymal sperm
than heterozygous or wild-type males. Spermatogenesis is present in some
seminiferous tubules of 3-5 month old ERKO males. However other tubules
either have a dilated lumen and a disorganised seminiferous epithelium with
few spermatogenic cells or tubules lack a lumen and contain mainly Sertoli cells.
There are no obvious differences between the seminiferous tubules of day 10
wild-type and ERKO mice but the lumen in ERKO males is dilated in all
seminiferous tubules by day 20. Serum testosterone levels are elevated
whereas gonadotropin levels are unaffected in the ERKO mouse when
compared to wild type. Sperm from adult ERKO mice have reduced motility
and are unable to fertilise an egg in vitro. In addition mutation of the ERa gene
alters normal male sexual behaviour leading to reduced mating frequency. It
has been proposed that lower sperm concentrations in ERKO mice are caused
by dilation of the seminiferous tubules due to a reduction in fluid resorption in
Chapter One Literature Review 34
the efferent ducts and epididymis (Hess et al., 1997) and such dilation inhibits
and disrupts spermatogenesis (Eddy et al., 1996).
Furthermore it has been proposed that ERa does not regulate genes expressed
in germ cells but affects sperm function indirectly through somatic cells which
support spermatogenesis and/or epididymal maturation. In the mouse
transplantation studies have demonstrated that germ cells do not need to
express ERa for normal development or for functioning during fertilisation
(Mahato et al., 2000).
Transgenic mice that lack ER(1 expression have also been generated (BERKO)
(Krege et al., 1998). These transgenic mice develop normally and are
indistinguishable grossly and histologically as young adults from wild type
mice. Female BERKO mice have reduced fertility whilst there are no overt
abnormalities in the male BERKO mice and reproduction is normal. Thus ER(3
is proposed to be essential for normal ovulation efficiency but is not essential
for female or male sexual differentiation or fertility. ERa but not aromatase or
ER(3 is essential for normal male fertility and sexual behaviour (Krege et al.,
1998). It has been proposed that ER|3 plays a role in the fine timing of
oestrogen actions on testicular function (Carreau et al., 1999).
1.5.8. Gene expression during Prepubertal Development
1.5.8.1. Follicle Stimulating Hormone (FSH)
FSH is produced by the anterior pituitary. mRNA transcripts for both FSH
subunits have also been located in spermatocytes, spermatogonia and round
spermatids suggesting possible paracrine roles for FSH in the testis (Baccetti et
al., 1998; Markkula et al., 1995). In vivo and in vitro experiments have
established an essential role for FSH in Sertoli cell mitosis which takes place
during fetal life and the first two weeks of postnatal life. In prepubertal rat
testis FSH is also essential for final Sertoli cell maturation which includes
formation of the blood testis barrier and the initiation of the first wave of
spermatogenesis (Posalaky et al., 1981; Solari and Fritz, 1978). FSH also
differentially stimulates Sertoli cell synthesis of inhibin and SGP-1 (Sanborn et
al., 1986).
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1.5.8.2. Follicle Stimulating Hormone Receptor (FSHR)
The biological action of FSH is initiated when FSH interacts with the FSH
receptor (FSHR). It is generally accepted that FSHR expression in the male is
restricted to Sertoli cells (Griswold, 1993). However there is limited evidence
indicating FSHR are expressed by spermatogonia (Orth and Christensen, 1978).
Full length FSHR mRNA is first detected in rat testis on fetal day 16.5 and
specific FSH binding can be observed in fetal rat testis from day 17.5 onwards
(Rannikki et ah, 1995; Warren et al., 1984). FSHR mRNA can be detected in the
postnatal testis and isolated Sertoli cells from rats aged between day 10 and
adulthood (Heckert and Griswold, 1991). As with other polypeptide hormone
receptors the FSHR has an extracellular N-terminal portion, seven
transmembrane helices and an intracellular C terminal region which interacts
with a Gs protein. Binding of FSH to FSHR activates the Gs protein which in
turn activates adenylate cyclase, cAMP levels increase with a subsequent
increase in protein kinase activity (for review see (Griswold, 1993). The overall
response of Sertoli cells to FSH is complex. Increased levels of protein kinase A
(PKA) result in an increase in the phosphorylation of Sertoli cell proteins. In
addition increased PKA levels upregulate phosphorylation of transcription
factors e.g. CREB, which in turn regulate transcription of specific Sertoli cell
genes which contain cAMP response elements in their promoter regions
(Griswold, 1993). Almost simultaneous with increased cAMP levels there is an
observed increase in mRNA levels of the proto-oncogene cfos. Upregulation of
cfos takes place within 15 minutes of FSH administration in cultured immature
Sertoli cells. Thus FSH has immediate effects on Sertoli cell gene transcription
as well as effects which are measurable within hours, such as the synthesis of
specific Sertoli cell proteins e.g. inhibin, SGP-1 (for review see (Griswold, 1993)
and Sertoli cell specific mRNA transcripts e.g. LRPR1 (Slegtenhorst-Eegdeman
et al., 1995). Resulting from the plethora of events which take place following
FSH binding to FSHR it is difficult to determine which factors are regulated
directly by FSH and which are regulated by secondary events.
Alongside Sertoli cell maturation, changes in the primary functions of FSH in
Sertoli cells also arise. Phosphodiesterase (PDE) degrades cAMP into AMP.
Both in vivo and in vitro research has shown an increase in PDE activity takes
place following FSH administration to immature rats and Sertoli cells isolated
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from prepubertal rats (Griswold, 1993). Levels of PDE in Sertoli cells have been
shown to increase with increasing age such that Sertoli cells become less
responsive or refractory to FSH stimulation. A marked fall in FSH-stimulated
cyclic AMP production even in the presence of a phosphodiesterase inhibitor is
observed with advancing age (Steinberger et al., 1978). The decline in Sertoli
cell responsiveness to FSH correlates with the age related diminishing effects of
FSH in the testis such that by day 25 the responsiveness of the testis to FSH has
already undergone a significant decline (Means et al., 1980).
FSH responsiveness in cultured Sertoli cells also decreases when Sertoli cells are
cocultured with pachytene spermatocytes and round spermatids (Griswold,
1993). As the responsiveness of the Sertoli cell to FSH declines during early
puberty, responsiveness of Sertoli cells to testosterone increases. This is partly
mediated by an increase in androgen receptors which is itself stimulated by
FSH. In the adult rat testosterone is the major regulator of FSH secretion
having taken over the prepubertal regulation of FSH secretion from inhibin B
(Sharpe, 1994).
1.5.8.3. SGP-1
SGP-1 is a heavily glycosylated and sulphated 70 kDa protein secreted in high
amounts by the seminiferous epithelium (Sylvester et al., 1984). SGP-1 is the rat
homologue of human prosaposin which is proteolysed into the four smaller (15
kDa) activator proteins: saposin A, B, C and D (O'Brien and Kishimoto, 1991).
Saposins are found in lysosomes and solubilise certain membrane glycolipids,
form complexes with lysosomal enzymes, and promote hydrolysis of
glycolipid substrates (Kretz et al., 1990). Sertoli cells synthesise two mature
forms of SGP-1 (Igoura and Morales, 1995): an intracellular form (65 kDa)
located to lysosomes, which is also found in the liver and spleen (O'Brien and
Kishimoto, 1991) and a secreted form which is found in several extracellular
fluids (Igoura and Morales, 1995). It is the lysosomal form of rat SGP-1 that is
broken down into the smaller 15 kDa polypeptides which correspond to
saposins (Igoura and Morales, 1995). The lysosomal form of SGP-1 is targeted
directly to the lysosomes from the Golgi apparatus.
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The lysosomes fuse with phagosomes containing cytoplasmic residual bodies
detached from spermatids during spermiation. It is proposed that saposins
play a role in the hydrolysis of membrane glycolipids present in phagocytosed
residual bodies (Igoura and Morales, 1995; Morales et al., 1998). The function of
the secreted form of SGP-1 is unclear. However the 70 kDa form does interact
with the plasma membrane of developing spermatids and is thought to act in
glycolipid transfer between Sertoli cells and developing spermatids (Morales et
al., 1995). In addition the presence of SGP-1 in a variety of biological fluids
suggests that secreted SGP-1 is also involved in the transport of lipids within
biological fluids (Morales et al., 1996).
Studies using quantitative PCR have examined changes in steady state levels of
SGP-1 mRNA in whole rat testes between the ages of postnatal day 3 and day
60. SGP-1 mRNA levels increase rapidly after birth reaching maximal levels
between days 10 and 20. A rapid decline in mRNA levels is observed thereafter
with adult levels ofmRNA similar to those in day 3 testes (Mathur et al., 1994).
A significantly lower amount of SGP-1 is secreted from immature seminiferous
tubules when compared to amounts secreted by adult seminiferous tubules
(McKinnell and Sharpe, 1997). Both in vivo and in vitro experiments have
shown that SGP-1 production by adult Sertoli cells is not regulated by germ
cells (Grima et al., 1992; Mathur et al., 1994; Sharpe et al., 1993; Stallard and
Griswold, 1990), although Sharpe et al., (1993)
observed a significant decrease in SGP-1 secretion by isolated seminiferous
tubules following co-depletion of pachytene spermatocytes and round
spermatids.
1.5.8.4. Inhibin
Inhibin is a member of the TGF(3 family of growth factors. The dimeric
glycoprotein is mainly produced by Sertoli cells in the adult testis and is able to
modulate the expression of FSH in the anterior pituitary. Inhibin is a
heterodimer composed of an a-subunit covalently linked by di-sulphide
bridges to either a PA subunit (inhibin A) or a PB subunit (inhibin B). During
fetal life inhibin a and PB protein subunits are expressed in fetal type Leydig
cells (Majdic et al., 1997). In the postnatal testis, following the replacement of
fetal type Leydig cells with adult counterparts expression of both inhibin
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subunits is restricted to Sertoli cells (Majdic et al., 1997). Expression of inhibin
(3A subunit has not been detected in rat testis (Majdic et al., 1997) and it has been
proposed that inhibin B is the major inhibin form synthesised in the male in the
human (Illingworth et al., 1996), rhesus monkey (Plant et al., 1997) and rat
(Woodruff et al., 1996). Sertoli cells are thought to be the predominant or sole
source of inhibin B in circulation.
Inhibin mRNA levels are maximal between days 15 and 25 and gradually
decline thereafter (Keinan et al., 1989). Serum levels and immunoexpression of
inhibin B are increased between day 3 and days 10-15 afterwhich levels plateau
and decline with late puberty (Majdic et al., 1997; Rivier et al., 1988; Sharpe et al.,
1999). In the postnatal rat testis stage specific immunoexpression of inhibin-a
and PB is observed as early as day 3 becoming fully stage dependent by day 27
(Majdic et al., 1997).
In the adult rat testis stage specific expression of inhibin by Sertoli cells (Majdic
et al., 1997) suggests that secretion may be regulated by germ cells. Sertoli cells
cultured in the presence of germ cells secrete lower levels of inhibin than
isolated Sertoli cells cultured alone (Ultee-van Gessel et al., 1986). Addition of
early spermatids to day 20 rat Sertoli cells in culture increased inhibin
production (Pineau et al., 1990) and the absence of late spermatids in intact adult
rat testis causes a decline in inhibin levels (Allenby et al., 1991; Maddocks et al.,
1992).
It is well established that FSH upregulates inhibin production by Sertoli cells
during early postnatal life. Between days 8 and 22 FSH and inhibin levels in
rat plasma are inversely related (Rivier et al., 1988). Numerous in vitro studies
have demonstrated an upregulation of inhibin B protein secretion and inhibin-a
mRNA levels following FSH administration or addition of factors known to
raise intracellular cAMP levels (dibutryl-cyclic AMP, cholera toxin, forskolin)
(Bicsak et al., 1987; Keinan et al., 1989; Klaij et al., 1990; Toebosch et al., 1989).
Recently an ELISA specific for inhibin B has demonstrated that in both male
humans and rats a dose and time dependent increase in inhibin B production by
Sertoli cells takes place following exogenous FSH administration both in vitro
and in vivo (Anawalt et al., 1996; Depuydt et al., 1999; Sharpe et al., 1999). FSH
Chapter One Literature Review 39
from the anterior pituitary regulates Sertoli cell expression of inhibin B by a
classical feedback loop. Inhibin B in turn regulates FSH production by the
anterior pituitary. Following castration, plasma FSH levels are increased in the
immature male (Hermans et al.r 1980). Sharpe et al., (1999) established an
association between FSH levels, Sertoli cell numbers and inhibin B plasma
levels. They showed that modification of neonatal FSH levels causes a
corresponding change in Sertoli cell number and testis weight in addition to a
proportional change in inhibin B plasma levels.
Neutralisation of endogenous inhibin with antiserum increases plasma FSH
levels in day 10 rats but has no effect in rats older than 26 days which suggests
that inhibin is only important in regulating FSH production in the immature
animal (Rivier et al., 1988). However stage specific expression of inhibin and
labelled binding of inhibin to germ cells suggests additional paracrine functions
of inhibin in the adult testis (Woodruff et al., 1992).
Testosterone has been shown to have either no effect or an inhibitory effect on
inhibin production by Sertoli cells in culture (Bicsak et al., 1987; Depuydt et al.,
1999; Morris et al., 1988; Toebosch et al., 1989) and in normal men following
exogenous testosterone administration (Anawalt et al., 1996). In contrast
oestrogen has a stimulatory effect or no effect on inhibin production by Sertoli
cells in culture (Bicsak et al., 1987; Depuydt et al., 1999; Morris et al., 1988).
Inhibin expression is also regulated by epidermal growth factor, transforming
growth factor-|31, tumour necrosis factor a and insulin-like growth factor
demonstrating paracrine regulation of inhibin production within the testis, (le
Magueresse-Battistoni et al., 1995; Morris et al., 1988; Toebosch et al., 1988).
1.5.8.5. GATA 1 and 4
The GATA binding proteins are a family of CX2CX17CX2C zinc finger
transcription factors (Evans and and Felsenfeld, 1989; Tsai et al., 1989) that bind
to the cis regulatory sequence WGATAR (Yamamoto et al., 1990) as well as
related sequences CGATGG and AGATTA (Ko and Engel, 1993; Merika and
Orkin, 1993). These sequences are found in promoter, enhancer and locus
control regions of a number of genes involved in neonatal testis development
including StAR (Silverman et al., 1999), AMH tViger et al., 1998) and inhibin-a
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(Feng et ai, 1998). There are so far six members of the vertebrate GATA
family: expression of GATA-1, 4 and 6 has been observed in mammalian
gonads (Ito et al., 1993; Ketola et al, 1999; Viger et al., 1998) and Onodera et al.
(1997) have also shown testicular expression of GATA2.
1.5.8.5.1. GATA-1
The predominant GATA-1 mRNA transcript found in the testis is transcribed
from a testis specific distal promoter and first exon found 8kb upstream from
the normal proximal promoter and first exon (Ito et al., 1993). Low levels of
GATA-1 mRNA and protein are observed in rat testes on postnatal day 7 and
maximum levels are reached between days 14 and 23 (Viger et al., 1998).
GATA-1 immunolocalisation is restricted to Sertoli cell nuclei and is not
observed in interstitial or germ cells (Ketola et al., 1999; Yomogida et al., 1994).
Yomogida et al., (1994) found a similar pattern of GATA-1 expression in the
mouse testis. Initially, Sertoli cell expression of GATA-1 is constitutive however
by day 35 expression appears to be becoming stage dependent such that in
adult testis GATA-1 protein is only observed in Sertoli nuclei during
spermatogenic stages VII-IX (Yomogida et al., 1994). This could explain the
very low levels of GATA-1 mRNA detected in the adult mouse testis (Ito et al.,
1993; Onodera et al., 1997) and the absence of GATA-1 protein in adult mouse
testis observed by Viger et al., (1998). Maximum expression levels of GATA-1
in both mouse and rat testis coincide with the cessation of Sertoli cell
proliferation and subsequent Sertoli cell maturation. Stage dependent GATA-1
expression is first observed during the onset of spermatogenesis.
Germ cells have been shown to negatively regulate GATA-1 expression in the
adult mouse testis (Yomogida et al., 1994). In the seminiferous tubules of c kit
mutant W/Wv adult mice (which do not contain germ cells) no stage specific
GATA-1 expression is observed and virtually all Sertoli cell nuclei express
GATA-1 protein. A similar pattern of expression is observed in tubules of adult
jsd/jsd (juvenile spermatogonial depletion) which contain type A
spermatogonia only. It has therefore been proposed that some germ cell types
present in the seminiferous epithelium between stages X-VI have an inhibitory
effect on Sertoli cell GATA-1 expression. Stages VII-VIII are androgen
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dependent therefore it has also been suggested that expression of GATA-1
could also be regulated by androgens.
1.5.8.5.2. GATA-4
Abundant GATA-4 mRNA transcripts are observed in undifferentiated gonads
of mouse embryos on fetal day 11.5 (Viger et al., 1998). By fetal day 13.5
GATA-4 mRNA expression is restricted to somatic cells of both testes and
ovaries. A day later GATA-4 expression becomes sexually dimorphic with
abundant levels of GATA-4 mRNA maintained in early Sertoli cells and
mesenchymal Leydig cell progenitors. However expression of GATA-4 is
rapidly downregulated in the ovary and does not return to the ovaries until full
maturity is reached. Expression of GATA-4 mRNA in neonatal Sertoli and
Leydig cells is maximal between birth and postnatal day 14, after which mRNA
levels decrease with increasing age but are still detectable in adult testes (Ketola
et al., 1999). GATA-4 protein levels increase during neonatal development and
reach a peak between day 4 (Ketola et al., 1999) and day 7 (Viger et al., 1998). In
agreement with mRNA levels, GATA-4 protein expression then decreases with
increasing age. There is some disagreement concerning the cellular location of
GATA-4 expression in the adult testes. Heikinheimo et al., (1997) and Ketola et
al., (1999) state that GATA-4 expression is restricted to somatic cells of the adult
testis and ovary. In contrast, Viger et al., (1998) observed a switch in GATA-4
protein expression from Sertoli cell to germ cells after day 23 resulting in germ
cell specific expression of GATA-4 in the adult testis. This is in agreement with
Arceci et al., (1993). It was proposed that loss of GATA-4 expression from
Sertoli cells coincides with the observed increase in Sertoli cell GATA-1
expression. It was suggested that GATA-1 takes over the role of GATA-4 in
the mature Sertoli cell (Viger et al., 1998). The sexually dimorphic expression of
GATA-4 observed during gonadal embryonic development is associated with
the earlier onset of endocrine function in the testes when compared to the
ovaries. Maximal levels of GATA-4 in Sertoli cells are concurrent with the
proliferative phase of Sertoli cell development. Therefore it has been suggested
that GATA-4 may play a role during Sertoli cell mitosis and Leydig and Sertoli
cell endocrine function.
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Administration of FSH to a mouse Sertoli cell line MSC-1 and a Leydig cell
tumour cell line resulted in a modest increase and a significant increase in
GATA-4 mRNA levels, respectively (Ketola et al., 1999). Similar results were
obtained by Heikinheimo et al., (1997) following treatment of MSC-1 Sertoli
cells and a granulosa cell line with FSH and forskolin. In vivo experiments have
indicated that testosterone is not required for GATA-4 expression in Sertoli
cells. Normal levels of GATA-4 were observed in hypogonadal mouse testes
(Ketola et al., 1999). In addition treatment of mice with the GnRH antagonist
azaline b did not alter GATA-4 protein levels and 15 days after EDS treatment
there was no difference in levels of GATA-4 protein between control and
treated animals (Ketola et al., 1999). In contrast hCG stimulates an increase in
GATA-4 expression by Leydig cells. A reduction in Leydig cell LH receptor
levels is associated with a decrease in GATA-4 mRNA levels. Thus FSH and LH
stimulate GATA-4 expression by Sertoli cells and Leydig cells respectively.
GATA-4 expression in immature mouse granulosa cells can be upregulated
after four days of DES treatment, GATA-4 levels decline after two days of DES
withdrawal and GATA-4 expression is undetectable following DES withdrawal
and administration of testosterone (Heikinheimo et al., 1997). It must be noted
that following DES withdrawal there is a dramatic increase in the number of
apoptotic cells within the follicles which become severely atretic following DES
withdrawal and testosterone administration. Therefore it is a possibility that
GATA-4 expression by immature granulosa cells can be induced by oestrogen
treatment. However GATA-4 may just act as a survival or mitotic factor during
follicular development in the ovaries.
Two GATA motifs have been located at positions -147 bp and -114 bp within
the inhibin-a promoter region. Using cotransfection and expression
experiments in an MA10 Leydig tumour cell line Feng et al., (1998) have shown
a dose dependent GATA-1 induced upregulation of inhibin-a expression.
GATA-4 has no effect on the activity of the inhibin a promoter in the
cotransfection experiments but is able to cause a specific band shift in EMSA
experiments. Ketola et al. (1999) have questioned this finding due to the fact
that GATA-1 is not normally expressed in Leydig cells whereas GATA-4 is. In
vitro transactivation experiments have indicated that GATA-4 can induce a
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significant upregulation in inhibin-a expression in Leydig tumour and
granulosa cell lines. The importance of these findings is supported by the
temporal expression pattern of GATA-4 in the testis. GATA-4 expression is
switched on earlier than that of both inhibin subunits and GATA-4 is expressed
in both Leydig and Sertoli cells. This evidence suggests that GATA-4 is able to
induce inhibin-a expression in both Leydig and granulosa cell lines. In addition
it is also possible that both GATA-4 and GATA-1 could transactivate inhibin-a
expression in Sertoli cells in vivo.
The StAR promoter also contains a GATA motif within its functional promoter
region. Silverman et al., (1999) have shown that the conserved GATA binding
motif is essential for StAR expression in prepubertal rat granulosa cells.
Mutation of the binding site results in a decrease in promoter activity. GATA-4
is expressed in Leydig cells prior to the onset of testosterone secretion and
GATA-4 expression is thought to be upregulated by LH. Therefore it is
possible that GATA-4 also has a role to play in steroidogenesis in the Leydig
cell.
1.5.8.6. Mouse-Musashi-1
Mouse-Musashi-1 (Msil) is a 39kDa RNA binding protein (RBP) and is a
member of the Musashi subfamily of RBPs which include drosophila Musashi-1
(id-Msi), Xenopus laevis nervous system-specific RNP protein-1 (Nrp-1) and the
human homologue Musashi-1 (MSI1). All four members of the family have a
conserved structure made up of two conserved tandem RNA recognition
motifs (RRM) which contain short, highly conserved regions called RNP1
(octamer) and RNP2 (hexamer). The RRM sequences of d-Msi and Nrp-1 are
77% and 90% homologous to Msil RRM sequences, respectively. Members of
the Musashi family have a conserved expression pattern which was originally
thought to be restricted to the nuclei of CNS stem cells and neural precursor
cells. Expression is always greatly downregulated in fully differentiated and
postmitotic neurones and glial cells. The restricted expression pattern of
Musashi family members to nuclei of neurone cells, suggested that Msil was
involved in RNA processing, a role carried out by other RBPs which are most
homologous to Msil.
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In addition to expression of Msil transcripts in fetal and adult neural tissue,
Northern blot analysis has shown expression of a 3.1kb transcript in the small
intestine and the ovary (Good et al., 1998). Msil expression in the ovary was
thought to be related to maternal expression similar to that observed in d-msi.
However Maguire et al.,(1999) located Msil and a rat homologue to Sertoli cells
in mouse and rat testis. Using both in situ hybridisation and
immunocytochemistry, Msil expression is restricted to Sertoli cells and is not
seen in any other cell type within the testis. Expression is highest in Sertoli cells
from immature testis (day 6) and is shown to decrease with increasing age. In
contrast to Msil expression in neuronal cells where expression is restricted to
the nuclei, Msil protein expression is observed in both nuclei and cytoplasm of
fetal and immature rodent Sertoli cells. Once Sertoli cells had ceased dividing
(around day 14-21) expression becomes predominantly nuclear. This indicated
that Msil plays an additional or alternative role to RNA processing in the
neonatal Sertoli cell. Msil may be involved in nuclear-cytoplasmic RNA
trafficking in mitotic Sertoli cells. However during Sertoli cell maturation Msil
then became predominantly involved in RNA processing within the nucleus. In
the adult testis Msil expression is seen in Sertoli cell nuclei at all spermatogenic
stages. However expression is most abundant in tubules at stages XI-VI which
corresponds to a time when testosterone levels are at their lowest. It has
therefore been suggested that Msil may be negatively regulated by
testosterone (Maguire et al., 1999).
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Figure 1.6: Diagram to show changes in Sertoli cell protein expression
patterns during early postnatal development. Sertoli cell cytoplasmic staining
is green; stage specific cytoplasmic staining is shown in black; nuclear Sertoli cell
immunostaining is shown in blue and joint cytoplasmic and nuclear staining is
represented by red.
1.6. Influence of Oestrogenic Chemicals on Postnatal
Gonadal Development
Over the past nine years, an increasing number of papers in the literature have
expressed concerns that human male reproductive health is declining and that
the incidence of congenital abnormalities and cancers of the male reproductive
tract is increasing. The causes behind these reported increases are not known
but one hypothesis that has been promoted in both the scientific community
and the media is that exposure to exogenous oestrogen or oestrogen like
compounds (xenoestrogens and environmental oestrogens) may be involved.
1.6.1. Sources of Oestrogenic Chemicals in the
Environment
Currently there are four major classes of environmental hormones that interact
directly with steroid hormone receptors: environmental oestrogens,
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environmental antioestrogens, environmental antiprogestins and
environmental antiandrogens. Environmental oestrogens include
phytoestrogens and synthetic chemicals such as pesticides, herbicides,
bisphenol A, some polychlorinated biphenyls (PCBs), plasticisers (phthalates)
and surfactant breakdown products also known as alkylphenol polyethoxylates
(APEOs). During sewage treatment APEOs are broken down by microbes and
some of the degradation substances produced have oestrogenic activity
(octyphenol and nonylphenol) (Turner and Sharpe, 1997). Dioxins are known
to have antioestrogenic activity and polyaromatic hydrocarbons, linuron,
vinclozolin and p,p'~ DDE have antiandrogenic activity (for review see (Cheek
and McLachlan, 1998).
All the synthetic environmental oestrogens described are at least 1000 times
less potent than oestradiol (Arnold et al., 1996). Exposure to very high levels of
environmental oestrogens would therefore be required to cause any biological
effect. Elowever these chemicals may be capable of causing additive,
synergistic or antagonistic effects. A recent study which examined sons of
farmers and gardeners for abnormalities in the genital tract found a significant
increase in the risk of cryptorchidism but not hypospadias in the sons of
mothers (but not fathers) who worked in these occupations. Farmers and
gardeners use a number of chemicals which are known to be oestrogenic or
possess other hormone disrupting effects. Thus occupational exposure to
certain environmental endocrine disrupters can be high enough to cause an
increased risk of congenital abnormalities (Weidner et al., 1998).
Natural plant or phytoestrogens are more likely to be a significant source of
human oestrogen exposure than synthetic oestrogens. Plant oestrogens are
found in soya, grains, vegetables and fruits and therefore humans consume a
large quantity of phytoestrogens in their diet. A high dietary intake of
phytoestrogens causes reproductive abnormalities in sheep (Kaldas and
Hughes, 1989) and can prolong the follicular phase of the menstrual cycle in
humans (Cassidy et al, 1994).
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1.6.2. Evidence of Oestrogenic Effects on Male Fertility
In male rodents it is well established that exposure to supra physiological doses
of oestrogens during the critical period of neonatal differentiation results in an
array of permanent reproductive defects, which include a decline in sperm
counts (de Mouzon et al., 1996), atrophy of testes and sexual accessory glands
(Brown-Grant et al., 1975; Kind et al., 1965; Newbold and McLachlan, 1985),
impaired maturation of germ, Sertoli and Leydig cells (Gaytan et al., 1986;
Pinilla et al., 1992; Sharpe et al., 1998), altered LH secretion (Pinilla et al., 1995)
and inappropriate puberty onset (Bellido et al., 1990; Brown-Grant et al., 1975).
Disruption of reproductive function by neonatal oestrogenisation is proposed
to arise via numerous mechanisms and the elucidation of such mechanisms is
still being researched.
It was first proposed in the early 1990s that exogenous oestrogens in the
environment were affecting sperm counts. In 1992 (Carlsen et al., 1992)
analysed data from 61 studies spanning 50 years and including approximately
15,000 men. The data suggested that a decrease in both sperm concentration
and semen volume had occurred over time. Sperm concentrations had fallen
from an average of 113 million/ml to 66 million/ml and semen volume was
reduced from 3.4 ml to 2.75 ml. The validity of the conclusions drawn from this
study have been questioned. However similar studies that were carried out in
the 1970s and 1980s also suggest that sperm counts have fallen and a negative
correlation between later year of publication and lower average sperm
production was observed (James, 1980).
Following these initial studies numerous other papers using various methods
of data analysis and different groups of men have been published. Studies
carried out in Paris, Scotland and Belgium (Auger et al., 1995; Irvine et al., 1996;
van Waelegham et al., 1996) stated that semen quality was falling and that a
relationship existed between sperm count and year of birth. Other studies in
France and Finland reported that sperm concentrations had not changed (Bujan
et al., 1996; Suominen and Vierula, 1993) whilst studies in the USA found a small
but significant increase in sperm counts had occurred between 1970 and 1994
(Fisch et al., 1996). The largest retrospective review of semen quality was
carried out on 7714 men and reported a significant decrease in semen quality
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with later year of birth; the mean sperm concentration of men born before
1939 was 92.5 million/ml compared to 77.1 million/ml for men born after 1965
(de Mouzon et al., 1996).
Thus if sperm concentrations were falling the literature indicates that it is a
regional phenomena which supports the hypothesis that factors in the local
environment are modifying male reproductive health. The data in the above
studies are inconclusive and all studies have been criticised as they are
retrospective and comparisons across studies can not be carried out due to
differences in selection criteria and methods of collection and analysis.
Other strong indicators of problems with male reproductive health are the
observed increases in the incidence of testicular germ cell cancer and congenital
abnormalities of the male reproductive tract. Incidences of testicular germ cell
cancer have been steadily increasing world wide, over the last 30 years such
that testicular cancer is now the commonest malignancy of men aged 15-45 in
the UK. The cause(s) of testicular cancer are unknown but it is proposed that
events occurring in utero during testis development lead to persistence of fetal
gonocytes within the testis which lead to the formation of pre-invasive
carcinoma in situ cells (CIS) (Skakkebaek et al., 1987). It has been hypothesised
that these cells become invasive after increased exposure to hormones which
occurs at puberty (Cortes et al., 1987).
There are several reports of increasing incidences in congenital abnormalities of
the male reproductive tract. Cryptorchidism is a condition when the testicles
do not fully descend into the scrotal sac but remain within the abdomen. In
Scotland, England and Wales studies show an increase in the number of boys
undergoing surgery to lower the testis over the last 40 years (Campbell et al.,
1987; Chilvers et al., 1984). Hypospadias is a congenital abnormality of the
penis in which the urethral opening does not appear at the tip of the glans but
can occur anywhere along the shaft of the penis. A number of studies carried
out across the world have reported an increase in the incidence of hypospadias.
However a review of data collected from a number of different countries does
not indicate an increase in hypospadia occurring over time but that increases in
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the abnormality are more frequently reported in more affluent nations
(Paulozzi, 1999).
Male alligators in Lake Apopka, Florida had abnormal germ cells and
abnormally small phalli following a bad chemical spill in the lake involving
trichloroethane (DDT) which can be degraded into DDD and p, p 'DDE which
have oestrogenic and anti androgenic effects, respectively. Normal male sexual
development of the juvenile male alligators had been permanently modified by
exposure to high doses of the polluting chemicals (Guillette et al., 1994).
Delayed maturation, smaller gonads, a lack of secondary sex characteristics,
reduced serum testosterone and dysfunctional hypothalamic-pituitary-gonadal
axis have all been observed in many species of fish living in water downstream
from kraft pulp mills (e.g. white sucker). Kraft mill effluents usually contain
high levels of dioxin and phytoestrogen ^-sitosterol (Munkittrick et al., 1991).
In addition rainbow trout living downstream from sewage treatment outflows
have increased incidence of hermaphroditism and produce large amounts of
the egg protein vitellogenin (Jobling and Sumpter, 1993; Purdom et al., 1994).
Alkylphenol-polyethoxylates are a major group of surfactants found in sewage
and are known to be oestrogenic to fish (Jobling et al., 1996). A study of
ejaculate volumes from Florida panthers found low sperm counts, low ejaculate
volumes and a high proportion of abnormal sperm. The incidence of
cryptorchidism had also increased. It was proposed that these abnormalities
were due to the bioaccumulation of p,p'-DDE and PCBs in the body fat of the
panthers as these chemicals have antiandrogenic and oestrogenic activity,
respectively, (Facemire et al., 1995). However it has also been argued that the
described abnormalities in Florida panthers could also result from in breeding.
In most cases there is no definitive proof that the changes observed in wildlife
have been caused directly by exposure to environmental oestrogens. When
the causative agent is known, the effects on the reproductive tract have been
induced only after exposure to high levels of environmental chemical. Thus
when discussing the observed effects of environmental oestrogens on wildlife it
is necessary not to extrapolate the causes directly to the reported changes in
human male reproductive health.
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The synthetic oestrogen diethylstilbestrol (DES) was prescribed to pregnant
women between 1940s to 1970s to prevent miscarriages. The sons of mothers
exposed to DES during pregnancy had increased incidence of hypospadias,
epididymal cysts, hypoplastic testis, cryptorchidism, microphallus and
abnormal semen parameters (Gill et al., 1977; Gill et al., 1979). In addition,
sperm counts were significantly lower in some DES exposed men (Gill et al.,
1979) and there is some evidence to suggest that DES induced a small increase
in the incidence of testicular cancer (Vessey, 1989).
Researchers have linked the above effects on male reproductive tracts to
endocrine disrupting chemicals in the environment. However exactly how
such chemicals interact with each other to counteract or synergise with
endogenous pathways within biological systems is not known.
1.6.3. Possible Mechanisms of Oestrogenic Action
During Postnatal Testis Development
Despite the classical contention that oestrogen is the 'female hormone', reports
so far indicate that oestrogen plays a pivotal role in the regulation of
development and function in several systems in the male. In mammals these
actions include permanent masculinisation of brain structures involved in
neuroendocrine control of gonadal function and reproductive behaviour
(Arnold and Gorski, 1984), regulation of differentiation and function of Leydig
cells in the neonatal testis (Abney and Myers, 1991; Brinkman et al., 1980),
modulation of luminal fluid resorbtion in the epididymis (Hess et al., 1997) and
control of FSH secretion (Sharpe et al., 1998) as well as direct effects on bone
and the cardiovascular systems (Sharpe et al., 1998).
The mechanisms by which inappropriate levels of oestrogen could cause the
abnormal development of the male reproductive tract are unknown. Neonatal
administration of oestradiol benzoate to male rats causes a significant dose
dependent delay in spermatogenesis thought to result from distension of the
rete testis and backflow impairment (Aceitero et al., 1998). This has also been
observed following neonatal administration of DES to rats. Resorbtion of STF
in the excurrent ducts was defective and this led to distension of the rete testis
(Fisher et al., 1998b). Infertility in male ERKO mice is partly caused by
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impairment of STF resorbtion in the efferent ducts and subsequently the rete
testis are distended and spermatogenesis is disrupted (Hess et ai, 1997). These
findings appear to contradict the role of oestrogen in STF resorbtion and
therefore highlight the complexities involved in establishing the role of
oestrogen in male reproductive development and the mechanisms by which
disruption in male development can arise.
Fertility in the male can also be compromised by alteration in germ cell, Leydig
cell and Sertoli cell function through direct action of oestrogen on ERa and ERfl.
Administration of oestradiol to adult rats increases germ cell apoptosis in
patterns distinct from those observed following gonadotropin and testosterone
withdrawal (Atanassova et ah, 1999; Bianco-Rodriguez and Martinez-Garcia,
1997). However administration of low doses of DES can also advance
spermatogenesis demonstrated by increases in the volume of spermatocytes
per Sertoli cell following DES treatment (Atanassova et ah, 1999). Thus
oestrogen may play a role in regulating early germ cell development by direct
action on spermatocytes and spermatogonia through expression of
ERP (Saunders et ah, 1998).
Oestradiol can also alter fertility through direct and paracrine effects on Leydig
cell differentiation, number and steroidogenesis. Oestradiol produced by
aromatisation of testosterone in the immature Sertoli cell, blocks ontogenic
development of adult type Leydig cells from precursor cells in the neonatal
testis (Abney, 1999). It is also postulated that oestradiol acts directly on mature
Leydig cells to block androgen production by inhibiting the activities of certain
steroidogenic enzymes (Abney, 1999) and decreasing AR levels (Sharpe et ah,
1998; Tena-Sempere et ah, 2000) thus inhibiting testosterone production
(Atanassova et al., 1999) and androgen action in the developing testis.
Neonatal administration of oestradiol can also impair spermatogenesis and
male reproductive development through modification of Sertoli cell maturation
and function. It was originally proposed that oestrogen treatment during fetal
and prepubertal development indirectly altered male reproductive health
through suppression of gonadotropin secretion by the anterior pituitary.
Decreased levels of FSH and LH led to decreased Sertoli cell numbers resulting
Chapter One Literature Review 52
in lowered sperm output in the adult testis, delayed onset of puberty and
impaired spermatogenesis due to permanent modification of Sertoli cell
function (Gaytan et al., 1986). Recent studies have shown that most of the
effects of neonatal oestrogen administration cannot simply be explained by
suppression of gonadotropin levels (Atanassova et al., 1999; Sharpe et al., 1998).
Neonatal treatment of rats with varying doses of DES and ethinyl oestradiol
causes a reduction in Sertoli cell numbers, a delay in normal expansion of
spermatogenesis and an increase in abnormal sperm as well as permanent
impairment of Sertoli cell functional maturation, demonstrated by a change in
expression levels of AR in the adult rat Sertoli cell. These results suggest that
oestrogen plays a physiological role in the maturational development of Sertoli
cells (Atanassova et al., 1999; Sharpe et al., 1998).
Neonatal immature Sertoli cells not only express ERfl but are also a source of
oestrogen in the prepubertal testis and oestrogen can therefore exert autocrine
effects on Sertoli cells during development. Oestrogen upregulates ER(i mRNA
levels and TGF(3 levels in neonatal Sertoli cells (Dorrington and Khan, 1993;
Tena-Sempere et al., 2000). TGF(3 and ERJ3 in association with FSH act to
increase Sertoli cell mitosis. Sertoli cell mitotic activity in the prepubertal testis
is proposed to be inhibited during normal testis maturation by paracrine
factors such that Sertoli cell proliferation ceases and cell differentiation begins.
However following DES or environmental oestrogen exposure such control
mechanisms regulating Sertoli cell proliferation will be short circuited and
consequently the artificially elevated oestrogen levels will result in a delay in
Sertoli cell maturation.
Sertoli cells carry out crucial functions in the postnatal development and
differentiation of Leydig cells and germ cells through paracrine interactions in
the prepubertal testis. Modification of Sertoli cell function and maturation by
increased oestrogen levels can modify Leydig cell differentiation and delay the
onset of spermatogenesis. Spermatogenesis is also affected by a decrease in
testosterone levels which occurs in the adult rat testis following neonatal
administration of DES (Atanassova et al., 1999). Sertoli cell maturation is a
prerequisite for normal spermatogenesis and permanent impairment of Sertoli
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cell functional maturation will therefore contribute to spermatogenic damage in
the mature testis of treated animals (Gaytan et al., 1986).
AR and ERs are all expressed at a number of cellular sites where aromatase is
also expressed. It is therefore a possibility that the balance between oestrogen
and androgen action is finely regulated at the local level. Androgens regulate
aromatase expression levels whilst oestrogen can inhibit testosterone synthesis
and AR expression. Oestrogen can also bind to AR and alter transactivation of
androgen regulated genes (Yeh et al., 1998) as well as inhibiting transcriptional
activation of AR when bound to ER (Kumar et al., 1994). Administration of
either antiandrogens or potent oestrogens causes remarkably similar changes
in the male reproductive tract which suggests that common pathways of action
are involved in these changes (Sharpe, 1998). Antiandrogens may elevate
endogenous oestrogen levels which cause additional changes to male
development on top of straightforward effects caused by a blockade in
androgen action. Conversely administration of oestrogen will interfere with
testosterone production and androgen action in addition to activating ER
mediated pathways. Both these scenarios would result in increased oestrogen
action at the expense of reduced androgen action. Thus exposure to
inappropriate levels of oestrogen during postnatal life could be modifying male
reproductive development by changing the testosterone:oestrogen balance
which will in turn permanently affect Sertoli and Leydig cell maturation and
function.
1.7. Aims of this study
The aims of this study were to investigate effects of oestrogen and testosterone
administration on immature rat Sertoli cell maturation. Initially, expression
patterns of known and novel markers of Sertoli cell functional maturation were
determined during normal postnatal development of the rat testis, after which
the effect of oestrogen and testosterone treatment on the expression patterns
of these factors was investigated at both protein and mRNA levels. In order to
clarify if changes in gene expression by steroids were the result of direct or
indirect actions on Sertoli cells, primary rat Sertoli cell cultures and an
immortalised mouse Sertoli cell line were included in this study.
Chapter 2.
General Materials and Methods
The techniques outlined in this chapter are common to a number of studies in
this thesis. Methods specific to individual experiments are described in the
relevant chapters.
2.1. Chemicals and suppliers
Molecular biology grade chemicals were obtained from Sigma, (Poole, UK) and
IBI, (Cambridge, UK). All radiolabelled nucleotides were obtained from
Amersham, (Buckinghamshire, U.K.). Enzymes were purchased from
Boehringer Mannheim, (Lewes, UK) or Promega, (Southampton, UK).
Phenol/chloroform was purchased from CAMLAB, (Cambridge, UK) and was
pre-buffered with Tris. pH 8.0. Autoradiography products were obtained from
Eastman Kodak, (Rochester, NY, USA), supplied by Sigma.
2.2. Animals
2.2.1. Rats
Animals used for these studies were mainly male Wistar rats; immature, aged
post partum day 3-35 and adult, aged day 65-90, when day of birth is called
postnatal day 1. The rats were bred in the MRC Reproductive Biology Unit in
Edinburgh and were maintained in standard conditions of a 12 hours light:12
hours dark cycle and an ambient temperature of 21°C. Food and water were
available ad libitum. Animals were killed by asphyxiation with C02 followed by
cervical dislocation.
2.2.2. Mice
Mice used in these studies were male C57black x CBL mice; immature, aged
post partum day 1-16, adult, day 40 and older when day of birth is designated
as postnatal day 1. The mice were bred in the MRC Reproductive Biology Unit
in Edinburgh and were maintained under standard conditions of 14 hours light:
10 hours dark cycle and at an ambient temperature of 21°C. Food and water
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dissolved in RNase-free water by warming to 65°C for 5 minutes. RNA
isolated in this way was then stored at -70°C.
RNA was scanned at 260 and 280nm on a spectrophotometer (GeneQuant,
Pharmacia Biotech, Cambridge, UK). The 260:280 ratio for each sample was
calculated to give an estimation of the purity of the RNA. A ratio of 1.6-1.9 was
considered acceptable. The concentration of the RNA was calculated from the
260nm value where an optical density of 1.0 is equal to 40/rg/ml RNA.
2.3.3. Separation of RNA on denaturing agarose gels
RNA was separated on a 1.5% denaturing agarose gel for both assessment of
RNA quality and prior to blotting onto nylon membranes for Northern
analysis (section 2.9). The gel was prepared by melting 2.25g Seakem agarose
(Boehringer Mannheim, Mannheim, Germany) in 127.5ml pure water. This was
cooled to about 60°C and 15ml of lOx running buffer (containing 200mM
MOPS, lOmM EDTA and 50mM sodium acetate at pH 7.0) plus 8.1ml 37%
formaldehyde was added. The solution was mixed gently and poured into a
gel tray (15 x 20cm) containing a 15 or 20 well comb in a fume hood. After
setting, the comb was removed and the gel submerged in lx running buffer in
a Sub-Cell electrophoresis cell (BioRad Laboratories, Hemel Hempstead, U.K.).
RNA (up to 20/xg) was prepared by adding 16pi sample buffer and heating at
60°C for 5 minutes. Sample buffer contained 100/xl lOx running buffer, 500/xl
deionised formamide and 178/d formaldehyde. After heating, 8pi dye solution
containing 7.5% w/v ficoll 400, 0.1% w/v bromophenol blue and lpl of
lmg/ml ethidium bromide was added to each sample. RNA was loaded into
individual wells of the gel and separated by running overnight at 34V or for 5
hours at 120V.
2.4. Tissue fixation and processing
2.4.1. Tissue fixation
Testes were quickly removed from asphyxiated rats, decapsulated and weighed
before they were placed in Bouin's fluid for 5 hours. Testes removed from rats
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aged day 35 and adults were perfusion fixed in Bouin's fluid by Dr. Richard
Sharpe. Perfusion fixed testis were then cut into 2-3mm transverse slices. Fixed
tissue was transferred to 70% ethanol for storage until processing for
immunohistochemistry.
2.4.2. Processing and sectioning of tissue
Tissue was processed through a graded series of alcohols in an automatic
TP1050 Processor (Leica, Milton Keynes, UK) using a standard 20 hour cycle
and embedded in paraffin wax. Tissue processing was kindly performed by Mr.
Mike Millar and Mrs Sheila MacPherson.
Glass microscope slides were dipped twice in a 4% v/v solution of 3-
aminopropyl triethoxysilane (TESPA, Sigma) in acetone (BDH) then rinsed in
acetone followed by sterile water and dried. The slides were coated to enhance
the adherence of tissue sections.
Paraffin wax embedded tissue was sectioned to a thickness of 5pm using a hand
operated microtome (Jung RM2035; Leica) and a D-profile knife. Sections were
floated onto distilled water, transferred onto the TESPA coated slides and dried
overnight before use.
2.5. Reverse transcription polymerase chain reaction (RT-
PCR)
2.5.1. Oligonucleotide primers
Oligonucleotides (17-24mers) were ordered from Genosys (Exeter, UK) and
were resuspended in either TE buffer (Appendix 1) or double distilled water
filtered through a 6.22pm bacterial filter. The concentration of oligonucleotide
was assessed by spectrophotometry at 260nm where an optical density of 1.0 is
equal to a concentration of 20ng/ml.
2.5.2. RT-PCR Reaction
Partial cDNAs were generated using a combination of reverse transcription and
polymerase chain reaction (RT-PCR). Reverse transcription and the production
of first strand cDNA pools was undertaken using lpg of total RNA and either
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lOOng/pg RNA of random primers (Promega) or 500ng/pg RNA of oligo dT
(12-18) primers (Gibco-BRL) in a volume of lOpl made up with distilled water.
Oligo dT primers reverse transcribe mRNA species possessing a polyA
sequence at their 3' end. Primers and RNA were denaturated at 70°C for 10
minutes followed by immediate annealing on ice for 5 minutes. First strand
buffer (50mM Tris-HCl pH 8.3, 75mM KC1, 5mM MgCl2 ), lOmM DTT (both
from Gibco BRL) and 500pM of each dNTP (Amersham Pharmacia
Biotechnology, St. Albans, UK) was added to each reaction, mixed and
incubated at 37°C for 1 minute. 200 U of Superscript™ II RNase IT Reverse
Transcriptase (Gibco BRL) was then added to the reaction mixture. Oligo dT
primed reactions were incubated at 37°C for 1 hour and random primed
reactions were incubated at 21°C for 10 minutes followed by 50 minute
incubation at 37°C. The reverse transcription reaction was terminated by the
addition of 8mM EDTA pH 8.0 and cDNA pools were stored at -20°C.
Double stranded DNA was amplified by polymerase chain reaction (PCR;(Saiki
et al, 1988) using the first strand cDNA as template. Specific 5' and 3'
oligonucleotide primers were used at a final concentration of 0.5pM in PCR
reactions containing 100/xM of each dNTP (Amersham Pharmacia
Biotechnology), Taq polymerase buffer (50mM KC1, lOmM Tris-HCl, 1.5mM
MgCl2,0.01% gelatin, 0.1% Triton X100) and 2.5U Taq polymerase (P.E. Applied
Biosystems, Warrington, UK). Template cDNA was used at a 1:50 dilution.
Thirty-five cycles of amplification were performed with annealing
temperatures determined by the melting temperature (Tm) of the primers
used. The Tm is dependent on the nucleotide content of the primers and was
calculated using the formula (4 x G+C) + (2 x A+T). Extension occurred at 72°C
and lasted 35 seconds to 2 minutes dependent on the length of desired
template.
2.5.3. Cloning of amplified cDNAs
Where RT-PCR reactions were conducted for obtaining probes for RNase
protection assay reactions, the amplified DNA fragments were subcloned into
appropriate plasmid vectors containing SP6 and T7 RNA polymerase
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promoters. The vectors used were the TA cloning vectors, pCRII (Invitrogen,
Abingdon, UK) illustrated in Figure 2.1. and pGEM-T easy vector, illustrated in
Figure 2.2. (Promega). Amplification of the cDNA was followed by ligation of
the PCR product and plasmid.
The pCRII vector was ligated to the PCR product using the TOPO™TA
cloning® kit (Invitrogen) and was carried out following manufacturer's
instructions. The vector is provided already linearised and covalently bound to
topoisomerase which undergoes spontaneous ligation after 5 minutes
incubation at room temperature. 5-20ng of PCR product and 1 volume of
vector were mixed together to give a final reaction mix of 5pl made up with
water.
Figure 2.1: Map of the pCR® II vector. The pCR®II vector shown above was
used in the subclonng of RTPCR products. The PCR product was ligated into
the region marked 'insert' using TA cloning such that the insert was flanked on
either side by EcoRI restriction sites. Diagram adapted from Invitrogen web
site.
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The pGEM-T easy vector was ligated with the PCR product at appropriate
molar ratios (3:1 respectively) with T4 DNA ligase (Promega). The
concentration of PCR product was assessed by comparison with known
standards on an agarose gel and was added to the ligation mixture such that
there was a 1:3 molar ratio of plasmid to PCR product. 25ng plasmid vector
and 1U T4 DNA ligase (as supplied by plasmid supplier) were mixed with 75ng
of PCR product, lpl lOx ligation buffer (contains 300mM Tris-HCl pH 7.8,
























Figure 2.2: Map of pGEM ®-T Easy vector. RTPCR products were subcloned
into the pGEM ®-T Easy vector using T4 DNA ligase. The PCR insert was
ligated into the region between the two T's such that the insert was flanked by
an EcoRI site and a Spel site. Diagram adapted from Promega web site
Following ligation, transformation of competent TOPIOF' (pCRII vector) or
JM109 (pGEM-T easy vector) E.Coli cells was carried out as follows; 2pl of 0.5M
(3-mercaptoethanol was added to each vial of competent cells prior to the
addition of 2pl of ligation reaction (as described above). The mixture was
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incubated on ice for 30 minutes, heat-shocked by incubating at 42°C for 30
seconds (pCRII) or 45 seconds (pGEM-T) and then placed on ice for 2 minutes.
Thereafter 450pl SOC medium (2% Bacto tryptone, 0.5% Bacto yeast extract,
lOmM NaCl, 2.5mM KC1, lOmM MgCl2, lOmM MgSCh and 20mM glucose)
prewarmed to 37°C was added to the cells which were subsequently incubated
at 37°C on a shaker at 225rpm for 1 hour. Aliquots (50^1 and 100^1) were plated
onto Luria Bertani (LB) agar plates (Appendix I) containing 50|ig/ml ampicillin,
50pl 50|ig/ml X-gal and lOOpl lOOmM IPTG (pCRII) or lOOpg/ml ampicillin,
50pl 50pg/ml X-gal and lOOgl lOOmM IPTG (pGEM-T) with a bent glass rod.
Plates were incubated inverted overnight at 37°C.
Identification of bacterial colonies which were transformed with plasmid
containing the cDNA insert was based on the lac Z blue/white selection. Both
pCRII and pGEM-T easy vectors contain the lac Z gene in their polylinker
region (Figures 2.2. and 2.1.). Lac Z gene expression was induced by IPTG to
express the product (l-galactosidase. This acted on the substrate X-gal, which
P-galactosidase converted into a blue coloured end product. The lac Z gene
was disrupted by the insertion of the cDNA sequence into the vector by
ligation. Therefore bacterial colonies that contained plasmid without the cDNA
insert had a functional lac Z gene and were blue whereas those colonies which
were successfully transformed with recombinant plasmid were white.
The bacterial colonies containing the cloned plasmid were restreaked on LB
agar plates which were again incubated inverted overnight at 37°C. Individual
white bacterial colonies were picked into LB broth (Appendix I) and were
propagated overnight at 37°C in LB broth containing 50pg/ml ampicillin in a
shaker at 225 rpm.
2.6. Plasmid recovery and analysis
2.6.1. Plasmid recovery
Plasmid DNA was isolated for analysis from bacterial cultures by the alkaline
lysis method using the Wizard Minipreps DNA purification system (Promega),
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according to the manufacturer's instructions. Briefly, bacterial suspensions
were pelleted by centrifugation at 1600g, the supernatant discarded, cells
resuspended in buffer containing 50mM Tris/HCl, pH 7.5, lOmM EDTA and
lOOpg/ml RNase and mixed with an equal volume of 0.2M NaOH containing
1% SDS. The resulting solution containing lysed bacterial cells was neutralised
by the addition of 2.25M potassium acetate. This suspension was centrifuged at
12000g to sediment the majority of bacterial genomic DNA. The supernatant
(approximately 600|ul) was removed, mixed with a 1ml suspension of DNA
purification resin and passed through a miniprep column which retained the
plasmid DNA bound to the resin. The plasmid DNA was then eluted into a
sterile tube by the addition of 50jul pure water and subsequent centrifugation at
12000g for 30 seconds.
The presence of cDNA insert of appropriate size was confirmed by restriction
digestion with the endonuclease EcoRI and electrophoresis of digestion
products on an agarose gel (section 2.6.2.) prior to definitive analysis by DNA
sequencing.
2.6.2. Analysis of plasmid DNA quality
The approximate concentration of plasmid DNA was determined by scanning
at 260nm on a spectrophotometer. The concentration of the DNA was
calculated from the 260nm value given that an optical density of 1.0 is equal to
50|iig/ml double stranded DNA. Purity of plasmid DNA was determined by
analysis on a 1.0% agarose minigel (Sambrook et al, 1989) prepared using
agarose (Sigma) dissolved in lxTAE buffer (appendix I). The agarose was
melted and approximately 200/xg/ml ethidium bromide was added for
visualisation of DNA. The gel was poured into a 7cm by 10cm gel tray
containing an 8 or 12 well comb and after setting was submerged in lxTAE
buffer in 'Minnie the Gel-Cicle' cell (Hoefer, Newcastle, UK). Plasmid DNA
(1/xl) was run in a sample solution containing 2pi loading buffer (contained
0.25% w/v orange G (Sigma, St Louis, USA), 15% ficoll and 0.5M EDTA at pH
7.0) and 7/xl water. Samples were separated in parallel with pGEM DNA
markers (range 36-2645 bps, Promega) by electrophoresis at 100V for 1-2 hours
in lxTBE, viewed under UV light and photographed. Pure plasmid DNA
appeared as two visible 'bands' of greater than 2kb (depending on plasmid
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size); one for the circular DNA and the other representing supercoiled DNA
which migrates more rapidly through the gel due to its compact form.
2.7. DNA sequencing
2.7.1. Automatic sequencing
Automatic sequencing reactions were carried out using the Taq DyeDeoxy
Terminator Cycle Sequencing kit (Applied Biosystems) and were run on the
Applied Biosystems Model 373A DNA sequencing system.
2.7.2. Sequencing reactions
The sequencing reaction was set up using the ABI PRISM Big Dye™ terminator
cycle sequencing ready reaction kit (Perkin Elmer, California, USA). 4/d of
terminator ready reaction mix (which contained Tris/HCl, pH 9.0, MgCl2,
thermal stable pyrophosphate, dNTPs, A-,C-,T- and I-dye terminators and
AmpliTaq DNA polymerase, FS), 4/xl half termmix (GENPAK Ltd, Brighton,
UK) and 5 pM of primer were used for each sequencing reaction. A maximum
volume of 11/rl DNA template was sequenced per reaction with 30-90ng of PCR
template and 200-500ng of plasmid template being optimal amounts. The total
volume per reaction was adjusted to 20/xl with sterile water.
Tubes were placed in a Hybaid Omn-E HBTRE thermal cycler (Hybaid,
Teddington, UK) preheated to 96°C and 25 cycles of thermal cycling carried out
as follows; rapid thermal ramp to 96°C, 96°C for 30 seconds, rapid thermal
ramp to 50°C, 50°C for 15 seconds, rapid thermal ramp to 60°C and 60°C for 4
minutes.
On completion of the sequencing reaction, the samples were extracted with 2pi
3M sodium acetate pH 4.6 and 50p\ cold 95% ethanol which were thoroughly
mixed and left at 21°C for 15 minutes to remove unincorporated labelled
terminators. Labelled DNA was pelleted by centrifugation at 12000g for 20
minutes, the supernatant discarded and the DNA washed using 75% ethanol,
air dried and resuspended in 8/xl loading buffer (deionised formamide/50mM
EDTA pH 8.0 buffer (5:1)) just before loading onto the gel.
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2.7.3. Automatic sequencing gel
A sequencing gel mix containing 50g urea (Sigma), 15ml 40% acrylamide and
water made up to a final volume of 80ml was prepared. Amberlite resin
(Sigma) was added to remove acrylamide free acid and the mixture was stirred
and heated until the urea had dissolved, the solution was filtered through a
150ml filter unit (Narseve, New York, USA) and 10ml lOx TBE added. The gel
mix was polymerised using 45gl TEMED and 500/rl 10% ammonium
persulphate and poured carefully between clean glass plates and a 0.8mm 24
well comb was used to form the lane wells.
The gel was prerun for 30 minutes at 30W. Samples resuspended in 8/rl of
loading buffer (section 2.8.2) were heated to 95°C for 5 minutes before loading
onto the gel. The gel was run overnight using automatic data collection and
analysis programs and Genejockeyll (Biosoft, Cambridge, U.K.).
2.8. Preparation of radiolabeled probes for Northern blot
analysis
2.8.1. Preparation of template DNA for radiolabelling
Double stranded DNA was usually prepared for radiolabelling by amplification
of the cloned cDNA insert from a plasmid vector using a PCR mix as described
in section 2.5.2. The appropriate oligonucleotide 5' and 3' primers used in the
original amplification of the cDNA insert were used. 0.5pM of primers were
used/ 50jU.l reactions containing 100-500ng of plasmid DNA as
template. Thirty-five cycles of amplification were performed as described in
section 2.5.2.
Amplification of the required DNA insert was checked by running 10/xl of the
PCR sample on a 1% agarose gel with known DNA markers (see section 2.6.2.).
The correct sized insert was excised from the gel and subsequently purified
using the QLAquick gel extraction kit (Qiagen), following the manufacturer's
instructions. Briefly, 3 volumes of buffer QG were added per lOOmg of gel,
buffer and gel were melted at 50°C and passed through a QIAquick column at
12000g for 1 minute. A further 0.5 volumes of buffer QG was washed through
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the column to remove all traces of agarose. The column and bound DNA were
washed twice with 0.5 volumes of buffer PE and dried with a final 12000g spin
for 1 minute. Bound DNA was eluted in 50pl of TE buffer (Appendix 1).
The concentration of purified DNA was calculated by scanning at 260nm on
spectrophotometer (GeneQuant). The concentration was determined from the
260nm value given that an optical density of 1.0 is equal to 50pg/ml DNA.
2.8.2. Radiolabelling double stranded DNA
Double stranded DNA was radiolabeled by the random primer method
(Feinberg and Vogelstein, 1983) using an Amersham 'Rediprime' kit
(Amersham Pharmacia Biotechnology) according to the manufacturer's
instructions. DNA (25-50ng) was denatured at 98°C for 5 min and was labelled
with 50/xCi of 32P-[a]-dCTP in a reaction containing 5/xl primer solution of
random hexanucleotides, lOmM each dATP, dGTP and dTTP and 5/xl reaction
buffer containing Tris/HCl (pH 7.5), 2-mercaptoethanol and MgC^. The
reaction was catalysed by addition of 2U Klenow enzyme and incubation was
for 15 minutes at 37°C. Labelled DNA was denatured with 5N NaOH (100/xl),
neutralised with 1M Tris HC1 pH 7.6 (600/xl) and 1M HC1 (375/xl) and added to
the hybridisation mixture without further purification (section 2.9.2.).
2.9. Northern blot analysis
2.9.1. RNA transfer to membrane
RNA separated on a denaturing gel (section 2.3.3.) was transferred to a nylon
membrane (Hybond NX from Amersham-Pharmacia Biotech,
Buckinghamshire, UK or Magna nylon transfer membrane, MSI, Westborough,
MA, USA) by capillary blotting as shown in Figure 2.3. The nylon membrane
was pre-wetted with pure water followed by lOx SSC (lx SSC containing 0.15M
NaCl and 0.015M sodium citrate, pH 7.0) before placing carefully on the gel.
Transfer using lOx SSC was allowed to continue for a minimum of 12 hours.
After transfer the position of the lanes was marked on the membrane and RNA
was bound using a spectrolinker X-L 1000 UV Crosslinker (Spectrotronics
Corporation, Cambridge, UK).










Figure 2.3. Transfer of RNA from agarose gel to nylon membrane. After total
RNA had been separated by gel electrophoresis apparatus was set up as above,
the gel was inverted and RNA was transferred to the nylon membrane by
capillary action over a 24 hour period.
2.9.2. Hybridisation of radiolabeled probe to membrane
Membranes were prehybridised at 42°C for 30 minutes in preheated (68°C)
ULTRAhyb™ buffer (Ambion). Radiolabeled probe was added to the
hybridisation mix at a final concentration of 0.5 - lxlO6 cpm/ml buffer.
Hybrisation was allowed to continue for overnight (14-24 hours) at 42°C.
2.9.3. Post-hybridisation washes
ULTRAhyb™ buffer was discarded and membranes were washed twice for 10
minutes at 42°C with buffer containing 2x SSC and 0.1% w/v SDS and then
twice for 20 minutes at 50°C in buffer containing O.lxSSC and 0.1% w/v SDS.
For more stringent washes the second wash buffer (O.lxSSC and 0.1% w/v
SDS) was repeated for 2x20 minutes at 60°C.
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2.9.4. Development of signal
After washing, membranes were wrapped in clingfilm. The membrane was
then exposed to X-ray film (XAR-5 or X-Omat S; Kodak) in cassettes with Du
Pont enhancing screens at -70°C. After a specific exposure time the signal was
developed using LX 24 developer and fixed using FX 40 fixative according to
the suppliers recommendations (both Kodak). In order to quantify signals,
membranes were placed in stormscanner cassettes containing storage
phosphor screens (Molecular Dynamics, Sunnydale, CA, U.S.A) for specific
exposure times. The relative optical density of the hybridised signals (both
specific probes and 18S standards) were determined on a Storm™ optical
scanner (Molecular Dynamics) using ImageQuant™ program (Molecular
Dynamics). The 18S standard was used to correct for loading variations in the
RNA samples.
2.10.lmmunohistochemistry
2.10.1. Tissue pretreatment and primary antibody
Paraffin tissue sections prepared as described in section 3.4. and mounted onto
glass slides. Sections were dewaxed in histoclear for approximately 5 minutes
and rehydrated in decreasing concentrations of alcohol (100%, 96% and 70%
respectively). The tissue sections were placed in 3% hydrogen peroxide in
methanol for 30 minutes to reduce endogenous peroxidase activity. Slides
were then washed in 0.05M Tris-HCl buffer pH7.4 containing 0.85% w/v NaCl
(TBS) for 5 minutes. If antigen retrieval (details given in appropriate chapters),
was required for the detection of the protein by the primary antibody it was
carried out at this point. The tissue sections were then incubated with normal
serum from the species in which the secondary antibody was raised (usually
swine or rabbit) and diluted 1:5 in TBS for 30 minutes at room temperature.
After this incubation, the normal serum was removed carefully from the
sections with a tissue and replaced with primary antibody (in 1:5 normal serum:
TBS) at an appropriate dilution, details of which are given in relevant chapters.
Tissue was incubated with the primary antibody overnight at 4°C in a
humidified chamber. The following day excess antibody was removed by two
5 minute washes with TBS.
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2.10.2. Secondary antibody and detection system
The secondary antibodies for the HRP detection system were biotinylated for
subsequent conjugation to avidin-linked peroxidase enzyme complexes.
Secondary antibodies were diluted 1:500 in TBS and incubated on the tissue
sections for 30 minutes. Excess antibody was removed by 2x5 minute washes
with TBS. Sections were incubated in the presence of avidin-biotin horseradish
peroxidase complex (Dako, Glostrup, Denmark) for 30 minutes. This bound to
the biotinylated secondary antibody and formed a complex which served to
amplify the signal obtained from the primary antibody. The solution was
prepared according to the suppliers instructions in 0.05M Tris-HCl pH7.4 at
least 20 minutes before use. Excess complex was removed by 2x5 minute
washes in TBS and bound antibody visualised with a solution of 225/zM DAB in
0.05M Tris/HCl, pH7.6 containing 0.01% hydrogen peroxide. Sections were
washed in tap water and counterstained in haemotoxylin. They were
subsequently dehydrated, cleared in xylene and mounted in pertex mounting
fluid (Solmedia Lab Suppliers, Essex, U.K.) with coverslips.
Chapter 3.
Expression of Maturational Markers During
Development of the Postnatal Rat Testis.
3.1. Introduction
During postnatal development in the rat, testicular cell populations undergo a
number of transformations critical for the establishment of efficient
spermatogenesis and the production of adequate amounts of testosterone by
the adult testis. The fetal Leydig cell population declines in number and function
after birth (Mendis-Handagama et al., 1987). The Sertoli cell population ceases
proliferation in parallel with proliferation and differentiation of adult Leydig
cells (Clermont and Perey, 1957; Hardy et al., 1989; Saez, 1994; Steinberger and
Steinberger, 1971; Zhengwei et al., 1990). The first wave of spermatogenesis
takes place with an increase in the number of spermatogonia, the spermatocyte
population becomes active followed by an expansion in spermatid numbers
(Clermont and Perey, 1957). A significant amount of apoptosis and cell loss is
also associated with the onset of spermatogenesis.
Postnatal development of the testis is a tightly regulated process controlled by
endocrine factors and paracrine and autocrine interactions. The functional
maturation of the Sertoli cell plays a pivotal role within this process. However
Sertoli cell differentiation cannot begin until the cell has ceased dividing. In
neonatal hypothyroidism Sertoli cell differentiation is delayed due to a
prolonged period of cell replication and this results in a delay in the onset of
germ cell proliferation and lumen formation (van Haaster et al., 1992). Proteins
secreted by immature Sertoli cells inhibit differentiation of Leydig cell
precursors and consequently mature Sertoli cells affect/modify Leydig cell
development via the production of paracrine factors (Kerr and Sharpe, 1985;
Perrard-Sapori et al., 1987).
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The control of postnatal testicular development is a complicated process and is
not yet fully understood. Numerous changes in key interactions involving
Sertoli cells arise during this time; the hypothalamic-pituitary-testicular axis is
established and a number of intratesticular paracrine interactions are set up in
addition to altered endocrine environments and changing spermatogenic cell
complements. In order to further investigate the regulation of postnatal
testicular development additional markers of testicular functional maturation
need to be established. Thus the aims of this study were to investigate normal
development of the postnatal rat testis with emphasis on maturational changes
in Sertoli cell protein expression. The expression patterns of known and
potential markers of Sertoli cell functional maturation were studied at the level
of gene transcription and protein expression. It was hoped that in future studies
these preliminary results could be used to better define the stages of postnatal
testicular development. Detailed markers of Sertoli cell development and
maturation are essential in studies in which testicular development has been
modified by exogenous agents (Sharpe et al., 1998). Sertoli cell proliferation
within the rat testis was also studied in order to establish when Sertoli cell
mitosis ceased and subsequent cell maturation began in the testes of the rats
being studied in this report. Examination of spatial and temporal changes in
oestrogen and androgen receptors was also carried out to determine the sites of
direct steroid action in the postnatal testis as it was hoped that in future studies
the effect of oestrogen and testosterone on Sertoli function would be
investigated.
Five proteins expressed in postnatal Sertoli cells were studied:
SGP-1. SGP-1 is one of the most abundant Sertoli cell products detectable by gel
electrophoresis. mRNA levels peak between postnatal days 10 and 20 after
which levels decline such that in the adult levels of SGP-1 mRNA are similar to
those in day 3 Sertoli cells (Mathur et al., 1994). SGP-1 expression by Sertoli cells
does not appear to be regulated by hormones or germ cell complement
(Mathur et al., 1994). It has been proposed that the pattern of SGP-1 expression
in Sertoli cells is dependent upon the chronological age of the Sertoli cell rather
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than the maturational stage of the cell (Bunick et al., 1994). SGP-1 was therefore
included in these studies as a possible marker of Sertoli cell 'age' rather than as a
marker of Sertoli differentiation.
Inhibin-alpha (a). The alpha subunit of both inhibins A and B is produced by
Sertoli cells and both mRNA and protein expression of inhibin-a is greatest
during immature testis development (Gondos and Berndston, 1994). Inhibin-a
levels have been extensively used as a marker of Sertoli cell function and
development due to the fact that expression becomes stage specific as the Sertoli
cell matures and germ cell complement increases (Majdic et al., 1997). Inhibin-a
was included in the present study as a well described and researched marker of
Sertoli cell functional maturation and could therefore be used as a standard by
which to compare other less well known Sertoli cell proteins.
Musashi-1. The RNA binding protein, Musashi-1 is expressed in Sertoli cells of
fetal, immature and adult testis. Expression is both cytoplasmic and nuclear.
However with the onset of Sertoli cell maturation preliminary studies have
suggested that Musashi-1 expression becomes predominantly nuclear (Maguire
et al., 1999). In the adult testis Musashi-1 expression is most abundant in tubules
at spermatogenic stages where expression levels of androgen receptor were
lowest (stages XI-VI) (Bremner et al., 1994; Maguire et al., 1999). For these
reasons Musashi-1 was investigated as a novel marker of Sertoli cell functional
maturation with the possibility of steroid or germ cell regulated expression.
GATA-1. Testicular expression of the zinc finger transcription factor GATA-1 is
restricted to Sertoli cell nuclei (Ketola et al., 1999; Yomogida et al., 1994) and
reaches maximal levels of expression between 14 and 23 days of age (Viger et al.,
1998). GATA-1 expression becomes stage dependent with the onset of the first
wave of spermatogenesis. Expression of GATA-1 in the adult testis is restricted
to stages VII-IX (Yomogida et al., 1994). These authors suggested that
expression may be inhibited by certain germ cell populations and /or
upregulated by testosterone. GATA-1 was included in this study as a possible
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marker of Sertoli cell maturation as expression is upregulated when Sertoli cell
differentiation begins and expression is possibly regulated by germ cells and /or
steroids. GATA-1 has also been shown to upregulate inhibin-a expression in
Leydig cells (Feng et al., 1998) and could therefore play an important role within
the differentiated Sertoli cell.
GATA-4. GATA-4 is another member of the GATA zinc finger family of
transcription factors and is expressed in Sertoli and Leydig cells of fetal and
immature testes. GATA-4 Sertoli cell mRNA levels are maximal up to postnatal
day 14 after which levels begin to decline alongside increasing Sertoli cell
maturation (Ketola et al.r 1999). There is some disagreement regarding GATA-4
expression in adult testis: Heikinheimo et al., (1997) and Ketola et al., (1999) state
that although mRNA levels are low in the adult testis, GATA-4 continues to be
expressed in both Sertoli and Leydig cells. Viger et al., (1998) disagree and state
that as Sertoli cell proliferation ceases GATA-4 expression switches from the
Sertoli cell to the germ cells. It has also been suggested that GATA-1 'takes
over' the function of GATA-4 within the Sertoli cell at this point (Viger et al.,
1998). During this study it was hoped to determine if GATA-4 continued to be
expressed in Sertoli cells following the onset ofmaturation or if the transcription
factor was a marker of immature proliferating Sertoli cells where expression
declined with increasing differentiation.
Expression patterns of steroid receptors in the postnatal rat testis were also
studied;
Androgen receptor (AR)
Levels of AR protein and mRNA have been previously shown to increase as
Sertoli cells develop and expression becomes stage dependent in the adult
Sertoli cell (Bremner et al., 1994; Majdic et al., 1995). Therefore AR expression in
Sertoli cells can be used as a marker of cell maturation.
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Oestrogen receptor alpha (ERa)
It is generally agreed that ERa expression in the postnatal rat testis is restricted
to fetal and adult type Leydig cells (Fisher et al., 1997).
Oestrogen receptor beta (ERfi)
ER(3 expression had not been investigated prior to this study but ER(3 expression
has since been observed in Sertoli cell nuclei throughout postnatal testis
development in the rat (Saunders et al., 1998; van Pelt et al., 1999).
3.2. Experimental Procedures
3.2.1. Preparation of cDNA probes
3.2.1.1. SGP-1
A 353bp cDNA for rat SGP-1 contained in a pCRII-TOPO vector had been
previously constructed 'in house' (Millar et al., 1995). The cloned SGP-1 cDNA
insert was prepared for radiolabelling as described in section 2.8.1.
3.2.1.2. Inhibin-a
A 432bp cDNA for rat inhibin-a had been previously cloned 'in-house' into
Bluescript vector (Pineau et al., 1990). The cDNA insert was prepared for
radiolabelling as described in section 2.8.1.
3.2.1.3. Musashi-1
A 413bp cDNA for rat Musashi-1 was obtained from Dr Sharon Maguire who
had amplified the partial cDNA from rat ovarian cDNA using sequence specific
primers. The cDNA was contained in pCRII-TOPO vector and was prepared for
radiolabelling as described in section 2.8.1.
3.2.1.4. GATA-4
Oligonucleotide primers were selected by Dr Philippa Saunders to amplify from
base 1198 to base 1860 of the published sequence of mouse GATA-4 (Arceci et
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al., 1993). The oligonucleotide sequences were; 5'primer 5'TTG ACG ACT TCT
CAG AAG GCA G3' (bases 1198-1219) and 3' primer 5'CCG ACA AGG TTC
TCA GGA C3' (bases 1842-1860). The cDNA was amplified by PCR from a pool
of day 10 rat testis cDNAs prepared by random priming (section 2.5.2). Using
the PCR mix as in section 2.5.2 thirty five amplification cycles were performed
with an annealing temperature of 60°C for 35 seconds and a 45 second extension
at 72°C. Following amplification the 663bp partial cDNA was purified,
sequenced and subcloned into pCRII-TOPO vector (see Chapter 2). The rat
GATA-4 partial cDNA had 96.2% sequence homology with the published mouse
GATA-4 cDNA over this region of sequence. The cloned cDNA was prepared
for radiolabelling as described in section 2.8.1.
3.2.1.5. GATA-1
Oligonucleotide primers were selected by Dr Philippa Saunders to amplify from
base 2417 to base 3045 of the published sequence of rat GATA-1 cDNA (Ito et al.,
1993). The oligonucleotide sequences were; 5'primer 5'GTT TGT GGA TTC TGC
CCT GGT GTC3' (bases 2417-2440) and 3' primer 5'CAT TGC ACA GGT AGT
GAC CTG TCC3' (bases 3022-3045). The cDNA was amplified by PCR from a
pool of day 21 rat testis cDNAs prepared by reverse transcription using oligo dT
primers (section 2.5.2). Using the PCR mix as in section 2.5.2 thirty five
amplification cycles were performed with an annealing temperature of 60°C for
35 seconds and a 45 second extension at 72°C. Following amplification the
627bp partial cDNA was purified, sequenced and subcloned into pCRH-TOPO
vector (see Chapter 2). The cloned cDNA was prepared for radiolabelling as
described in section 2.8.1.
3.2.1.6. 18S ribosomal RNA
A 423bp cDNA for rat 18S which had been previously cloned into a pCRII-TOPO
vector was obtained from Dr. Katie Turner. The cDNA was prepared for
radiolabelling as described in section 2.8.1.
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3.2.2. RNA extraction and separation
Total RNA was extracted from rat tissue and separated on a 1.5% denaturing
agarose gel as described in sections 2.3.2. and 2.3.3., respectively. RNA was
obtained from testis of rats aged between postnatal day 1 to adult rats (which
were older than postnatal day 70). For each age group used, testes were
obtained from two separate litters. Due to the small size of testes from rats
aged postnatal days 1 and 5, RNA from these litters was pooled.
3.2.3. Northern blot analysis
Separated total RNA was transferred onto a nylon membrane as described in
section 2.9.1. and Northern blot analysis was performed as in section 2.9.
3.2.4. Bromodeoxyuridine (BrDU) Treatment
BrDU (Sigma) treatment of immatureWistar rats was very kindly carried out by
Dr. Richard Sharpe as described in Sharpe et al., (1999). Briefly, groups of four
to six male Wistar rats aged postnatal day 3 to day 21 were administered
lOOmg/kg of BrDU 1 hour before the rats were killed as described in section
2.2.1. BrDU is a thymidine analogue and was used to label cells undergoing
DNA replication during the S phase of the cell cycle.
3.2.5. Tissue Collection and Fixation
Rats testes were collected and fixed as described in Chapter 2. At the mid point
of fixation testes were weighed and testis weight was recorded in mg. Tissue
sections were cut and prepared for immunocytochemical staining as described
in sections 2.4. Testes fixed for immunocytochemical staining were from a
minimum of two different animals per age group and were analysed on the
same slide.
3.2.6. Immunocytochemical staining
Immunocytochemical staining was performed as described in section 2.10.
Specific details for each antibody are given below:
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3.2.6.1. Markers of cell division
Three different antibodies were used to study cell proliferation during
prepubertal development;
Proliferating cell nuclear antigen (PCNA). PCNA functions as an auxiliary protein
to DNA polymerase delta (Bravo et al., 1987) and is strongly expressed in cells
during G1 and S phases of the cell cycle. Weaker PCNA expression also occurs
during the M phase (Kurki et al., 1986). A mouse monoclonal antibody raised
against PCNA (DAKO) was used at a dilution of 1:100 and biotinylated rabbit
anti-mouse immunoglobulins were used as secondary antibodies. No antigen
retrieval was carried out.
Ki67. Ki67 is abundantly expressed during the G2 and M phases of the cell cycle.
A monoclonal antibody raised against Ki67 in the mouse (Novocastra) was used
at a dilution of 1:50 and biotinylated rabbit anti-mouse immunoglobulins were
employed as the secondary antibody. Tissue sections were subjected to antigen
retrieval prior to the application of primary antibody. Slides were pressure
cooked for 5 minutes in pre boiled 0.01M citrate buffer pH 6. The pressure was
then released and sections were allowed to stand for 20 minutes undisturbed
before washing twice in TBS for 5 minutes.
BrDU. An anti-BrDU mouse monoclonal antibody (Boehringer) was used at a
dilution of 1:30. Biotinylated rabbit anti-mouse immunoglobulins were applied
as the secondary antibody. Antigen retrieval on tissue sections was carried out
as for Ki67.
3.2.6.2. Markers of testicular development
SGP-1. A rabbit polyclonal antibody, kindly donated by Dr. Steven Sylvester
(University of Washington, Seattle) was used to immunolocalise SGP-1 to tissue
sections. The antibody was used at a dilution of 1:1000 and biotinylated swine
anti-rabbit immunoglobulins were used as the secondary antibody. No antigen
retrieval was carried out.
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Inhibin-a. Immunolocalisation of inhibin-a was carried out using a monoclonal
antibody (173/9K) which was a gift from Dr. Nigel Groome (Oxford Brookes
University, Oxford). The antibody was used at a dilution of 1:450 and the
secondary antibody was biotinylated rabbit anti-mouse immunoglobulin.
Antigen retrieval was carried out as for Ki67.
Musashi-1. Dr. Sharon Maguire kindly carried out the immunolocalisation of
Musashi-1 to rat testes tissue sections using an anti-mouse-Musashi-1
monoclonal antibody raised in the rat according to standard procedures using a
GST-mouse-Musashi-1 fusion protein (Sakakibara et al., 1996). The antibody was
a gift from Professor Okano (Osaka University, Japan) to Dr. Philippa Saunders
and was used at a dilution 1:25000. Biotinylated rabbit anti-rat immunoglobulins
(Vector, Peterborough, U.K.) were used as the secondary antibody. Tissue
sections were subjected to antigen retrieval as given for Ki67. An avidin-biotin
block using the Avidin/Biotin blocking kit from Vector was carried out to
reduce non-specific interstitial staining. 4 drops of the Avidin D blocking
solution was added per ml of normal rabbit blocking serum which was left on
the tissue sections for 30 minutes followed by 2 x 5 minute TBS washes. 4 drops
of Biotin solution per ml of TBS used was added to the slides for 15 minutes
followed by two additional 5 minute TBS washes. The primary antibody was
then added and immunocytochemical staining was continued as in section 2.10.
GATA-4. A goat polyclonal anti-rat GATA-4 antibody (SantaCruz) was used at
a dilution of 1:500. Biotinylated rabbit anti-goat immunoglobulins (DAKO)
were utilised as secondary antibodies. Antigen retrieval was carried out as
described for Ki67.
GATA-1. A rat monoclonal antibody against GATA-1 (Santa Cruz) was used at
a dilution of 1:500 and biotinylated rabbit anti-rat immunoglobulins (Vector)
were used as the secondary antibody. Tissue sections were subjected to antigen
retrieval as described for Ki67. Due to non-specific interstitial staining an
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Avidin/Biotin block was carried out between antigen retrieval and primary
antibody addition, as described for Musashi-1.
3.2.6.3. Steroid hormone receptors
Androgen receptor (AR). A rabbit polyclonal antibody (Santa Cruz) was used to
immunolocalise AR to the tissue sections. The antibody was used at a dilution of
1:200 and antigen retrieval was carried out as for Ki67. In place of the
biotinylated secondary antibody and avidin-conjugated horseradish peroxidase
complex, DAKO EnVision + System (anti rabbit) with peroxidase (DAKO) was
applied to the sections for 30 minutes, following manufacturers instructions.
The system is based on an HRP labelled polymer which is conjugated to an anti-
rabbit secondary antibody resulting in a more sensitive detection system. DAB
was then applied to the sections as in section 2.10.2.
Oestrogen receptor beta (ER/3). A sheep polyclonal antibody raised against a
peptide within the hinge domain of human ER(3 was generated in house by Dr.
Philippa Saunders (Saunders et al., 2000). The ER[3 antibody was used at a
dilution of 1:1000. Biotinylated rabbit anti-sheep immunoglobulins were
employed as secondary antibody (Vector). Antigen retrieval was carried out as
for Ki67 except that 0.01M glycine pH 3.5 was used in place of 0.01M citrate
buffer pH6.
Oestrogen receptor alpha (ERa). A monoclonal anti-human ERa antibody
(Novacastra) was utilised to immunolocalise ERa. The antibody was used at a
dilution of 1:20 and antigen retrieval was carried out as for Ki67. DAKO
EnVision + System (anti mouse) with peroxidase (DAKO) was used in place of
secondary antibody and conjugated horseradish peroxidase. The system is
based on an HRP labelled polymer which is conjugated to an anti-mouse
secondary antibody resulting in a more sensitive detection system. DAB was
then applied to the sections as in section 2.10.2.
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The specificity of the specific antibodies (except for ER(3) was checked by
replacing each antibody with normal serum from the animal species that the
primary antibody was raised in. The normal serum was diluted to ensure
protein content was the same as in the diluted primary antibody. In the case of
ERfb the peptide to which the primary antibody was raised was incubated in the
presence of the primary antibody overnight at 4°C. The concentration of
incubated peptide was ten times that of the antibody with regards to protein
content. The pre-absorbed antibody was then diluted to the working
concentration which corresponded to that of the primary antibody. None of the
above controls resulted in any signal above background.
Sections were analysed using an Olympus Provis microscope and images were
captured onto computer using either a Kodak DCS420 camera or a Kodak
DCS330 camera and images were stored on the computer using the Photoshop
5.0 programme (Adobe).
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3.3. Results
3.3.1. Sertoli cell multiplication
mean testis weight (mg)
Figure 3.1 Changes in mean testis weight during postnatal development.
Graph to show changes in weight of testis during postnatal development in the
rat. Testes removed from rats aged between postnatal day 3 and 34 were
weighed (mg). Mean testes weight for each age group was calculated and the
number of animals per age group are shown in brackets.
Testes removed from rats aged postnatal day 3 to day 34 were weighed and
mean testis weight in mg for each age were calculated and are presented in
Figure 3.1. The bar chart clearly shows that testis weight remained fairly
constant between days 3 and 9 of postnatal life but thereafter more than
doubled over the next 12 days such that by day 28 testes weighed nearly fifty
Chapter Three Postnatal Development of the Rat Testis 81
times that at day 3. By day 34, testis weight had further increased at least one
hundred fold compared to testis weight at day 3.
3.3.1.1. PCNA
Immunocytochemical staining with anti-PCNA antibody resulted in a strong
immunopositive signal restricted to the nuclei of cells. At all ages examined
there were immunonegative cells within the interstitium. However there was
strong immunolocalisation of PCNA to some interstitial cells in day 3 and day 9
testes (Fig. 3.2.a, b). Numbers of positively stained interstitial cells appeared to
be reduced in day 15 and 16 testes (Fig. 3.2.c, d) but increased again in day 18
and 21 testis (Fig. 3.2.e, f). In day 3 testes the majority of cells in the
seminiferous tubules were strongly immunopositive for PCNA (Fig. 3.2.a). The
number of immunopositive Sertoli cells was reduced as postnatal development
progressed such that by day 15 and 16 the majority of Sertoli cell nuclei were
immunonegative for PCNA (Fig. 3.2.c, d, arrows). The number of
immunopositive Sertoli cells continued to decline although at day 21 a small
number of Sertoli cells remained immunopositive (Fig. 3.2.f, black arrowheads).
In the adult testes all Sertoli cell nuclei were immunonegative for PCNA (Fig.
3.2.g). Immunopositive spermatogonia were first observed in day 9 testes (Fig.
3.2.b blue arrowheads). Thereafter increasing numbers of immunopositive
spermatogonia were observed as germ cell numbers increased. With the first
wave of spermatogenesis some immunopositive primary spermatocytes could
be observed in day 18 rat testes. The number of positively stained
spermatocytes was increased by day 21 (Fig. 3.2.f). However in the adult testis
spermatogonia were the only immunopositively labelled cells (Fig. 3.2.g, blue
arrowheads).
3.3.1.2. Ki67
An intense immunopositive signal for Ki67 antibody was restricted to the nuclei
of dividing cells. A large proportion of interstitial cells were stained
immunopositively for Ki67 in day 3 testes (Fig. 3.3.a). By day 18 the number of
positively stained interstitial cells had declined (Fig. 3.3.c) and remained low in
day 21 testes (Fig. 3.3.d). The majority of cells within the seminiferous tubules
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of day 3 testes were strongly immunostained for Ki67 (Fig. 3.3.a, arrowheads).
By day 14 the majority of Sertoli cells were immunonegative (Fig. 3.3.b, arrows)
and in day 18 testes all Sertoli cell nuclei were immunonegative for Ki67 (Fig.
3.3.c, arrows). Spermatogonia had weak Ki67 immunostaining in day 3 testes
(Fig. 3.3.a). However by day 14 (Fig. 3.3.b) the intensity of staining and the
number of immunopositive spermatogonia had increased such that by day 18
and 21 the majority of spermatogonia were immunopositive (Fig. 3.3. c, d).
Ki67 was first localised to primary spermatocytes in day 18 testes and
immunostaining of primary spermatocytes was still present in day 21 testis (Fig.
3.3. c, d).
3.3.1.3. BrDU
The anti-BrDU antibody localised strongly to nuclei of cells in the S phase of
mitosis. Non uniform BrDU labelling of interstitial cells was observed in day 3,
day 5 and day 8 testes (Fig. 3.4.a-c). The number of labelled interstitial cells was
low in day 10 testis. However some interstitial cells were immunopositive for
BrDU in day 15 and day 21 testes (Fig. 3.4.e,f). Some Sertoli cells had strong
BrDU labelling in day 3 testes. However the intensity of labelling was variable
and some cells were immunonegative for BrDU at this age (Fig. 3.4.a). In day 5,
day 8 and day 10 rat testes (Fig 3.4 b-d) there were numerous positively labelled
Sertoli cell nuclei. However by day 15 (Fig 3.4.e) this number had markedly
declined and the majority of Sertoli cells had no BrDU labelling; in day 21 testis
no positively labelled Sertoli cell nuclei could be seen (Fig 3.4.f). In day 15 testes
weak BrDU labelling of spermatogonia could be observed in some tubules. By
day 21 BrDU labelling had become stronger and the number of labelled
spermatogonia had increased. The first labelled primary spermatocytes were
also seen at this age however some seminiferous tubules did not contain any
positively labelled germ cell (Fig. 3.4. f, asterisks).
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Figure 3.2: Immunolocalisation of PCNA to dividing cells in the postnatal
rat testis. Testes obtained from rats aged postnatal day 3 (a), day 9 (b). day 15
(c), day 16 (d), day 18 (e), day 21 (f), and adult (g) are shown. A representative
negative control using normal mouse IgGs in place of primary antibody on
day 15 testis is also shown (h). Arrowheads point to immunopositive Sertoli
cell nuclei. Blue arrowheads point to immunopositive spermatogonia. Arrows
point to immunonegative Sertoli cell nuclei. Scale bar represents 50pm.
Figure 3.3: Immunolocalisation of Ki67 to dividing cells in the postnatal
rat testis. Testes from rats aged postnatal day 3 (a), day 14 (b), day 18 (c)
and day 21 (d) are shown. Inset shows representative negative control
when primary antibody was replaced with normal mouse IgGs. Arrowheads
point to immunopositive Sertoli cell nuclei, arrows point to Sertoli cell nuclei
with low Ki67 immunostaining. Scale bar represents 50pm.
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Figure 3.4: BrDU labelling of proliferating cells in the postnatal rat testis.
Testes from rats aged postnatal day 3 (a), day 5 (b), day 8 (c), day 10 (d), day
15 (e) and day 21 (f) are shown. Inset shows a representative negative control
when primary antibody was replaced with normal mouse IgGs. Arrowheads
point to strongly labelled Sertoli cell nuclei, arrows point to Sertoli cell nuclei
with low BrDU labelling. Asterisks mark tubules containing immunonegative
cells only. Scale bar represents 50pm.
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3.3.2. mRNA expression in the postnatal Sertoli cell
3.3.2.1. SGP-1
The cDNA probe specific for rat SGP-1 was found to hybridise to a 2.6kb
transcript (as described in Collard et al., (1988) in testicular RNA from rats aged
postnatal day 1 (birth) to day 70 (adult) (Fig 3.5A). The RNA was reprobed
using a cDNA probe specific for rat 18S which hybridised to a 1.9kb transcript
(Fig 3.5B). Signals for both transcripts were quantified (section 2.9.4.) and the
SGP-1 signal was corrected for loading using the 18S signal (Fig 3.5 C). SGP-1
mRNA was rapidly upregulated after day 11 and maximal levels were reached
between days 15 and 18. SGP-1 mRNA levels declined slightly after day 21 and
by day 28 levels were similar to those seen in the adult testes.
3.3.2.2. Inhibin-a
Northern blot analysis using a cDNA probe for rat inhibin-a detected a 1.6kb
transcript in testicular RNA from rats aged postnatal day 1 (birth) to day 70
(adult). A strong signal for the inhibin-a transcript was seen at all ages studied
(Fig. 3.6A). Following 18S correction for loading error (Fig 3.6B) (section 2.9.4.)
changes in inhibin-a mRNA expression in testis during postnatal development
were examined (Fig. 3.6C). Inhibin-a mRNA levels slowly increased after birth
up to day 15 after which there was a slight decline in levels at day 18. Inhibin-a
mRNA expression was upregulated again in day 21 testes followed by a rapid
decline in inhibin-a mRNA levels such that expression in the adult testis was a
third of that at birth.





Figure 3.5: Northern blot analysis of SGP-1 mRNA expression during
postnatal rat testis development. All lanes were loaded with 10 jig of
total RNA extracted from testes obtained from rats aged postnatal day 1,
5,11,15,18, 21, 28, 35 and adult (rats aged day 70 and over). RNA was
hybridised with 32P-labelIed SGP-1 cDNA which detected a 2.6kb transcript
(A). The RNA was reprobed with a 32P-labelled 18S cDNA which hybridised
to a 1.9kb 18S rRNA transcript and was used to check for even loading of
RNA (B). Following quantification of hybridisation signals the ratios of
SGP-1 mRNA expression to 18S rRNA were plotted for each age to show
changes in testicular SGP-1 mRNA expression during postnatal
development (C).





Figure 3.6: Northern blot analysis of inhibin-a mRNA expression during
postnatal rat testis development. All lanes were loaded with 10 pg of total
RNA extracted from rats aged postnatal day 1,5,11,15,18, 21, 28, 35 and
adult (rats aged day 70 and over). RNA was hybridised with 32P-labelled
inhibin-a cDNA probe which detected a 1.5kb transcript (A). The RNA
was reprobed with a 32P-labelled 18S cDNA which hybridised to a 1.9kb
18S rRNA transcript and was used to check for even loading of RNA (B).
Following quantification of hybridisation signals the ratios of inhibin-a
mRNA expression to 18S rRNA were plotted for each age to show changes
in testicular inhibin-a mRNA expression during postnatal development (C).
A
















1 11 15 18 21 28 35 adult
Age (days postnatal)
Figure 3.7: Northern blot analysis of Musashi-1 mRNA expression during
postnatal rat testis development. All lanes were loaded with 10 [ig of total
RNA extracted from testes obtained from rats aged postnatal day 5,15,
18, 21, 28, 35 and adult (rats aged day 70 and over). RNA was hybridised with
32P-labelled Musashi-1 cDNA which detected a 3kb transcript (A). The RNA
was reprobed with a 32P-labelled 18S cDNA which hybridised to a 1.9kb 18S
rRNA transcript and was used to check for even loading of RNA (B). Following
quantification of hybridisation signals the ratios of Musashi-1 mRNA expression
to 18S rRNA were plotted for each age to show changes in testicular Musashi-1
mRNA expression during postnatal development (C).
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Figure 3.8: Northern blot analysis of GATA-4 mRNA expression during
postnatal rat testis development. All lanes were loaded with lOjig of total
RNA extracted from testes obtained from rats aged postnatal day 1,5,11,
15,18, 21, 28, 35 and adult (rats aged day 70 and over). RNA was hybridised
with 12P-labelled GATA-4 cDNA which detected a 3.1kb transcript (A).
The RNA was reprobed with a 32P-labeIled 18S cDNA which hybridised to a
1.9kb 18S rRNA transcript and was used to check for even loading of RNA (B).
Following quantification of hybridisation signals the ratios of GATA-4 mRNA
expression to 18S rRNA were plotted for each age to show changes in testicular
GATA-4 mRNA expression durng postnatal development (C).
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3.3.2.3. Musashi-1
Using a cDNA probe specific for rat Musashi-1, a 3kb transcript was detected in
testicular RNA from rats aged postnatal day 1 (birth) to day 70 (adult) (Fig.
3.7A). A cDNA probe for rat 18S was used to reprobe the RNA and a 1.9kb
transcript was detected (Fig. 3.7B) and used to correct the quantified Musashi-1
hybridisation signal for loading error (Fig 3.7C). Between birth and day 18
there was an upregulation in Musashi-1 mRNA levels reaching maximal levels at
day 18. Expression of Musashi-1 then rapidly declined and levels remained low
into adulthood.
3.3.2.4. GATA-4
A single 3.1kb transcript for rat GATA-4 was detected in testicular RNA from
rats aged postnatal day 1 to day 70 (Fig 3.8A). The signal for the GATA-4
transcript was quantified and corrected for 18S loading using the signal in Figure
3.8B. GATA-4 mRNA expression was rapidly upregulated after birth (Fig. 3.8C)
and reached maximal levels by day 18. GATA-4 mRNA expression levels then
declined and remained low into adulthood.
3.3.3. Immunoexpression of markers of testicular
development
3.3.3.1. SGP-1
Immunolocalisation of SGP-1 showed cytoplasmic staining in a number of
different testicular cell populations. In fetal day 20.5 and postnatal day 3 (Fig.
3.9. a, b) SGP-1 immunolocalisation was observed in cytoplasm of interstitial
cells and the intensity of staining was non uniform between what appeared to
be different cell populations. Interstitial immunolocalisation of SGP-1 remained
strong up to day 15 (Fig. 3.9. d); thereafter the number of immunopositive
interstitial cells declined such that in the adult testes all interstitial cells were
immunonegative for SGP-1 (Fig. 3.9. g). Positive immunoreaction of SGP-1 in
Sertoli cells was faint from
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Figure 3.9: Immunolocalisation of SGP-1 to postnatal rat testis. Testes from
rats aged fetal day 20.5 (a), postnatal day 3 (b), day 9 (c), day 15 (d), day 18 (e),
day 21 (f) and adult (g) are shown. A representative negative control using
normal rabbit IgGs in place of primary antibody on day 18 testis is also shown (h).
Arrows point to immunopositive macrophages. Scale bar represents 50pm
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Figure 3.10: Immunolocalisation of inhibin-a to postnatal rat testis. Testes
from rats aged fetal day 20.5 (a), postnatal day 3 (b), day 9 (c), day 15 (d),
day 18 (e), day 21 (f) and adult (g) are shown. A representative negative
control using normal mouse IgGs in place of primary antibody on day 15
testes is also shown (h). Arrows point to immunopositive interstitial cells
which are thought to be fetal type Leydig cells. Scale bar (g) represents
lOOpM. Scale bar (h) represents 50pm.
f
g
Figure 3.11: Immunlocalisation of Musashi-1 in postnatal rat testis. Testes from rats aged fetal day
17.5(a),postnatal day 5(b), day 11(c), day 16(d), day 19(e), day 21(f) and adult(g) are shown. A repre¬
sentative negative control using normal rat IgGs on day 19 testis is also shown (h). Arrowheads
point to Sertoli cells with predominantly nuclear staining. Arrows point to Sertoli cells with equal
nuclear:cytoplasmic immunolocalisation. Scale bar represents 50jim
Figure 3.12: Immunolocalisation of GATA-4 in postnatal rat testis.Testes from
rats aged fetal day 20.5 (a), postnatal day 3 (b), day 9 (c), day 15 (d), day 18 (e),
day 21 (f) and adults (g) are shown. A representative negative control
using normal goat IgGs in place of primary antibody on day 18 testis is also
shown (h). Scale bar represents 50pm.
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Figure 3.13: Immunolocalisation of GATA-1 in postnatal rat testis.Testes from
rats aged postnatal day 3 (a), day 14 (b), day 15 (c), day 18 (d),day 21 (e), day 28
(f) and adult (g) are shown. A representative negative control using normal rat
IgGs in place of primary antibody on day 18 testis is shown (h) with non specific
interstitial staining. Arrowheads point to immunopositive Sertoli cell nuclei.
Arrows point to immunonegative Sertoli cell nuclei. Spermatogenic stages 1,11, V
and VII are shown in the adult testis (g). Scale bar represents 50pm.
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fetal day 20.5 until day 15 (Fig. 3.9. a-d) after which the intensity of Sertoli cell
immunostaining increased and by day 21 (Fig. 3.9.f) there was a strong
immunopositive signal seen in all tubules and levels remained elevated into
adulthood (Fig. 3.9.g).
3.3.3.2. Inhibin -a
Anti-inhibin-a antibody was localised to cytoplasm of interstitial cells in the fetal
testis and in both fetal and postnatal Sertoli cells. In fetal day 20.5 testes (Fig
3.10.a) inhibin-a was strongly localised to the cytoplasm of interstitial cells:
however the intensity of interstitial staining was reduced in day 3 testes (Fig
3.10.b). Between days 9 and 35 inhibin-a was not detected in interstitial tissue:
however some interstitial cells were positively stained for inhibin-a in day 35
testes. Weak cytoplasmic Sertoli cell staining could be seen in fetal day 20.5
testis (Fig 3.10.a) and immunostaining was slightly upregulated by postnatal day
3 (Fig. 3.10.b) followed by a rapid upregulation in Sertoli cell inhibin-a
expression between days 3 and day 9 (Fig 3.10.c). Inhibin-a immunostaining in
all Sertoli cells remained strong up to day 15 when the intensity of staining
became non uniform between tubules (Fig. 3.10.d). Variation in the intensity of
immunostaining between Sertoli cells in tubules became more apparent
between days 18 and 35 and inhibin-a expression was stage dependent in adults
(Fig. 3.10.e-g).
3.3.3.3. Musashi-1
Using an anti-Musashi-1 antibody, strong immunolocalisation was observed in
Sertoli cells at all ages examined. Some non-specific interstitial staining was also
seen (Fig. 3.11.h). In fetal day 17.5 rat testes (Fig 3.11.a) there was intense
immunopositive staining of both cytoplasm and nuclei which had decreased in
intensity by postnatal day 5 (Fig. 3.11.b). At this time point staining was
stronger in some Sertoli cell nuclei than in others. In day 11 and day 16 the
number of Sertoli cells with prominent nuclear staining was increased whilst
cytoplasmic staining remained uniform across all tubules (Fig.3.11.c, d). The
majority of Sertoli cell nuclei in day 19 and day 21 testes had stronger nuclear
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staining than cytoplasmic staining (Fig. 3.11.e, f) and in adult testes Musashi-1
nuclear staining was strongest in tubules at stages XI-VII. Cytoplasmic staining
remained uniform across all stages (Fig. 3.11. g).
3.3.3.4. GATA-4
Strong immunolocalisation of antiserum directed against GATA-4 was restricted
to Sertoli cell and interstitial cell nuclei in the rat testes. GATA-4 interstitial
staining was observed in fetal day 20.5 and postnatal day 3 testes (Fig. 3.12.3, b)
after which interstitial expression of GATA-4 was undetectable until day 18 (Fig.
3.12 e). Following day 18, interstitial cell expression of GATA-4 continued into
adulthood (Fig. 3.12.g). Expression of GATA-4 in Sertoli cell nuclei was strong at
all ages from fetal day 20.5 through to adulthood (Fig. 3.12.a-g). Expression of
GATA-4 protein in Sertoli cells appeared to be upregulated after day 18.
3.3.3.5. . GATA-1
Specific immunolocalisation of anti-GATA-1 antibody was restricted to Sertoli
cell nuclei. Non specific interstitial staining was observed in some testes (Fig.
3.13.h). Specific GATA-1 immunolocalisation was not observed in neonatal testis
(Fig. 3.13.a). Weak GATA-1 nuclear staining was first observed in a very small
number of Sertoli cells in day 14 testes (Fig. 3.13.b, arrowhead). GATA-1
expression was upregulated in day 15 testes (Fig. 3.13.c) and strong Sertoli cell
nuclear immunostaining could be seen in all tubules by day 18 (Fig. 3.13.d).
Between days 21 and 28 (Fig. 3.13.e,f) levels of GATA-1 expression varied
between tubules. In the adult testes GATA-1 immunolocalisation was restricted
to Sertoli cell nuclei in tubules at stages IV to VIII (Fig. 3.13.g).
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Figure 3.14: Immunolocalisation of androgen receptor in the postnatal rat testis.
Testes from rats aged fetal day 20.5 (a), postnatal day 3 (b), day 9 (c), day 15 (d),
day 18 (e), day 21 (f) and adult (g) are shown. A representative negative control
where normal rabbit IgGs replaced the primary antibody in day 21 testis is also





Figure 3.15: Immunolocalisation of oestrogen receptor-P in the postnatal rat testis.
Testes from rats aged postnatal day 1(a), day 3 (b), day 9 (c), day 15 (d), day 18 (e),
day 21 (f) and adult (g) are shown. Immunostainng withpreabsorbed primary antibody
on day 15 testis is also shown (h). Black arrowheads point to immunopositive Sertoli
cell nuclei, blue arrowheads point to immunopositive spermatogonia and blue arrows





Figure 3.16: Immunolocalisation of oestrogen receptor-cc in the postnatal rat
testis. Testes from rats aged postnatal day 3 (a), day 9 (b), day 18 (c) and adult
(d) are shown. Inset shows a representative negative control using normal mouse
IgGs in place of primary antibody in adult testis is also shown. Arrows point to
immunopositive fetal type Leydig cells. Arrowheads point to immunopositive
adult type Leydig cells. Scale bar represents 50pm.
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3.3.4. Immunoexpression of steroid hormone receptors
3.3.4.1. Androgen receptor (AR)
In the postnatal testis expression of AR protein was restricted to nuclei of Sertoli
cells some interstitial cells and cells surrounding the outside of the tubules which
were thought to be peritubular myoid cells. In fetal day 20.5 testis (Fig. 3.14.a)
AR were localised to the nuclei of interstitial and peritubular myoid cells only.
Between postnatal days 3 and 9 (Fig. 3.14.b, c) weak Sertoli cell AR
immunostaining was observed and peritubular and interstitial cell staining
remained strong. Sertoli cell AR immunoexpression was high in day 15 testes
and levels of expression remained elevated through into adulthood where
expression was stage specific (Fig. 3.13.d-g). The intensity of AR
immunostaining in interstitial and peritubular myoid cells was high at all ages
studied.
3.3.4.2. Oestrogen receptor beta (ERP)
Using an anti-ERP antibody, immunopositive staining was restricted to the
nuclei of testicular cells. In day 1 testes (Fig.3.15.a) the intensity of ERP Sertoli
cell and gonocyte nuclear immunostaining was low. Between days 3 and 9 (Fig.
3.15.b, c) immunolocalisation of ERp to Sertoli cells was upregulated (black
arrowheads) whilst spermatogonial ERP immunolocalisation remained low.
After day 15, Sertoli cell nuclear ERP staining had increased and ERP expression
levels remained high thereafter (Fig. 3.15.d-g). The intensity of ERP
immunostaining in spermatogonia was high from day 15 onwards (blue
arrowheads) and low levels of expression in spermatocytes was present
following day 21 (blue arrows). Interstitial staining was observed at all ages
except in the adult.
3.3.4.3. Oestrogen receptor (ERa)
Immunolocalisation of an anti-ERa antibody was restricted to interstitial cell
nuclei. Interstitial cells expressed ERa from postnatal day 3 through to
adulthood (Fig. 3.16.a-d). Large clumps of positively immunostained cells could
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be seen in interstitial tissue until postnatal day 9 (Fig. 3.16.a, b, arrows). By
postnatal day 18 the majority of ERa immunostained nuclei were individually
located throughout the interstitial tissue (Fig 3.16.C, arrowheads). This pattern
of ERa immunoexpression remained into adulthood (Fig. 3.16.d).
3.4. Discussion
Development of the fetal testis into the mature adult testis is a highly organised
and complex process. The modifications in cell proliferation, structure,
morphology and function that take place during testicular postnatal
development need to be tightly regulated and controlled. Due to the numerous
paracrine interactions which are present within the testis at this time an
alteration in the differentiation of one cell type can affect the functional
maturation of the whole testis (De Franca et al., 1995). In the present study, the
development of the postnatal rat testis was investigated and selected 'markers'
of Sertoli cell functional maturation were studied in detail. An alteration in
Sertoli cell maturation either functionally (e.g. protein expression),
morphologically (e.g. cytoplasmic extensions) or structurally (e.g. blood testis
barrier formation) can affect the onset of spermatogenesis, the differentiation of
adult type Leydig cells and tubule lumen formation (Bunick et al., 1994; De
Franca et al., 1995; van Haaster et al., 1992; van Haaster et al., 1993) all of which
might subsequently affect fertility in the adult.
During the present study, before maturational changes in the expression of
Sertoli cell proteins were investigated it was deemed necessary to establish
when Sertoli cells ceased dividing in the testis of the Sprague Dawley rats
studied. During development testis weight is frequently used as a crude
measure of growth and development. The changes in mean testes weight
observed in the Sprague Dawley rats bred in our colony shown in Fig. 3.1
followed the same pattern of growth as shown in previous studies of rat
testicular development (Kirby et al., 1992; Meachem et al., 1996; van Haaster et
al., 1993). The increases in testis weight in the present study were identical to the
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increases in testis volume reported by Wang et al., (1989) and Zhengwei et al.,
(1990). PCNA and Ki67 immunolocalisation and BrDU incorporation suggested
that the majority of Sertoli cell division had stopped between postnatal days 15
and 18 (Fig. 3.2-3.4). Thus the expansion in testis weight and volume which
occurs after day 18 is due to the massive expansion in the germ cell population.
In the present study primary spermatocytes were first detected in the rat testis
on day 15 which is in agreement with previous reports (Clermont and Perey,
1957; Zhengwei et al, 1990). Between birth and day 90 the volume density of
the rat seminiferous tubules increases from 35.51% to 91.24% whilst absolute
3 3seminiferous tubule volume increases from 1.04mm to 1238.42mm at the same
ages (Mendis-Handagama et al., 1987). Thus the rapid expansion in testis weight
after day 18 observed in the present study and in the literature is due to a
massive increase in primary spermatocyte numbers after day 15 and the
subsequent expansion in numbers of other germ cell types (Zhengwei et al.,
1990).
Immunostaining using an antibody directed against PCNA resulted in intense
uniform, nuclear staining in the majority of cells in the testis from birth to day
21. Immunonegative cells were observed in the interstitial tissue at all ages
studied and these cells may be non-proliferating Leydig cells. Immunonegative
cells were also seen within the seminiferous tubules from day 9 onwards (Fig.
3.2.b). On day 9 immunopositive spermatogonia were present at the base of the
tubules and the number of immunopositive spermatogonia had increased by
day 18 (Fig. 3.2.e). The number of primary spermatocytes immunopositive for
PCNA was increased by day 21 (Fig. 3.2.f) and this is in agreement with
previously published results (Clermont and Perey, 1957; Zhengwei et al., 1990).
Staining of Sertoli cell nuclei was very intense in the neonatal testis (days 3-9):
however by day 16 the majority of Sertoli cells were immunonegative for
PCNA. A very small number of immunopositive Sertoli cells were present in
day 21 testes which was a surprise as Sertoli cell proliferation is thought to cease
by day 18 (Clermont and Perey, 1957; Orth, 1982), although Nagy, (1972) stated
that rat Sertoli cells continued to incorporate 3H-thymidine until the 7th week of
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postnatal life. Expression of PCNA protein is reported to be maximal during the
transition from the G1 to the S phase during the normal cell cycle and lowest
during the M phase (Celis and Celis, 1985; Kurki et al., 1986). Mathews et al.,
(1984) have reported that PCNA is present continuously throughout mitosis.
The biological half-life of PCNA is 20 hours (Bravo et al., 1987) and therefore
cells which have recently ceased to divide are likely to be immunopositive for
PCNA. Hence immunopositive Sertoli cells in day 21 testis may have recently
ceased proliferation but had remained immunopositive due to the long half-life
of PCNA.
Due to the persistence of the PCNA protein in non-proliferating cells the same
testicular series was examined using Ki67 immunolocalisation. The pattern of
interstitial and germ cell Ki67 immunostaining was similar to that seen for
PCNA except that the numbers of cells immunopositive for Ki67 were lower
than for PCNA. This could be due to the fact that abundant expression of Ki67
is restricted to the G2 and M phases of the cell cycle with weaker Ki67
immunostaining in the S and late-Gl phases (Sasaki et al., 1987; Wersto et al.,
1988). The biological half life of Ki67 is 1-2 hours: hence cells which have ceased
proliferation will be immunonegative for Ki67 2 hours later (Duchrow et al.,
1994). The amount of Ki67 protein is at its lowest level immediately after
mitosis and may not be detectable by immunohistochemical methods (Wersto et
al., 1988). This could not only explain the non-uniform staining pattern
observed in Fig. 3.3 where some nuclei are stained more strongly than others
but could also explain the lower number of mitotic cells which were detected
using Ki67 compared to PCNA immunostaining. In comparison to PCNA
immunolocalisation very few Sertoli cells were strongly stained for Ki67 in day
14 testis and by day 18 no positively stained Sertoli cells could be seen.
The thymidine analogue BrDU is incorporated into the DNA of cells only during
the S phase of the cell cycle. In the present study the pattern of cells labelled
with BrDU during the one hour between administration and tissue collection
was similar to that reported previously (Meachem et al., 1996; Sharpe et al., 1999;
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van Haaster et al., 1993). Very few cells had intense BrDU immunolocalisation in
day 15 testes. However some germ cells were immunopositive at this age. Low
levels of BrDU labelling could result from low levels of BrDU incorporation due
to DNA synthesis within these cells being almost complete when BrDU was
administered. No immunopositive Sertoli cells could be seen in day 21 testes,
BrDU labelling at this age was exclusively found in spermatogonia and primary
spermatocytes and a few interstitial cells.
Immunolocalisation of PCNA, Ki67 and BrDU incorporated during the last hour
prior to death, in the postnatal rat testis showed that the postnatal testicular
development of the rats used in the present study agreed with patterns of
development previously described (Clermont and Perey, 1957; Orth, 1982;
Steinberger and Steinberger, 1971; Wang et al., 1989) and that the majority of
Sertoli cell proliferation occurs before day 10 and cessation of proliferation in
most Sertoli cells takes place between days 15 and 18. A very small population
of Sertoli cells may continue to proliferate until day 20 indicated by the
perstitence of PCNA immunolocalisation in day 21 testis. The majority of
spermatogonia and primary spermatocytes had entered cell division by day 15
and 18 respectively and germ cell populations expanded thereafter as indicated
by the increase in testis weight observed at this time. Interstitial cell
populations which included Leydig cells, replicated throughout the period of
development studied. However non-proliferating cells were present in the
interstitial tissue at all ages investigated.
Once we had established the age at which Sertoli cells stopped proliferating and
the timing of the onset of spermatogenesis began in our rat colony expression,
patterns of known and potential markers of Sertoli cell maturation were
studied. Changes in mRNA expression were investigated using Northern blot
analysis which provided an overview of changes in gene expression over the
whole testis during development. In addition, using a phosphoimager and
Imagequant programmes, hybridisation signals could be quantified enabling
comparisons of mRNA expression over development to be carried out.
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Immunocytochemistry was used to establish cellular localisation of proteins
during development as well as enabling rough changes in protein levels of
expression to be investigated.
The cDNA probe for rat SGP-1 detected a single 2.6kb transcript in testicular and
kidney (not shown) RNA as described by Collard et al., (1988). The pattern of
SGP-1 protein and mRNA expression observed in the present study was in
agreement with previous reports (Mathur et al., 1994).
SGP-1 immunopositive interstitial cells observed in the fetal and mature testis
(days fetal 20.5 to postnatal day 15) are thought to be macrophages which are
known to express SGP-1 (Morales et al., 1996). Interstitial macrophages are
individually distributed within the interstitial tissue in close proximity to Leydig
cells (Niemi et al., 1986). During postnatal development testicular macrophages
are involved in the development and differentiation of adult type Leydig cells
(Gaytan et al., 1994) which begin maturation after day 15 (Mendis-Handagama et
al., 1987). Large quantities of SGP-1 protein may be required by macrophages
during Leydig cell development. Once Leydig cells undergo differentiation the
role of macrophages within the interstitial tissue could be modified resulting in a
downregulation of SGP-1 protein synthesis. In fetal and neonatal testis some
'clumps' of SGP-1 positive cells were also found in the interstitium and their
location suggested that they were likely to be the fetal population of Leydig
cells.
To my knowledge there are no previous reports of SGP-1 protein expression in
fetal type Leydig cells and the possible role of SGP-1 in these cells is unknown.
Fetal type Leydig cells contain high levels of lipids and SGP-1 is involved in the
transport and breakdown of glycolipids. Northern blot analysis of SGP-1
mRNA levels observed changes in total testis RNA extracts. Therefore the
observed decline in SGP-1 mRNA expression after postnatal day 1 may be due
to the decrease in function and number of fetal type Leydig cells (Mendis-
Flandagama et al., 1987). Analysis of SGP-1 mRNA localisation in the postnatal
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testis using in situ hybridisation techniques would need to be carried out in
order to confirm SGP-1 expression in fetal Leydig cells.
Quantified 18S signals from Northern blot analysis were used to normalise
mRNA signals in the present study such that changes in expression of factors
across all cell types in the testes could be studied. Initially, quantified SGP-1
signals at each age were to be used in order to establish changes in Sertoli cell
mRNA expression alone. However changes in SGP-1 expression which were
observed when immunostaining and Northern blot analysis were undertaken
meant that we felt the data might be compromised by using this marker as an
internal standard and 18S rRNA values were therefore used. Values normalised
against 18S reflect changes in levels of mRNA across the whole of the rat testis
extract. In the present study assessment of testicular inhibin-a, Musashi-1 and
GATA-4 mRNA levels showed decreases in mRNA levels after day 18; the age
when germ cell populations are expanding. Thus Sertoli cell expression of the
above factors may not be decreasing after day 18 but dilution of Sertoli cell
mRNA transcripts in total testis RNA extracts by increasing germ cell mRNAs
maybe taking place.
Expression of inhibin-a mRNA in total testicular extracts reached maximal
levels on day 15. The slight decrease in inhibin-a expression observed in day 18
testis is thought to result from the high background signal surrounding the
actual 18S signal in the day 18 RNA sample in Fig. 3.6.B resulting in over
estimation of the amount of RNA loaded. There is general agreement in
previously published studies and the present study that levels of inhibin-a
mRNA in total testis extracts increase immediately after birth. In the present
study expression of inhibin-a declined after day 21 and inhibin-a mRNA levels
in the adult testes were approximately 33% of levels in the testes at birth. This
was in agreement with published changes in inhibin-a mRNA levels during
postnatal development (Keinan et al., 1989; Tena-Sempere et al., 1999). Inhibin-a
expression levels in whole testis RNA extracts are therefore maximal at the time
that Sertoli cell proliferation ceases.
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The observed developmental pattern of inhibin-a protein expression in both
Sertoli and Leydig cells was similar to that described in the literature (Majdic et
al.r 1997; Noguchi et al., 1997; Rivier et al., 1988). Changes in plasma levels of
inhibin-a also reflect the pattern of changes in protein levels observed by
immunocytochemical staining. Inhibin-a plasma levels are highest at day 14
and then decline with increasing age (Maddocks and Sharpe, 1990; Rivier et al.,
1988; Ultee-van Gessel and de Jong, 1997). Stage dependent expression of
inhibin-a is first observed in day 18 testis and it is around this time that
pachytene spermatocytes are first observed in the seminiferous tubules
(Clermont and Perey, 1957). Levels of inhibin-a mRNA and protein are
increased in tubules which lack pachytene spermatocytes (Kaipia et al., 1991).
Thus the onset of stage specific inhibin-a expression in Sertoli cells may be due
to the appearance of pachytene spermatocytes which then inhibit Sertoli cell
inhibin-a expression.
Novel results were found in the expression pattern of Musashi-1 mRNA during
postnatal development and were different from those seen in a preliminary
study byMaguire et al., (1999). In the initial study levels were maximal in day 6
testes and declined thereafter. However in this study Musashi-1 mRNA
expression was maximal at day 18 and then levels declined. In the present study
Musashi-1 mRNA was normalised against 18S values which therefore showed
changes in expression over the whole testis. Musashi-1 expression in the testis
is restricted to Sertoli cells (see Fig. 3.11). Therefore any changes in Sertoli cell
Musashi-1 expression between different ages would still be apparent. Maguire
et al (1999) (Maguire et al., 1999) used SGP-1 mRNA levels to normalise Musashi-
1 mRNA signals. This would also show any changes in specific Sertoli cell
Musashi-1 expression. However SGP-1 mRNA levels are themselves changing
over this period of time (see Fig. 3.4.C). This may account for the discrepancies
in Musashi-1 expression observed between the two studies.
After birth, Musashi-1 mRNA levels increase. However there is no
simultaneous increase in protein levels observed at this time. It is possible that
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Musashi-1 mRNA transcripts have a short half life in the proliferating Sertoli cell
such that in order to maintain functional levels of Musashi-1 protein an
upregulation in mRNA expression is required. On the other hand Musashi-1
protein could have a short half life such that an increase in protein levels during
this period of development is not detected by immunocytochemistry. Musashi-
1 expression in Sertoli cells has only recently been reported and consequently
very little research has been carried out regarding patterns of expression or
regulation of Musashi-1 in the Sertoli cell. Musashi-1 is used as a marker of
undifferentiated and proliferating neuronal cells and Musashi-1 expression is lost
following neuronal cell differentiation (Kaneko et al., 2000). The increase in
nuclear immunolocalisation of Musashi-1 detected in both Maguire et al., (1999)
and this study, is maximal at the onset of Sertoli cell differentiation. This
indicates that the role of Musashi-1 in Sertoli cells may be modified as the cell
switches from a proliferating undifferentiated cell to a morphologically and
functionally mature cell. Musashi-1 may be involved in nuclear-cytoplasmic
RNA trafficking in mitotic Sertoli cells but becomes predominantly involved in
RNA processing within the nucleus during Sertoli cell differentiation. In the
adult testis nuclear localisation of Musashi-1 protein is maximal in tubules at
stages with low testosterone levels (Maguire et al., 1999) which suggests the
possibility of steroidal regulation of Musashi-1 expression. However further
research is necessary to confirm this.
The expression pattern of GATA-4 during postnatal development were similar
to that already reported in the literature. In the present study GATA-4 mRNA
levels increased steadily after birth reaching maximal levels between days 11
and 18 after which levels rapidly decreased to low levels which were observed
in the adult testes. Ketola et al (1999) saw a similar pattern of expression in the
mouse postnatal testis. However Viger et al., (1998) saw maximal levels of
GATA-4 mRNA between birth and day 14. In all three studies a decline in
GATA-4 mRNA was concurrent with Sertoli cell maturation and the appearance
of germ cells. Possible reasons for the differences between this study and that
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of Viger et al., (1998) include differences in GATA-4 expression between
different strains of rat.
Studies on the expression of GATA-4 in the postnatal testis were extended to the
protein and cellular level using immunocytochemistry. GATA-4 protein was
strongly expressed in Sertoli cell nuclei through out postnatal development and
expression levels remained high in the adult. Interstitial staining was also strong
in fetal day 20.5 testes, levels decreased slightly during neonatal development
but increased again in day 18 testes and expression remained high in adult
interstitial tissue. GATA-4 protein has been previously shown to be expressed
in Leydig cells (Ketola et al.r 1999) and thus the interstitial cell population that
was immunopositive for GATA-4 in this study were thought to be Leydig cells.
It has been previously stated that GATA-4 mRNA expression is restricted to
germ cells in the adult mouse and rat testis (Arceci et al, 1993; Viger et al., 1998).
GATA-4 protein expression in germ cell nuclei was not observed in this study
using rat testes nor was it observed in germ cells in mouse postnatal testes by
Ketola et al., (1999). Identical primary antibodies at the same concentrations
were used in all three studies and the same immunocytochemical protocols
were carried out except that different fixation techniques were used to those in
Viger et al., (1998) and frozen tissue sections were used by Ketola et al., (1999).
Further research is necessary to confirm the expression of GATA-4 in the
differentiated Sertoli cell.
GATA-4 expression is essential for the proliferation and differentiation of
cardiomyocytes (Grepin et al., 1995). Granulosa cells in early follicles have
strong GATA-4 expression up until ovulation and GATA-4 levels then decline
with luteinization of the follicle (Heikinheimo et al., 1997). It has been suggested
that GATA-4 acts as a survival transcription factor in cellular development and
differentiation. In the present study GATA-4 was expressed throughout Sertoli
cell development, differentiation and maturation and could therefore act as a
survival transcription factor in Sertoli cells. GATA-4 expression does not
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however appear to change with increasing Sertoli cell maturation as has been
previously reported and is therefore not an ideal marker for Sertoli cell
functional maturation.
Analysis of GATA-1 mRNA expression over the postnatal period of
development was investigated using both Northern blot analysis and
Ribonuclease Protection Assays (RPA). However using both techniques no
GATA-1 transcripts could be detected at any age or in the control spleen RNA
sample (not shown). The GATA-1 cDNA probe which was used in the above
analysis was originally amplified using PCR from a pool of cDNA species from
day 21 rat testis created using oligo dT primers. Thus GATA-1 mRNA is
expressed in day 21 rat testis. RTPCR was not used to determine changes in
GATA-1 mRNA expression over the postnatal period as although RTPCR is a
more sensitive technique, accurate quantification of RTPCR results could not be
carried out and hence Northern blot and RPA analysis were subsequently
attempted.
Changes in spatial and temporal GATA-1 protein expression were investigated
using immunocytochemistry. GATA-1 protein could not be detected in neonatal
testes however low levels of GATA-1 protein were detected in the nuclei of a
small population of Sertoli cells in day 14 testes. GATA-1 protein levels
increased thereafter and expression was becoming stage specific by day 18
testes. In the adult testis GATA-1 protein expression is restricted to Sertoli cell
nuclei in tubules at stages IV to VIII.
The chronology of GATA-1 protein expression in the testis observed in this
study is in good agreement with reported patterns of GATA-1 mRNA (Beau et
ah, 2000; Onodera et al., 1997; Viger et al., 1998) and protein expression (Beau et
al, 2000; Viger et al., 1998; Yomogida et al., 1994) in rat and mouse testes. In
adult mouse testes GATA-1 protein localisation was restricted to stages VI-IX
(Yomogida et al., 1994) whilst stage specific staining in the present study was
very low in stage IV and was then restricted to stages V-VIII. These differences
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in stage specific expression may result from species differences in GATA-1
expression between mice and rats. Moreover the staging of spermatogenesis is
slightly different between the two species; in the mouse, spermatogenesis is
divided into 12 stages compared to 14 stages in the rat testis. The stage
dependent expression of GATA-1 is thought to result from inhibition of GATA-1
expression by germ cells (Yomogida et al., 1994). GATA-1 is involved in a
negative autoregulatory loop such that in immortal Sertoli cell lines GATA-1 can
bind to its own promoter region and specifically repress its own transactivation,
This is also thought to contribute to the stage specific expression of GATA-1
(Martin and and Orkin, 1990; Onodera et al., 1997; Whyatt et al., 1997).
GATA-1 expression is essential for the survival and cell differentiation of
erythroid cell populations. (Heikinheimo et al., 1997). The increase in GATA-1
protein expression is concomitant with the cessation of Sertoli cell proliferation
and the start of Sertoli cell maturation. Thus it has been suggested that GATA-1
may act as a survival factor in non proliferating Sertoli cells and is involved in
the transcription of genes expressed during cell maturation and differentiation
as well as regulating the expression of genes involved in the onset and
continuance of spermatogenesis.
In the present study Sertoli cell expression of SGP-1, inhibin-a and GATA-1
proteins was upregulated at the time of Sertoli cell differentiation.
Immunolocalisation of Musashi-1 in Sertoli cell nuclei became more abundant
with the increased maturation of the Sertoli cell. Therefore in future studies
these factors will be used as markers of Sertoli cell functional maturation.
In the final part of this study immunolocalisation of ERa, ER(3 and AR during
testicular development was investigated so that possible sites of direct steroid
action within the postnatal testis could be established. The expression pattern of
AR observed in the present study was in agreement with previously published
work (Bremner et al., 1994; Buzek and Sanborn, 1988; Majdic et al., 1995; Sharpe
et al., 1998). AR was expressed in interstitial and peritubular myoid cells
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throughout postnatal development whereas AR expression was only detected in
Sertoli cell nuclei from postnatal day 3 onwards. Levels of AR in the Sertoli cell
increased with increasing age and became stage dependent between day 21 and
adulthood. No AR expression was observed in any germ cells at any of the ages
studied. Expression of ER(3 protein during postnatal testes development
corresponded well with published reports on ERp expression in the testis
(Saunders et al., 1998; van Pelt et al., 1999). From birth through to adulthood
ER(3 was strongly expressed in Sertoli cell nuclei. ERP expression was also
observed in gonocytes, spermatogonia and pachytene spermatocytes as well as
in interstitial cells which were thought to be fetal and immature Leydig cells. In
contrast, testicular ERa expression was restricted to Leydig cells. Both fetal and
adult type Leydig cells expressed ERa throughout postnatal development which
was also observed in Fisher et al., (1997).
Therefore both fetal and adult type Leydig cells express all three steroid
receptors throughout rat postnatal development. Prespermatogonia,
spermatogonia and early spermatocytes strongly express ERP during postnatal
life. Sertoli cells express ERp throughout postnatal development and AR from
the third day of life. Consequently during postnatal rat testis development both
testosterone and oestrogen can directly affect Sertoli cells. In future studies the
effect of both steroids on Sertoli cell maturation during postnatal development
will be investigated using the Sertoli cell proteins assessed in the present study
as indicators of modified Sertoli cell functional maturation.
Chapter 4.
The effect of in vivo manipulation of oestrogen levels
on Sertoli cell gene expression.
4.1. Introduction
The function of oestrogen in the male reproductive tract, in particular the role of
oestrogen during the development and maturation of the testis, has become the
subject of considerable research activity. This interest has been stimulated by
the proposed link between increases in the incidence of male reproductive
abnormalities in humans and other wildlife and increased levels of oestrogen
and oestrogen like chemicals in the environment (Sharpe and Skakkebaek, 1993;
Toppari et al., 1996). It is notable that fetal/neonatal exposure of rodents to high
levels of oestrogen cause a range of abnormalities of the male reproductive
system including small testis and delayed puberty (Arai et al., 1983; Gaytan et al.,
1986; Newbold and McLachlan, 1985; Toppari et al., 1996). It was initially
suggested that these abnormalities were indirectly caused via suppression of
gonadotropin release from the anterior pituitary by the elevated oestrogen
levels (Gharib et al., 1990). It was proposed that the net result of decreased
levels of FSH was a delay in the onset of puberty and a reduced rate of Sertoli
cell proliferation (Cunningham et al., 1978; Meachem et al., 1996) which in turn
lowered the sperm output of the adult testis (Bellido et al., 1990).
Male ERKO transgenic mice which express inactivated ERa protein are infertile.
This finding not only illustrates that oestrogens act directly within the male
reproductive tract but demonstrates an essential role for oestrogen during
normal male reproductive function (Eddy et al., 1996). ERa expression within
the testis is restricted to Leydig cells (Fisher et al., 1997): however the P form of
the oestrogen receptor, ER(k has recently been localised to Sertoli cells as well as
germ cells throughout development and thus provides a direct pathway for
oestrogen action in the developing Sertoli cell (Saunders et al., 1998; van Pelt et
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al., 1999). Direct action of oestrogens on Sertoli cell maturation and function has
been investigated by Sharpe et al., (1998). Neonatal administration of oestrogen
to male rats not only resulted in a delay in Sertoli cell maturation within the
peripubertal testis but also had a permanent adverse effect on Sertoli cell
function in the mature testis. It is notable that the results obtained suggest that
these changes were not caused by suppression of FSH levels alone.
In Chapter 3 the expression pattern of GATA-1 and Musashi-1 proteins in Sertoli
cells were found to be altered with increased Sertoli cell differentiation.
Heikinheimo et al., (1997) have observed an upregulation of GATA-4 expression
in granulosa cells following treatment with DES. In addition, FSH upregulates
GATA-4 mRNA expression in MSC-1 Sertoli cells transfected with FSH receptor
(Heikinheimo et al., 1997). In erythroid cells ERa forms ligand-dependent
protein:protein interactions with GATA-1 protein which subsequently inhibits
GATA-1 transactivation of essential survival and differentiation genes (Blobel
and Orkin, 1996; Blobel et al., 1995). Although ERa is not expressed in Sertoli
cells it is possible that ERP could form protein associations with GATA-1 or
GATA-4 in the postnatal Sertoli cell and suppress transactivation of GATA-1/4
regulated genes which are thought to include inhibin-a, aromatase, AMH, FSH
receptor and GATA-1 itself (Beau et al., 2000; Feng et al., 1998; Martin and and
Orkin, 1990; Onodera et al., 1997; Whyatt et al., 1997).
The present study made use of tissue sections which had been used previously
in Sharpe et al., (1998). The effect of in vivo neonatal oestrogen administration
on the immunoexpression patterns of GATA-1, GATA-4 and Musashi-1 in the
rat testis has not previously been investigated. In the present study the effect of
oestrogen on functional maturation of Sertoli cells was further investigated by
assessing changes in expression of GATA-1 and Musashi-1 proteins during
Sertoli cell differentiation. It had already been established that this treatment
regime caused a maturational delay in Sertoli cell development and it was
therefore hoped that a change in the expression patterns of the above factors
would be observed hence confirming their use as markers of Sertoli cell
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maturation. In addition the possible regulation of GATA-1, Musashi-1 and
GATA-4 protein expression by oestrogen in the postnatal Sertoli cell could be
studied for the first time.
4.2. Materials and Methods
Rat testes used in the present study had been originally collected for a separate
study by Dr. Richard Sharpe the results of which have been published
(Atanassova et al., 1999; Sharpe et al., 1998).
4.2.1. Animals and treatments
The experimental set up and treatment of animals was kindly carried out by Dr.
Richard Sharpe and details are described in Sharpe et al., (1998) (Sharpe et al.,
1998) and Atanassova et al., (1999). Briefly, male Wistar rats were administered
by subcutaneous injection either 10pg of DES (Sigma) in 20pl of corn oil, lOpg of
ethinyl oestradiol (EE) in 20pl of corn oil or 20|il of corn oil (control group) on
postnatal day 2, 4, 6, 8, 10 and 12. On day 18 or day 25 rats were killed as
described in section 2.and testes were removed, fixed and processed as
described in Chapter 2.
4.2.2. immunocytochemistry
Testes from control animals and both treatment groups were placed on the
same slide and were processed in parallel. Testes from a minimum of three
different animals per group and from two separate experiments were analysed.
Immunolocalisation of inhibin-a, Musashi-1, GATA-4 and GATA-1 to fixed testes
sections was performed as in section 3.2.6.2. A monoclonal antibody against
PCNA was applied to fixed testes sections as described in section 3.2.6.1.
Sections were analysed using an Olympus Provis microscope and images were
captured onto computer using either a Kodak DCS420 camera or a Kodak
DCS330 camera and images were stored on the computer using the Adobe
Photoshop 5.0 programme.
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4.3. Results
The delay in the onset of spermatogenesis in day 18 testes of DES and EE treated
animals suggested that postnatal testicular development had been modified; the
delay in testicular development was most notable in testes from DES -treated
animals. Immunoexpression patterns of all five proteins (inhibin-a, GATA-4,
Musashi-1, GATA-1 and PCNA) in control day 18 and day 25 testes were
identical to those reported in chapter 3. Following either neonatal DES or EE
treatment no stage dependent inhibin-a immunoexpression could be observed
in day 18 testes (Fig. 4.1.d, g). However there was no change in GATA-4
immunoexpression in day 18 testes of DES and EE treated rats when compared
to control rat testes (Fig. 4.1.b, e, h). Stage dependent immunolocalisation of
Musashi-1 was observed in day 18 control testes but not observed in either DES
or EE treated testes. Nuclear immunolocalisation of Musashi-1 was stronger in
EE treated testes than in DES treated testes where nuclear and cytoplasmic
immunostaining were of similar intensity (Fig. 4.1.f, i).
In Figure 4.2 no GATA-1 nuclear immunolocalisation could be observed in the
day 18 testes following neonatal DES treatment (Fig. 4.2. b, e). Similar levels of
strong GATA-1 immunoexpression could be seen in Sertoli cell nuclei of both EE
treated and control day 18 rat testes (Fig. 4.2 a, c, d, f). Sertoli cell nuclei were
immunopositive for GATA-1 in both control and neonatal DES treated day 25
rat testes (Fig. 4.2. g-j). GATA-1 immunoexpression in Sertoli cell nuclei was
becoming stage specific in day 25 DES treated testes and looked similar to the
pattern of immunoexpression in day 18 control and EE treated testes.
Intense immunostaining for PCNA was localised to spermatogonia, Sertoli cells
and Leydig cells in day 18 testes. In DES treated testes the majority of Sertoli cell
nuclei were immunopositive in contrast to testes from control and EE
Figure 4.1: Immunolocalisation of markers of Sertoli cell functional maturation
Immunolocalisation of inhibin-a (a, d, g), GATA-4 (b, e, h) and Musashi-1 (c, f, i)
to day 18 postnatal rat testes following neonatal treatment with DES-10pg (d, e, f),
EE-10pg (g, h, i) and corn oil (a, b, c). Representative negative controls can be seen
in Figures 3.10-12. Scale bar represents 50(am.
Figure 4.2: Immunolocalisation of GATA-1 to postnatal rat testes following
neonatal treatment with DES (lOpg) and EE (lOpg). Testes from rats aged
postnatal day 18 (a-f) are shown following neonatal treatment with DES-lOpg
(b, e), EE-lOpg (c, f) and corn oil (a, d). Testes from rats aged postnatal day 25 (g-j)
are shown following neonatal treatment with DES-lOpg (h, j) and corn oil (g, i).
Images a-c, g, h were taken at X400 magnification and scale bar (h) represents
50pm. Images d-f, i, j were taken at XI000 magnification and scale bar (j)
represents 20pm. A representative negative control can be seen in Figure 3.13.
Arrows point to immunonegative Sertoli cell nuclei and arrowheads point to
immunopositive Sertoli cells.
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Figure 4.3: Immunolocalisation of PCNA to dividing cells in the postnatal rat
testes following neonatal treatment with DES (lOjjg) and EE (lOpg). Testes from
rats aged postnatal day 18 (a-f) are shown following neonatal treatmentwith
DES-lOpg (b, e), EE-lOpg (c, f) and corn oil (a, d). Testes from rats aged postnatal
day 25 (g-j) are shown following neonatal treatment with DES-lOpg (h, j) and
corn oil (g, i). Images a-c, g, h were taken at X400 magnification and scale bar
(h) represents 50pm. Images d-f, i, j were taken at X1000 magnification and scale bar
(j) represents 20pm. A representative negative control can be seen in Figure 3.2.
Arrows point to immunonegative Sertoli cell nuclei. Arrowheads point to
immunopositive Sertoli cell nuclei.
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treated animals where the majority of Sertoli cell nuclei were immunonegative
(Fig 4.3. a-f). In day 25 testes no immunopositive Sertoli cell nuclei could be seen
in control or DES treated testes. However spermatogonia and early
spermatocytes were strongly immunostained for PCNA at this age (Fig. 4. 3.
g-j)-
4.4. Discussion
The treatment regime used in the present study had been previously shown to
cause a delay in Sertoli cell maturation and the onset of spermatogenesis in the
postnatal rat testis. DES had a direct effect on the neonatal testis and
modification of testis development was not solely due to suppression of
gonadotrophin release from the anterior pituitary (Sharpe et ah, 1998). Testes
from day 18 rats were used in the present study as previous results (Chapter 3)
and published reports, confirmed that under normal conditions the majority of
Sertoli cells in male Wistar rats had ceased dividing at this age and
differentiation had been initiated. The pattern of PCNA immunolocalisation in
the control day 18 testes in the present study was similar to the pattern of
PCNA immunoexpression seen in previous studies (Chapter 3) demonstrating
that the rats used in this study followed the normal pattern of rat testicular
development.
It has been previously stated that SGP-1 is a marker of Sertoli cell chronological
age and that expression of SGP-1 is not altered by the maturational state of the
Sertoli cell (Bunick et al., 1994). SGP-1 immunoexpression was not investigated
in the present study as Sharpe et al., (1998) had previously shown a delay in the
establishment of the normal pattern of SGP-1 immunoexpression following
neonatal DES treatment consistent with the proposal that SGP-1
immunoexpression is regulated by Sertoli cell maturation.
Careful examination of the expression patterns of Musashi-1 and GATA-1 in the
Sertoli cells of treated rat testes compared with controls suggested that neonatal
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DES administration caused a slightly greater delay in testicular development
than EE treatment. Previous results had shown an increase in Musashi-1 nuclear
localisation with increasing Sertoli cell differentiation (Maguire et al., 1999),
Chapter 3). In the present study Musashi-1 immunoexpression in Sertoli cell
nuclei of EE treated rats was more intense than that seen in nuclei of in DES-
treated rat Sertoli cells. The difference in the extent of maturational delay
between the two treatment groups was more marked when the pattern of
GATA-1 immunoexpression was examined. A small number of day 18 testes
from EE treated animals contained Sertoli cells with very low levels of GATA-1
expression. In contrast all Sertoli cell nuclei in DES-treated testes were
immunonegative for GATA-1. These differences in the extent of maturational
delay between the two treatment groups suggests that DES has a greater
adverse affect on Sertoli cell maturation via ER(! than EE. One possibility is that
the effect reflects differences in affinity for ER|3 between the two oestrogens
(Kuiper et al., 1997).
In the present study delays in testicular development and Sertoli cell
differentiation were demonstrated by the absence of stage specific expression of
inhibin-a protein in both groups of treated rat testes recovered on day 18.
Similar results were presented in Sharpe et al., (1998). The normal pattern of
Musashi-1 immunoexpression characteristic of a mature Sertoli cell was delayed
in both treatment groups: however the delay in Sertoli cell differentiation was
more apparent in DES treated rat testes. No difference in GATA-4
immunoexpression between control and treated rat testes was observed. This
was no surprise as immunolocalisation of GATA-4 protein remains fairly
constant throughout normal Sertoli cell proliferation and differentiation. GATA-
4 immunoexpression was included in the present study in an attempt to
determine ifGATA-4 expression was upregulated by DES administration as this
had been previously observed in developing granulosa cells of three week old
female rats (Heikinheimo et al., 1997). GATA-4 expression was also shown to be
upregulated at the mRNA level following FSH stimulation of MSC-1 Sertoli cells
transfected with the FSH receptor (Heikinheimo et al., 1997). No reduction in
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GATA-4 expression was observed in the present study and this may be due to
the fact that subtle changes in GATA-4 protein levels could not be detected using
immunocytochemistry or that FSH levels were not sufficiently suppressed in the
day 18 treated testis. Sharpe et al., (1998) stated that FSH levels in DES treated
rats were not significantly reduced until day 35. The effect of oestrogens on
GATA-4 expression in granulosa cells may be indirect. Oestrogen stimulates
granulosa cell differentiation. Therefore the observed increase in GATA-4
expression following DES treatment may be an indirect effect whereby GATA-4
expression is upregulated coincident with granulosa cell differentiation. In
addition ovarian GATA-4 expression was rapidly decreased following ovulation
and the onset of granulosa cell apoptosis (Heikinheimo et al., 1997). It is possible
that GATA-4 functions as a cell proliferation and differentiation transcription
factor in granulosa and Sertoli cells in the same way that GATA-4 expression is
essential to cardiomyocyte differentiation and survival (Grepin et al., 1995).
Comparisons of GATA-1 immunoexpression between neonatal day 18 treated
and control testes showed a small decrease in immunoexpression following EE
treatment. However GATA-1 protein expression was totally absent in day 18
DES treated testes. During normal testis development GATA-1 is first localised
to Sertoli cell nuclei in a small population of Sertoli cells on day 14 of postnatal
life and a day later immunoexpression is increased such that by day 18 the
majority of Sertoli cells have strong nuclear immunolocalisation of GATA-1.
This pattern of expression suggests that GATA-1 is only expressed in non-
proliferating Sertoli cells undergoing the process of differentiation. Therefore
DES treatment may not directly inhibit GATA-1 expression but by delaying
differentiation and prolonging Sertoli cell proliferation DES administration
prevents/delays GATA-1 protein expression. In order to address this theory
GATA-1 immunolocalisation was investigated in testes from rats which had
undergone the same neonatal DES treatment regime but were killed on day 25
rather than day 18. GATA-1 immunoexpression was observed in Sertoli cells of
day 25 treated testes and therefore the absence of GATA-1 expression in day 18
DES treated rats appears to be due to an indirect effect of DES treatment on
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Sertoli cell differentiation. To ensure that detection of GATA-1
immunoexpression in day 25 DES treated testes was not due to loss of DES from
the general circulation resulting from the length of time between DES treatment
(day 12) and testes removal (day 25), PCNA was immunolocalised to both day
18 and day 25 testes. Immunolocalisation of PCNA to day 18 testes indicated
that a greater number of Sertoli cells continued to proliferate in DES treated
testes when compared with the number of immunopositive PCNA Sertoli cells
in control and EE treated rats. However by day 25 no immunopositive Sertoli
cells could be observed in either control or treated rat testes. Therefore Sertoli
cell replication had ceased by day 25 and all Sertoli cells had begun the process
of differentiation and this was consistent with detection of GATA-1 protein in
the nuclei of Sertoli cells.
It is therefore proposed that GATA-1 is only expressed in differentiating, non-
proliferating Sertoli cells and may function as a transcription factor to regulate
genes involved in cell differentiation. Although GATA-1, GATA-4 and Musashi-
1 protein expression did not appear to be regulated by oestrogens the potential
that ligand-dependent protein:protein interactions occurred between GATA-1
and/or GATA-4 and ER(3 was not investigated. Both GATA-1 and GATA-4 have
been shown to transactivate the inhibin-a promoter in Leydig tumour cell lines
(Feng et al, 1998; Ketola et al., 1999). In the present study apart from the delay
in stage specific expression associated with the delay in Sertoli cell maturation no
significant changes in levels of expression of inhibin-a were noted. Proliferating
Sertoli cells synthesise oestrogen during postnatal development and it has been
suggested that oestrogen has a positive autocrine effect on Sertoli cell
proliferation thus blocking Sertoli cell differentiation (Dorrington and Khan,
1993). Under normal conditions this autoregulatory loop is broken by paracrine
and endocrine interactions which shut down Sertoli cell aromatase expression
and therefore allow Sertoli cell differentiation to take place. It is possible that
oestrogen bound to ER(1 in the proliferating Sertoli cell interacts with GATA-1
which subsequently blocks the transactivation of genes essential for cell
differentiation. Exogenous oestrogen administration may extend the period of
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oestrogen/ER|3/GATA-l interactions resulting in a delay in Sertoli cell
differentiation. In order to investigate whether these protein:protein contacts
do occur coimmunoprecipitation experiments between steroid receptors and
GATA factors in Sertoli cells need to be carried out.
In conclusion inhibin-a, GATA-1 and Musashi-1 immunoexpression was
modified with altered Sertoli cell maturation in the present study. GATA-1 and
Musashi-1 protein expression was shown to be regulated by the stage of Sertoli
cell maturation and consequently in the future both factors could be used as
markers of Sertoli cell differentiation. In order to assess the direct effect(s) of
steroid treatment on transcriptional regulation of Sertoli cell genes
investigations employing isolated Sertoli cells were carried out (Chapter 5).
Chapter 5.
Effects of steroid treatment on isolated rat Sertoli cell
gene expression
5.1. Introduction
Sertoli cell maturation takes place in a very dynamic and changing testicular
environment. Differentiation of adult type Leydig cells occurs alongside Sertoli
cell maturation and the onset of spermatogenesis (for review (Gondos and
Berndston, 1994). All of these cellular changes contribute to the establishment of
complex paracrine interactions within the postnatal testis. In parallel with Sertoli
cell maturation, changes in the regulation of Sertoli cell function are influenced
by a decline in FSH control concomitant with an increase in Sertoli cell androgen
responsiveness (for review (Gondos and Berndston, 1994). Differentiated Sertoli
cell function in vivo is regulated and influenced by numerous endocrine and
paracrine interactions occurring during prepubertal testis development which
can overshadow direct regulatory effects of steroids on Sertoli cell function
when investigated in vivo. In previous chapters, expression patterns and
regulation of known (inhibin-a, GATA-4 and GATA-1) and novel (Musashi-1)
Sertoli cell proteins were investigated. The effect of neonatal E treatment on
Sertoli cell protein expression was determined in vivo. However difficulty was
found when determining direct modification of Sertoli cell function by E as
changes in protein expression patterns could have arisen indirectly via E action
on Sertoli cell maturation. Consequently in the present study direct effects of
steroids on Sertoli cell gene expression were investigated using an in vitro
primary Sertoli cell culture system where the complex paracrine and endocrine
interactions present within the postnatal testis were removed allowing
controlled manipulation of the Sertoli cell environment to be carried out.
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Reports in the literature and preliminary results in previous chapters have
provided evidence of possible regulation of GATA-1, GATA-4 and Musashi-1
Sertoli cell expression by E and T. For example differentiating mouse granulosa
cells show an upregulation in GATA-4 mRNA expression following in vivo DES
administration (Heikinheimo et al., 1997). However T was not found to be
essential for Sertoli cell GATA-4 protein expression in vivo (Ketola et al., 1999).
Ligand bound ERa has been shown to interact with GATA-1 in erythroid cells
(red blood cell precursors) (Blobel and Orkin, 1996; Blobel et al., 1995). It has
therefore been proposed that ligand bound ERP could interact with GATA-1 and
GATA-4 proteins in Sertoli cell nuclei. Such interactions would inhibit
transactivation ofGATA regulated genes expressed in differentiating Sertoli cells
including GATA-1 and inhibin-a (Feng et al., 1998; Heikinheimo et al.,
1997). Both GATA-1 and Musashi-1 proteins are expressed in stage specific
patterns; GATA-1 expression in Sertoli cells is restricted to stages V-XIII
(Chapter 3) when AR levels within the seminiferous tubules are at the highest
(Bremner et al., 1994; Sharpe, 1994). In comparison, Musashi-1 Sertoli cell
nuclear immunolocalisation is of greatest intensity during stages XI-VI (Maguire
et al., 1999) when AR levels within seminiferous tubules are at the lowest
(Bremner et al., 1994; Sharpe, 1994).
Forskolin is an activator of adenyl cyclase and mimics the effect of FSH on
Sertoli cells through an upregulation in cAMP levels (Bicsak et al., 1987). Sertoli
cell expression of both inhibin-a protein and GATA-4 mRNAs are upregulated
in vitro by FSH administration (Bicsak et al., 1987; Heikinheimo et al., 1997).
Forskolin treatment of Sertoli cells was included in the present study as a control
treatment to ensure that Sertoli cells in the in vitro system retained normal
Sertoli cell characteristics and functions. Isolated Sertoli cells secrete inhibin B
protein into culture media. Inhibin B secretion by Sertoli cells is modified by
steroid treatment (Depuydt et al., 1999). Therefore levels of inhibin B protein in
Sertoli cell conditioned media were measured using an immunoassay to
determine if the treatment regimes used in the present study modified the
behaviour of the Sertoli cells in the culture system employed.
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In the present study it was hoped to establish if oestrogen and testosterone,
acting via ER(3 and AR had a direct effect on isolated Sertoli cell gene expression
of GATA-1, GATA-4, Musashi-1 and inhibin-a. Steroid regulation of Sertoli cell
function was investigated at both mRNA and protein expression levels.
5.2. Materials and Methods
5.2.1. Rat primary Sertoli cell culture
5.2.1.1. Isolation of rat Sertoli cells
Testes were quickly removed from male Wistar rats, decapsulated, weighed and
chopped into approximately 3mm pieces. Sertoli cells were isolated by
enzymatic digestions using a modified method from Toebosch et al., (1988).
Tubules were separated from the testis by gentle agitation in Hanks balanced
salt solution (HBSS), (Gibco-BRL, Paisley, UK) with 0.25% trypsin (Gibco-BRL)
and 13.5pg/ml deoxyribonuclease 1 (DNase 1) (Sigma) at 37°C for 25 minutes.
At the end of the incubation 1.7mg of trypsin inhibitor (Sigma)/2g original
tissue was added for 2 minutes at 21°C. Dispersed tubules were allowed to
settle by unit gravity, washed in fresh HBSS and interstitial cells were removed
in the supernatant. Separation of peritubular myoid cells from the seminiferous
tubule walls occurred during incubation in O.lmg/ml of collagenase type 1A
(Sigma), 6.75pg/ml DNase 1 in HBSS at 37°C for 15 minutes. Contaminating
germ cells were removed from Sertoli cell aggregates by repeated washing and
centrifuging at 500g for 2 minutes. Washing and centrifuging was repeated until
the supernatant was clear indicating that all germ cells had been removed in the
supernatant. Clumps of Sertoli cells were plated out in Ham's F12 nutrient
mixture with L-glutamine and sodium bicarbonate (Gibco-BRL), buffered with
1.5M Hepes pH 7.45, 50 Units/ml penicillin/streptomycin (Gibco-BRL) and
2.5pg/ml amphotericin B (Sigma) and were placed in a 32°C incubator at 5%
C02 and 95% humidity.
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Additional contaminating germ cells were removed after 24 hours, using
hypotonic treatment as described by Galdieri et al., (1981). Briefly, medium was
aspirated and 20mM Tris HC1, pH 7.4 was added to the cells at 21°C for 2.5
minutes. Fresh medium was added to the remaining Sertoli cells. Medium was
replaced every 24 hours until cells and conditioned media were harvested after 5
days (120 hours) in culture.
5.2.1.2. Treatments
lOOpg of testosterone (Sigma, androsten-17(3-ol-3-one) (T) was dissolved in 1ml
absolute ethanol producing a stock solution at lOOpg/ml and appropriate
volumes were added to cell culture media to give a final working solution of
lOOng/ml. A stock solution of oestradiol benzoate (Sigma) (E) in absolute
ethanol (10pg/ml) was added to cell culture media such that a final working
concentration of lOng/ml was produced. Equivalent volumes of absolute
ethanol were added to control media. Forskolin (Sigma) was dissolved in
DMSO to give a stock solution at lOmM. Appropriate volumes were added to
media to give a working concentration at lOpM.
All Sertoli cells were harvested at the same time after 5 days in culture. 5 day
treatment of Sertoli cells began at time 0 hours when Sertoli cell cultures were
set up and treatment continued until time 120 hours (5 days) when Sertoli cells
were harvested. 24 hour treatment of Sertoli cells began at time 96 hours i.e. 24
hours before Sertoli cells were harvested and 4 hour Sertoli cell treatments were
carried out at time 116 hours (4 hours before Sertoli cells were harvested).
Therefore all Sertoli cells were in culture for the same amount of time.
5.2.2. RNA extraction and separation
RNA was extracted from whole rat tissue as described in Chapter 2.
5.2.2.1. Lysis of cultured cells
Sertoli cells cultured for RNA extraction were grown on 150mm and 100mm
round culture dishes (Gibco). At time 120 hours, medim was carefully aspirated
from the cells and any remaining medium washed away with PBS. Cells were
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lysed in 750pl of Tri-Reagent™ and detached from the culture plate with a cell
scraper, the solution was split between two 1.5 ml eppendorfs. An additional
250pl Tri-Reagent™ was added to the flask and used to remove any remaining
cells.
5.2.2.2. RNA extraction
Sertoli cell RNA was extracted from lysed Sertoli cells in Tri-Reagent™ as
described in Chapter 2 with appropriate adjustment of volumes.
5.2.2.3. RNA separation
lOpg of total RNA extracted from cultured rat Sertoli cells and whole rat tissues
was separated on 1.5% denaturing agarose gels and blotted onto nitrocellulose
membranes as described in Sections 2.3.3 and Section 2.9, respectively. RNA
was extracted from Sertoli cells in each treatment group. Experiments
containing the same treatment groups were duplicated and RNA from each
experiment was separated alongside total RNA extracted from day 18 whole rat
testes and rat kidney which were used as control RNA samples.
5.2.3. Northern blot analysis
Northern blot analysis of total RNA was carried out as described in Section 2.9
and cDNA probes for SGP-1, inhibin-a, Musashi-1, GATA-4 and 18S were
acquired as described in Chapter 3 and were radiolabeled following the
protocol given in Chapter 2. Quantification of radiolabeled signals was carried
out as described in Section 2.9/Chapter 3.
5.2.4. Immunocytochemistry
Sertoli cells cultured for immunocytochemical analysis were grown on glass
chamber slides containing one or four culture wells (Lab-Tek, Nunc, Gibco). The
treatment of Sertoli cells was carried out as described in section 5.2.1.2. and
different timed treatments were set up on the same slide as shown below
(Figure 5.1.)





















Figure 5.1: Diagram to show set up of timed treatment of isolated Sertoli cells
cultured on 4 chamber glass slides. Isolated rat Sertoli cells were cultured in
each chamber. At appropriate time points the media in each chamber was
removed and replaced with media containing ethanol, F (10pM), E (lOng/ml) or
T (lOOng/ml).
At time 120 hours, medium was aspirated and cells were washed twice in PBS at
4°C for 5 minutes, slides were air dried and Sertoli cells were then fixed in 4%
neutral buffered formaldehyde (NBF) for 10 minutes followed by two 10 minute
washes in PBS at 4°C. Fixed Sertoli cells were stored in PBS at 4°C and
immunocytochemical analysis was carried out within 48 hours of fixation.
After cultured Sertoli cells had been fixed onto the glass chamber slides all other
slide fixtures attached to the glass slide were removed and the slides were air
dried for approximately 10 minutes. Slides were briefly rehydrated in PBS prior
to blocking of endogenous peroxidase for 20 minutes in PBS:H202 (3% v/v)
followed by 2 x 5 minute PBS washes. Slides were permeabilised in PBS
containing 10% v/v blocking serum (using normal serum from the animal that
the secondary antibody was derived from), 1% w/v BSA and 0.1% v/v NP40 for
30 minutes. 2x5 minute PBS washes were carried out prior to application of
20% v/v blocking serum in PBS containing 5% w/v BSA. Blocking serum was
removed after 30 minutes and primary antibody was applied at the appropriate
dilution and left overnight in a humidified chamber at 4°C. Employment of
secondary antibody and detection of immunolocalisation was carried out as
described in Section 2.10 except that PBS was used in place of TBS.
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5.2.4.1. Steroid receptors
Androgen receptor (AR). A rabbit polyclonal antibody (Santa Cruz) was used at
a dilution of 1:100. In place of the biotinylated secondary antibody and avidin-
conjugated horseradish peroxidase complex, DAKO EnVision + System (anti
rabbit) with peroxidase (DAKO) was applied to the slides for 30 minutes,
following manufacturers instructions. The system is based on an HRP labelled
polymer which is conjugated to an anti-rabbit secondary antibody resulting in a
more sensitive detection system. DAB was then applied to the sections as in
section 2.10.
Oestrogen receptor beta (ERfi). A sheep polyclonal antibody raised against a
peptide within the hinge domain of human ER(3 (Saunders et ah, 2000) was used
at a dilution of 1:2000. Biotinylated rabbit anti-sheep immunoglobulins were
employed as secondary antibody (Vector).
5.2.4.2. Sertoli cell proteins
SGP-1. A rabbit polyclonal antibody, kindly donated by Dr. Steven Sylvester
(University of Washington, Seattle) was used to immunolocalise SGP-1 to
cultured Sertoli cells. The antibody was used at a dilution of 1:500 and
biotinylated swine anti-rabbit immunoglobulins were used as the secondary
antibody (DAKO).
Musashi-1. An anti-mouse-Musashi-1 monoclonal antibody raised in the rat
according to standard procedures using a GST-mouse-Musashi-1 fusion protein
(Sakakibara et al., 1996) was a gift to Dr. Philippa Saunders from Professor H.
Okano (Osaka University, Japan) and was used at a dilution of 1:1000.
Biotinylated rabbit anti-rat immunoglobulins (Vector, Peterborough, UK) were
used as the secondary antibody.
GATA-4. A goat polyclonal anti-rat GATA-4 antibody (SantaCruz) was used at a
dilution of 1:250. Biotinylated rabbit anti-goat immunoglobulins (DAKO) were
utilised as secondary antibodies.
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5.2.4.3. Other proteins
Smooth muscle actin-a. A mouse monoclonal antibody (Sigma) was used to
immunolocalise smooth muscle actin-a to peritubular myoid cell cytoplasm.
The antibody was used at a dilution of 1:500 and rabbit anti-mouse biotinylated
IgGs were used as the secondary antibody (DAKO).
The specificity of the specific antibodies (except for ERf3) was checked by
replacing each antibody with normal serum from the animal species that the
primary antibody was raised in. The normal serum was diluted to ensure
protein content was the same as in the diluted primary antibody. In the case of
ER{3, the peptide to which the primary antibody was raised against was
incubated in the presence of the primary antibody overnight at 4°C. The
concentration of incubated peptide was ten times that of the antibody with
regards to protein content. The pre-absorbed antibody was then diluted to the
working concentration which corresponded to that of the primary antibody.
None of the above controls resulted in any signal above background.
Sections were analysed using an Olympus Provis microscope and images were
captured onto computer using either a Kodak DCS420 camera or a Kodak
DCS330 camera and stored on the computer using the Adobe Photoshop 5.0
programme.
5.2.5. Inhibin B assay
Sertoli cells in culture secrete inhibin B into culture media and in vitro Sertoli cell
expression of inhibin B is regulated by steroid treatment (Depuydt et al.r 1999).
Inhibin B secretion by cultured Sertoli cells was measured in the present study to
establish if the treatment regimes used were appropriate.
Media from cultured Sertoli cells were collected at time 120 hours into 15ml
centrifuge tubes (Corning, New York, USA) and centrifuged at 1500g for 10
minutes at 4°C to pellet any cell debris present. The supernatant was retained
and placed in clean 15 ml centrifuge tubes and stored at -20°C until the inhibin B
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assay was carried out. The inhibin B assay was very kindly carried out by Mr.
Ian Swanston, Mrs Fiona Pitt and Mr. Paul Hartely using the protocol described
in Groome et al., (1996) (Groome et al., 1996). In preliminary experiments levels
of inhibin B in Sertoli cell conditioned media could be detected in neat media
however in later experiments levels of inhibin B in the conditioned media were
too low to be detected using the assay. The Sertoli cell conditioned media was
therefore concentrated 10 fold using Centrex® UF centrifugal ultrafilters for
proteins sized 30 kDa and above (Schleicher and Schuell, New Hampshire, USA)
and inhibin B levels in the concentrated media were then assayed. Each Sertoli
cell treatment per experiment was carried out in duplicate and measurement of
inhibin B levels in each sample were assayed in duplicate, the mean of which
was calculated and used as the inhibin B value for that sample.
5.3. Results
5.3.1. Maintenance of normal Sertoli cell function and
morphology after 5 days in culture
The majority of cells isolated for in vitro cell culture were identified as Sertoli
cells by immunolocalisation of SGP-1 to Sertoli cell cytoplasm after 5 days in
culture at 32°C (Fig. 5.2.a, Fig. 5.3.a). Other cell types present in Sertoli cell
cultures were immunopositive for smooth muscle actin-a and cellular
morphology suggested that they were peritubular myoid cells (Fig. 5.2.b). No
quantitative determinations of cell contamination in Sertoli cell cultures were
carried out. Hypotonic osmotic shock of germ cells and subsequent changes of
media ensured that by day 5 the majority of contaminating germ cells had been
removed. This was confirmed morphologically by light microscopy. A very
small number of peritubular myoid cells remained in Sertoli cell culture at day 5
and could easily be detected due to the different size and morphology of the
myoid cells. After 5 days in culture at 32°C both AR and ER(1 were
immunolocalised to Sertoli cell nuclei in the absence of T and E (Fig 5.3. b, c).
Figure 5.2: General appearance of isolated rat Sertoli cells in culture.
SGP-1 was immunolocalised to the cytoplasm of Sertoli cells from postnatal
day 18 rat testes which had been in culture for 5 days (120 hours) at 32"C (a).
Inset shows negative control when primary antibody was replaced with
normal rabbit IgGs. Immunolocalisation of smooth muscle actin-a to the
cytoplasm of peritubular myoid cells present in the Sertoli cell cultures (b).
Inset shows negative control when primary antibody was replaced with
normal mouse IgGs. Scale bar represents 150pm.
\
Figure 5.3: Immunoexpression of steroid receptors and SGP-1 to rat Sertoli cells
in culture. Immunoexpression of SGP-1 to the cytoplasm of isolated rat Sertoli cells
after 5 days (120 hours) in culture at 32°C (a). Immunoexpression of androgen
receptor (AR) (b), and oestrogen receptor p (ERp) (c), in day 18 rat Sertoli cells
cultured for 5 days (120 hours) in the absence of testosterone and oestrogen.
Insets show negative controls when primary antibodies were replaced with normal
rabbit IgGs (a, b) or preabsorbed peptide (c). Scale bar represents 20pm.
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5.3.2. Sertoli cell mRNA expression following steroid
treatment
Northern blot analysis with an SGP-1 partial cDNA detected a single 2.6kb
mRNA transcript in Sertoli cell RNA. No change in SGP-1 mRNA expression
following F, E and T treatment for 24 and 4 hours could be observed on the
Northern blot (Fig. 5.4.A, B). However following normalisation of SGP-1
mRNA expression with corresponding 18S rRNA levels from two separate
experiments mean SGP-1:18S values were calculated and indicated that T
treatment for 4 hours could upregulate SGP-1 mRNA expression in contrast to a
possible downregulation in SGP-1 mRNA expression following 24 hour T
administration (Fig. 5.4. C). E treatment did not appear to change SGP-1 mRNA
levels whilst 24 hour F treatment resulted in a decrease in SGP-1 mRNA
expression in this study.
A 1.5kb mRNA transcript was detected in Sertoli cell RNA using a radiolabeled
inhibin-a partial cDNA. Inhibin-a mRNA expression was detected in day 18 rat
testis and F 24 hour treated Sertoli cell RNA but inhibin-a mRNA expression in
all other Sertoli cell RNA samples was too low to be detected using Northern
blot analysis (Fig. 5.5. A). SGP-1 mRNA expression and 18S rRNA levels were
determined on the same Northern blot and confirmed that Sertoli cell RNA was
present in the lanes in which inhibin-a mRNA expression could not be detected
(Fig. 5.5. B,C).
A 3kb Musashi-1 mRNA transcript was detected in Sertoli cell RNA samples
using a Musashi-1 cDNA probe (Fig 5.6. A). Musashi-1 mRNA levels were low
in E and ethanol (control) 4 hour treated RNA samples. Musashi-1 mRNA
expression was undetectable in the T 24 hour treated Sertoli cell RNA sample.
However Musashi-1 mRNA was detected in E, F and control 24 hour and T 4
hour treated RNA samples where SGP-1 and 18S Northern blot analysis showed
increased amounts of total RNA had been loaded into these lanes (Fig. 5.6. B,
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C). In a separate duplicate experiment (not shown) levels ofMusashi-1 mRNA in
all Sertoli cell samples were very low. Quantification of hybridisation signals
was not carried out due to the absence or very low level of Musashi-1
hybridisation signals in a number of Sertoli cell RNA samples across both
experiments.
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Figure 5.4: Northern blot analysis of SGP-1 mRNA expression in isolated rat
Sertoli cell cultures following steroid treatment. All lanes were loaded with
lOpg of total RNA extracted from day 18 rat Sertoli cells in culture following
treatment with oestradiol benzoate (lOng/ml) for 4 hours (1) and 24 hours (2);
testosterone (lOOng/ml) for 4 hours (3) and 24 hours (4); ethanol for 4 hours (5)
and 24 hours (6). From a separate experiment Sertoli cells were treated with
10|iM forskoiin (7) and ethanol (8) for 24 hours. Total RNA extracted from
rat kidney (k) and postnatal day 18 rat testis (18) were analysed as control RNA
samples. RNA was hybridised with a 32P-labelled SGP-1 cDNA which detected
a 2.6kb transcript (A). The RNA was reprobed with a 32P-labelled 18S cDNA
which hybridised to a 1.9kb 18S rRNA transcript and was used to check for even
loading of RNA (B). Following quantification of hybridisation signals the ratios
of SGP-1 mRNA expression to 18S rRNA from two separate experiments was
calculated and the mean SGP-1:18S ratios were plotted for each Sertoli cell RNA




Figure 5.5: Northern blot analysis of inhibin-a mRNA expression in isolated rat
Sertoli cell cultures following steroid treatment. All lanes were loaded with lOpg
of total RNA extracted from day 18 rat Sertoli cells in culture following treatment
with oestradiol benzoate (lOng/ml) for 4 hours (1) and 24 hours (2); testosterone
(lOOng/ml) for 4 hours (3) and 24 hours (4); ethanol for 4 hours (5) and 24 hours
(6). From a separate experiment Sertoli cells were treated with lOpM forskolin
(7) and ethanol (8) for 24 hours. Total RNA extracted from rat kidney (k) and
postnatal day 18 rat testis (18) were analysed as control RNA samples. RNA was
hybridised with a 12P-labelled inhibin-a cDNA which detected a 1.5kb transcript
(A) in sample 7 and 18. RNA was reprobed with a 32P-labelled SGP-1 cDNA which
detected a 2.6kb transcript in all RNA samples (B). RNA was then reprobed with a
32P-labelled 18S cDNA which hybridised to a 1.9kb 18S ribosomal RNA transcript
in all samples (C).
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Figure 5.6: Northern blot analysis of Musashi-1 mRNA expression in isolated rat
Sertoli cell cultures following steroid treatment. All lanes were loaded with lOpg
of total RNA extracted from day 18 rat Sertoli cells following treatment with
oestradiol benzoate (10ng/ml) for 4 hours (1) and 24 hours (2); testosterone
(lOOng/ml) for 4 hours (3) and 24 hours (4); ethanol for 4 hours (5) and 24 hours
(6) and forskolin (10pM) for 24 hours (7). Total RNA extracted from rat kidney (k)
and postnatal day 18 rat testis (18)were analysed as control RNA samples.
RNA was hybridised with a 32P-labelled Musashi-1 cDNA which detected a 3kb
transcript in all RNA samples (A). RNA was reprobed with a 32P-labelled SGP-1
cDNA which hydbrised to a 2.6 kb transcript in all RNA samples (B). RNA was
also reprobed with a 32P-labelled 18S cDNA probe which detected a 1.9kb 18S
rRNA transcript in all RNA samples (C).
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Figure 5.7: Northern blot analysis of GATA-4 mRNA expression in isolated rat
Sertoli cell cultures following steroid treatment. All lanes were loaded with
10 pg of total RNA extracted from day 18 rat Sertoli cells in culture following
treatment with oestradiol benzoate (10ng/ml) for 4 hours (1) and 24 hours (2);
testosterone (lOOng/ml) for 4 hours (3) and 24 hours (4); ethanol for 4 hours (5)
and 24 hours (6) and forskolin (10[iM) for 24 hours (7). Total RNA extracted
from rat kidney (k) and postnatal day 18 rat testis (18) were used as control
RNA samples. RNA was hybridised with a 32P-labelled GATA-4 cDNA which
detected a 3.1kb RNA transcript (A). RNA was reprobed with a 32P-labelled
SGP-1 cDNA which hybridised to a 2.6kb transcript (B) and a 32P-labelled 18S
cDNA was used to detect a 1.9kb 18S rRNA transcript (C).





































Figure 5.8: Changes in GATA-4 mRNA expression following steroid treatment
of rat Sertoli cells in culture. GATA-4 mRNA expression was normalised
against corresponding 18S rRNA values and the calculated GATA-4:18S results
from two separate experiments are shown. In (A) forskolin (F) 24 hour
treatment was carried out in a separate experiment and is shown alongside a
corresponding 24 hour control sample from the same experiment.
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A single 3.1kb GATA-4 mRNA transcript was detected in all Sertoli cell RNA
samples using a radiolabeled GATA-4 partial cDNA (Fig. 5.7. A). GATA-4
hybridisation signals were quantified and normalised against corresponding 18S
rRNA values. In Fig.5.8. both experiments (A and B) demonstrated a
downregulation in rat Sertoli cell GATA-4 mRNA expression following E
treatment for 4 hours and in contrast T treatment for the same time period
upregulated GATA-4 gene expression. Following 24 hour treatment with T
mRNA levels for GATA-4 were decreased in both experiments. However
inconsistent results were obtained in both experiments following 24 hour E
administration. This inconsistency in the results could be due to a non-specific
mark (not shown) covering part of the GATA-4 signal in the Fig 5.8.B-24 hour
sample. Subsequently the GATA-4 value for this sample will be artificially high.
F treatment for 24 hours caused a downregulation in GATA-4 mRNA
expression by Sertoli cells. However a greater decrease in mRNA levels was
observed in experiment A.
5.3.3. Effect of steroid treatment on Sertoli cell
immunoexpression
AR was immunolocalised to Sertoli cell nuclei after 5 days in culture in both the
presence and absence of F, E and T (Fig. 5.9.). Some Sertoli cell nuclei were
immunonegative for AR (black arrows) as were contaminating germ cells (blue
arrowheads). Non-specific AR immunostaining in Sertoli cell cytoplasm could be
observed (Fig. 5.9. h). Intensity of AR immunostaining in Sertoli cells treated
with F (Fig. 5.9. b) and E (Fig. 5.9. c, f) was lower than the intensity of staining
observed in control (Fig. 5.9. a, e) and T (Fig. 5.9. d, g) treated Sertoli cells.
ER(3 was immunolocalised to Sertoli cell nuclei (Fig. 5.10.). A small population of
Sertoli cells were immunonegative for ER(3 (black arrows) and contaminating
germ cells were also immunonegative (blue arrowheads). A small number of
immunopositive peritubular myoid cell nuclei were observed and were
identified due to their morphological appearance (Fig. 5.10. e). F treatment did
not affect the intensity of ERfl immunostaining in Sertoli cell nuclei (Fig. 6.9. b, f,
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h) when compared to control Sertoli cells (Fig. 5.10. a, e, i.). However following
E and T treatment for 5 days (Fig. 5.10. c, d) the intensity of
ER(3 immunoexpression in Sertoli cell nuclei was slightly higher than in the
nuclei of control Sertoli cell nuclei. Non-specific immunostaining was not
observed (Fig. 5.10. inset).
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Figure 5.9: Effect of steroid treatment on AR immunolocalisation in cultured rat
Sertoli cells. Sertoli cells were treated with ethanol (a, e,), forskolin at lOpM (b),
oestradiol benzoate (E) at 10ng/ml (c, f) and testosterone (T) at lOOng/ml (d, g).
Treatments carried out for 5 days (120 hours) are shown in a-d and 24 hour
treatments can be seen in e-g. A representative negative control is shown in h
where primary antibody was replaced with normal rabbit IgGs. Black arrows
point to immunonegative Sertoli cell nuclei and blue arrowheads point to
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Figure 5.10: Effect of steroid treatment on immunolocalisation of ER[3 to rat
Sertoli cells in culture. Sertoli cells were treated with ethanol (a, e, i), forskolin
at 10pM(b, f, j), oestradiol benzoate at lOng/ml (E) (c, g, k) and testosterone at
lOOng/ml (T) (d, h, 1). Treatments were carried out for 5 days (120 hours) (a-d),
24 hours (e-h) and 4 hours (i-1). Inset shows a representative negative control
when primary antibody was replaced with preabsorbed peptide. Black arrows
point to immunonegative Sertoli cell nuclei and blue arrowheads point to
contaminating germ cells. Astericks marks immunopositive myoid cell.



























Figure 5.11: Effect of steroid treatment on immunolocalisation of Musashi-1 to rat
Sertoli cells in culture. Sertoli cells were treated with ethanol (a, d, g), forskolin at
lOpM (b, e, h) and oestradiol benzoate at lOng/ml (E) (c, f, i). Treatments were
carried out for 5 days (120 hours) (a-c), 24 hours (d-f) and 4 hours (g-i). Inset
shows a representative negative control when primary antibody was replaced with
normal rat IgGs. Black arrows point to immunonegative Sertoli cell nuclei and blue
arrows point to contaminating germ cells. Scale bar represents 20pm.
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Figure 5.12: Effect of steroid treatment on immunolocalisation of GATA-4 to rat
Sertoli cells in culture. Sertoli cells were treated with ethanol (a, e, i), forskolin
at 10pM(b, f, j), oestradiol benzoate at 10ng/ml (E)(c, g, k) and testosterone at
lOOng/ml (T) (d, h, 1). Treatments were carried out for 5 days (120 hours) (a-d),
24 hours (e-h) and 4 hours (i-1). Inset shows a representative negative control
when primary antibody was replaced with normal goat IgGs. Black arrows
point to immunonegative Sertoli cell nuclei and blue arrowheads point to
contaminating germ cells. Scale bar represents 20pm.
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Musashi-1 protein was immunolocalised to Sertoli cell nuclei (Fig. 5.11.). A very
small population of Sertoli cells were immunonegative for Musashi-1 (black
arrows) as were contaminating germ cells (blue arrowheads). Results for T
treated Sertoli cells were only observed in one experiment. Musashi-1 protein
expression did not appear to be changed with T treatment. However the effect
of T treatment on Sertoli cells is not shown due to the fact that n=l. Following
F and E treatment for 5 days, 24 hours and 4 hours, Musashi-1 immunostaining
in Sertoli cell nuclei was of a greater intensity than in control Sertoli cell nuclei.
The difference in intensity was most notable in E treated Sertoli cells (Fig. 5.11. c,
f, i.). Non specific Musashi-1 immunostaining was not observed (Fig. 5.11.
inset).
GATA-4 was immunolocalised to the nuclei of Sertoli cells (Fig. 5.12.). Some
Sertoli cell nuclei were immunonegative for GATA-4 (black arrows) as were
contaminating germ cells (blue arrowheads). No consistent change in the
intensity of GATA-4 immunostaining could be observed with F, E or T
treatment at any time studied. Non-specific GATA-4 immunostaining was not
detected (Fig. 5.12. inset).






















































Figure 5.13: The effect of steroid treatment on secretion of inhibin B protein
by rat Sertoli cells in culture. Day 18 rat Sertoli cells in culture were treated
with ethanol (C), oestradiol benzoate (lOOng/ml) (E), testosterone (lOng/ml) (T)
and forskolin (lOpM) (F) for 24 and 4 hours after which the conditioned media
was removed and levels of inhibin B secreted into the media by the Sertoli cells
were assayed. Each sample was assayed in duplicate and a mean of the
duplicates was used as the sample inhibin B value. Numbers of separate
samples assayed per treatment are given in brackets the mean of which is
shown. In (A) where n=l the level of inhibin B in the duplicate sample was
undetectable by the assay whilst in (B) when n=l the duplicate sample was not
present. Inhibin B protein levels in the 4 hour treated samples in (B) were below
the limits for detection in the assay.
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Figure 5.14: Changes in inhibin B secretion by cultured rat Sertoli cells
following steroid treatment; inhibin B values have been normalised against
the quantity of RNA obtained from each treatment group. Inhibin B values
given in Fig. 5.13 were normalised against the amount of RNA obtained from
each culture sample (as an indicator of Sertoli cell numbers). All results shown
are n=l as RNA was extracted from only one of the treated samples from each
experimental group.
After inhibin B values had been normalised against the quantity of RNA
extracted from corresponding Sertoli cell pellets, 24 hour F treatment
upregulated inhibin B secretion in both experiments. E treatment also increased
inhibin B levels in the media but not to the same extent as F (Fig. 5.13, 5.14). T
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treatment on the other hand downregulated Sertoli cell inhibin B secretion. In
both experiments 4 hour treated media contained less inhibin B protein than 24
hour treated media.
All the results shown in this chapter were from individual experiments which
were duplicated and unless stated otherwise the results displayed are
representative of the results obtained in the duplicate experiments.
5.4. Discussion
Sertoli cells from day 18 rats were employed in the present in vitro study as it
has been previously shown that the majority of Sertoli cells in Wistar rats have
ceased dividing by day 18 and were undergoing differentiation. Sertoli cells
removed from testes of older animals would be further along the maturational
process. However the mass expansion of germ cell populations accompanying
Sertoli cell maturation was found to hinder the isolation and establishment of a
'pure' Sertoli cell primary culture (not shown). Therefore a balance was struck
when obtaining primary cultures of Sertoli cells between the extent of Sertoli cell
maturation and the expansion of germ cell numbers. Sertoli cells in the present
study formed characteristic epithelial-like monolayers (Steinberger and
Jakubowiak, 1993) after 3 days in culture and continued to express Sertoli cell
specific proteins after 5 days in culture. SGP-1 protein was immunolocalised to
Sertoli cell cytoplasm and expression of both AR and ER(3 protein was
maintained in the absence of E, T and F indicating that throughout the culture
period Sertoli cells had not de-differentiated or lost normal cellular physiology.
The inhibin B assay demonstrated that Sertoli cells had retained the ability to
respond to hormonal treatment in the same way as reported in the literature
(Anawalt et al., 1996; Depuydt et al., 1999; Turner et al., 1989; Ultee-van Gessel et
al, 1986).
The changes in inhibin B levels also demonstrated that the administration of
testosterone and oestradiol benzoate at the concentrations employed were
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appropriate and capable ofmodifying Sertoli cell gene expression. lOOng/ml of
testosterone had been previously shown in published data to modify rat Sertoli
cell function and gene expression (Depuydt et al., 1999; Foucault et al., 1992;
Lamb et al., 1981; Lim et al., 1994). Testosterone concentrations within the
mature rat testis are thought to range from 25-100ng/ml (Sharpe, 1994).
Therefore the concentration of testosterone used in the present study was
within the normal physiological range found in the mature rat testis.
Treatment of cultured rat Sertoli cells with E had not been studied extensively
when this study was set up hence the administration of lOng/ml of oestradiol
benzoate (EB) had not been previously shown to modify Sertoli cell behaviour
in vitro. The increase in inhibin B protein secretion in the presence of EB
demonstrated that lOng/ml of EB did alter Sertoli cell gene expression in vitro.
Neonatal in vivo administration of EB to male rats has been previously shown
to delay Sertoli cell maturation, cause dilation of the rete testis and backflow
impairment of spermatogenesis (Aceitero et al., 1998; Gaytan et al., 1986) in
addition to causing permanent atrophy of the testes and reduced serum FSH,
LH and T levels (Bellido et al., 1985; Bellido et al., 1990; Brown-Grant et al., 1975;
Kind et al., 1965; Pinilla et al., 1995; Tena-Sempere et al., 2000). Similar
abnormalities of the male reproductive tract in rats have been observed
following neonatal administration of DES and EE (Fisher et al., 1999; Fisher et al.,
1998; Sharpe et al., 1998) demonstrating that oestrogenic chemicals can have a
physiological effect on the rat testis. Forskolin treatment upregulated inhibin-a
mRNA expression and increased GATA-4 and inhibin B protein production by
isolated rat Sertoli cells which was in agreement with previously published
literature (Bicsak et al., 1987; Depuydt et al., 1999; Heikinheimo et al., 1997). It
was not investigated whether the observed effects of F on Sertoli cell gene
expression were due to the administration of F or the vehicle, DMSO. Stocco et
al., (1995) observed an inhibition in StAR protein production in cultured MA-10
Leydig cells following administration of 5% DMSO. 0.1% DMSO was used in the
present study and to the best of my knowledge there are no reports of DMSO at
this concentration modifying the function of cells in vitro.
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Sertoli cell inhibin B assay results were normalised against differences in
numbers of Sertoli cells present at the time of media recovery by dividing
inhibin B values by the total mass of RNA extracted from the corresponding cell
pellet/culture dish. Inhibin B levels were down regulated in the presence of T
and were markedly upregulated following F treatment as had been previously
reported in the literature (Anawalt et al., 1996; Bicsak et ah, 1987; Depuydt et ah,
1999; Keinan et al., 1989; Toebosch et al., 1989; Ultee-van Gessel et al., 1986).
However when protein production was normalised against approximate cell
numbers the extent of inhibin B upregulation by E was greatly reduced in
experiment A (see Figs. 5.13, 14). This observation highlighted the technical
problem experienced in the current study of obtaining and maintaining equal
numbers of Sertoli cells between treatment groups and experiments. Plating
out of Sertoli cells was performed by pipetting equal volumes of Sertoli cell
suspension onto the culture plates. Due to the presence of Sertoli cell
aggregates and contaminating germ cells when Sertoli cells were first isolated,
final numbers of Sertoli cells varied between treatment groups. Initially it was
decided that the different numbers of Sertoli cells between treatment groups
could be c normalised by correcting mRNA expression levels against SGP-1
mRNA values. SGP-1 is constitutively expressed by Sertoli cells (Chapter 3) and
is often used in the literature as a control Sertoli cell gene by which expression of
other Sertoli cell factors are standardised. In the present study SGP-1 mRNA
expression levels were normalised against 18S rRNA values and SGP-1
expression in the cultured rat Sertoli cells was upregulated after 4 hour T
administration. In contrast SGP-1 mRNA levels were downregulated following
T treatment for 24 hours. Due to these novel findings, 18S rRNA values were
used to normalise Sertoli cell mRNA expression and although this was not ideal
due to the contribution of contaminating cells to 18S rRNA values, levels of
contamination were considered to be too low to markedly alter results.
However it is well established that differences in cell density can dramatically
affect Sertoli cell function and morphology and therefore simple correction
using 18S rRNA values may not be sufficient. For example increasing the cell
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density of day 20 rat Sertoli cells caused a decrease in E production (Schteingart
et al., 1995). In contrast levels of steroid receptor protein are increased in parallel
with increased Sertoli cell density (Nakhla et al., 1984). Therefore it is generally
agreed that the density at which cells are cultured can influence cellular
behaviour and physiology. Even though differences in mRNA mass and cell
numbers were controlled in the present study modification of Sertoli cell
function (e.g. protein expression and steroid receptor numbers) by varying cell
densities could not be controlled and consequently changes in Sertoli cell gene
expression observed cannot be definitely stated to result from hormonal
regulation but maybe caused by differences in cell densities between treatment
groups.
Immunocytochemical techniques were useful in determining the subcellular
location of steroid receptors and other Sertoli cell protein expression in vitro.
However the effects of hormonal treatment on levels of protein expression
were not accurately quantified using immunocytochemistry. Due to time
constraints further investigations using a range of antibody concentrations were
not carried out which was unfortunate as subtle changes in intracellular protein
levels may not have been detected because of the high concentrations of
primary antibody that were employed. Sertoli cells adhered well to one
chambered glass slides but cells did not adhere as well to smaller four
chambered glass slides. This may be due to the increased surface tension of
media in the smaller chambers which resulted in a greater number of Sertoli
cells floating on the surface of the medium rather than sinking and adhering to
the glass. Although smaller media volumes were employed to overcome this
effect, Sertoli cell numbers in four-chambered slides remained low and
subsequently the effect of short term hormonal treatment on AR protein
expression and T treatment on Musashi-1 protein expression could not be
determined due to inadequate numbers of cells in some culture chambers. Due
to the smaller surface area in the four-chambered slides difficulty was also
experienced in removal of contaminating germ cells which were usually
dislodged from Sertoli cells by swirling of the media between media changes.
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The 'swirling action' was reduced in the smaller chambers which resulted in
inadequate removal of the germ cells. Thus the number of contaminating germ
cells in Sertoli cell cultures grown on glass slides was greater than the number of
germ cells remaining in Sertoli cell cultures grown on plastic dishes.
AR protein was expressed in cultured Sertoli cell nuclei in the absence and
presence of F, EB and T. T is known to upregulate the level of AR protein
expression in cultured Sertoli cells. In contrast T administration decreases or
causes no detectable change in AR mRNA levels (Blok et al, 1989; Cardone et al.,
1998; Sar et al., 1993; Verhoeven and Caillaeu, 1988). It has been proposed that T
administration increases the stability of AR protein structure and does not
directly increase AR gene expression. T administration did not alter detectable
AR protein levels in the present study. In day 18 rat testis Sertoli cells are
becoming increasingly responsive to androgens at the expense of FSH
regulation (Gondos and Berndston, 1994). Altered T levels had no effect on AR
protein levels in day 21 male Sprague-Dawley rats (Shan et al., 1994) and it is
possible that in the day 18 male Wistar rats used in the present study the
increase in androgen responsiveness is delayed in comparison to other strains of
rat. It is also a possibility that an upregulation in AR protein levels following T
administration was not observed due to the length of T treatment (5 days and
24 hours). Sanborn et al., (Sanborn et al., 1977) demonstrated a 30% decrease in
AR nuclear accumulation 1 hour following T administration. Therefore some
ligand-AR complexes may have dissociated 24 hours after T administration.
However if this was the case an increase in cytosolic AR levels might have been
observed. It has been reported that E decreases AR levels in Sertoli cells at both
mRNA and protein expression levels in vivo (Sharpe et al., 1998; Tena-Sempere
et al., 2000) and in vitro (Cardone et al., 1998; Collins et al., 1994). A slight
decrease in the intensity of AR immunostaining was observed in Sertoli cell
nuclei following EB treatment for 5 days (120 hours) and 24 hours. A similar
decrease in AR protein levels was observed following 120 hours of F
administration. Previous research has shown that FSH treatment of cultured
Sertoli cells upregulates AR levels (Blok et al., 1989; Sanborn et al., 1991;
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Verhoeven and Caillaeu, 1988). FSH also increases Sertoli cell aromatase
expression and therefore any endogenous T present in the cell culture system
could be metabolised into E which could then decrease AR protein levels. In
addition F is known to dephosphorylate AR protein in cultured LnCAP cells
(Blok et al, 1998). Dephosphorylation prevents ligand binding to the AR and
consequently endogenous T would be prevented from binding to AR resulting
in the observed downregulation in AR levels following F administration.
The intensity of nuclear ER(3 Sertoli cell immunostaining was increased
following EB and T administration. The intensity of ER(3 immunostaining was
greatest when Sertoli cells were constantly exposed to E and T for 120 hours. In
vivo EB treatment caused a direct upregulation of ERP mRNA levels in
immature and prepubertal rat testis (Tena-Sempere et al., 2000). However to
my knowledge there are no previous reports of T upregulating ER(3 protein
levels in Sertoli cells. In neonatal rat cardiac myocytes T indirectly upregulates
ERP mRNA levels via aromatisation (Grohe et al., 1998) and aromatisation of T
could also occur in the present study. F treatment has been shown to
downregulate ERP mRNA levels in cultured granulosa cells (Byers et al., 1997)
and a similar effect of F on ERP protein levels was also observed in the present
study.
Steroid regulation of Sertoli cell gene expression was assessed at both mRNA
and protein levels. RTPCR analysis of mRNA expression levels is a more
sensitive technique than Northern blot analysis. However accurate
quantification of mRNA levels was required in the present study and therefore
Northern blot analysis was employed. Preliminary investigations had detected
GATA-1 mRNA expression in the isolated rat Sertoli cells using RTPCR.
However GATA-1 gene expression could not be detected in the cultured Sertoli
cells using Northern blot analysis and immunocytochemistry. Onodera et al.,
(1997) reported that GATA-1 protein expression was lost in mouse Sertoli cell
cultures between days 1 and 3, although RTPCR studies demonstrated GATA-1
mRNA was expressed in Sertoli cells cultured over five days it is possible that
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GATA-1 expression levels were very low by this stage of culture and
consequently could not be detected using the techniques employed in the
current study. Inhibin-a protein could not be detected in the isolated rat Sertoli
cells using immunocytochemistry and consistent with this inhibin-a mRNA was
only detected in F treated Sertoli cells. Upregulation of inhibin protein levels
following F administration in cultured rat Sertoli cells was previously
demonstrated by Bicsak et al., (1987). It appears that Sertoli cells had not lost the
ability to express inhibin-a during the culture period but basal levels were too
low for detection using Northern blot analysis. In previous reports larger
volumes of Sertoli cell RNA have been required for detection of inhibin-a
mRNA in rat Sertoli cell cultures (Keinan et al., 1989; Klaij et al., 1990; le
Magueresse-Battistoni et al., 1995; Toebosch et al., 1988). Expression of Musashi-
1 in cultured rat Sertoli cells has not been previously reported. However levels
of Musashi-1 mRNA were also at the limit of Northern blot detection such that
in order to determine the effects of steroids on Musashi-1 and inhibin-a gene
expression increased mass of RNA or RPA analysis will be needed in future
studies. Musashi-1 protein was immunolocalised to Sertoli cell nuclei as well as
to Sertoli cell cytoplasm but at a lower intensity than nuclear staining. Thus
Sertoli cells in vitro express Musashi-1 protein in a similar pattern to the
characteristic immunostaining observed in differentiating cells in vivo (Chapter
3). Following E and F treatment Musashi-1 protein levels were upregulated in
Sertoli cell nuclei. However the possible significance of these findings is
unknown and therefore requires further investigation.
GATA-4 gene expression was investigated in the present study in an attempt to
determine if E had a direct affect on GATA-4 expression. EB treatment of Sertoli
cells for 4 hours downregulated GATA-4 mRNA expression. (Upregulation of
GATA-4 mRNA expression following E treatment for 24 hours observed in Fig.
5.8.B is artificially high due to a non specific mark on the Northern membrane
covering part of the GATA-4 signal for this sample). Heikinheimo et al., (1997)
showed that DES administration upregulated GATA-4 mRNA expression in
cultured granulosa cells. However these differences in the effect of oestrogens
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on GATA-4 expression may result from different regulatory systems existing in
the different cell types. In addition as has been previously discussed in Chapter
4 oestrogens may indirectly increase GATA-4 mRNA levels in granulosa cells via
increasing cellular differentiation. T treatment of Sertoli cells for 4 hours
upregulated GATA-4 mRNA levels whilst 24 hour administration had the
opposite effect on GATA-4 mRNA. FSH has been previously shown to
significantly upregulate GATA-4 mRNA levels in MSC-1 Sertoli cells transfected
with an FSH receptor gene and F significantly increased GATA-4 mRNA levels
in cultured mouse granulosa cells (Heikinheimo et al., 1997). In the present
study F decreased GATA-4 mRNA levels in the cultured rat Sertoli cells. During
Sertoli cell maturation FSH responsiveness of Sertoli cells begins to decline with
a parallel increase in regulation of Sertoli cell function by T (Gondos and
Berndston, 1994). It is therefore proposed that in day 18 rat Sertoli cells in
culture the effect of F (FSH) on GATA-4 gene expression is declining whilst T
regulation of expression is increasing and consequently F does not increase
GATA-4 mRNA levels whilst T has a negative effect on GATA-4 gene
expression. The relevance of these findings is uncertain due to the fact that
GATA-4 protein levels remained unchanged following steroid treatment.
However this could result from high antibody concentrations employed in the
present study which could mask subtle changes in GATA-4 protein levels.
Moreover in vivo levels of GATA-4 protein in Sertoli cells appear constant
throughout development and across all spermatogenic stages.
In the present study expression of both AR and ER(3 proteins in cultured Sertoli
cells was maintained in the absence of either T or EB. The cultured Sertoli cells
also retained the ability to respond to hormonal treatment in patterns
characteristic of Sertoli cells in vivo. Preliminary data regarding steroid
regulation of ER(3 protein expression in cultured rat Sertoli cells was reported in
addition to the regulation of GATA-4 mRNA and protein levels by EB and T.
The expression of Musashi-1 mRNA and protein has not previously been
reported in cultured rat Sertoli cells. However further investigations are
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necessary in order to determine if steroid regulation of Musashi-1 takes place In
the differentiating Sertoli cell.
In addition these preliminary investigations highlighted a number of problems
that are associated with primary cultures of Sertoli cells. The importance of
obtaining equal distribution of Sertoli cells across treatment groups was
demonstrated as were the problems associated with achieving adequate
numbers of cells to adhere to smaller chambers on glass slides. Insufficient cell
numbers on slides not only restricts the amount of information that can be
obtained but results may be confounded by problems associated with variations
in cell density. Low cell numbers also restrict the quantities of RNA and protein
that can be extracted from the cultures which in turn limits the analysis of
mRNA levels to the more abundant mRNA transcripts. All these
aforementioned problems are linked to the number of Sertoli cells harvested in
the primary isolation procedure as day 18 rat Sertoli cells have a very low
mitotic index and numbers do not appear to increase during the culture period.
One option to try to overcome the above problems is to utilise an immortalised
Sertoli cell line in order to address the direct actions of steroids on Sertoli cell
gene.
Chapter 6.
Steroid treatment of an immortal mouse Sertoli cell
line (SK11).
6.1. Introduction
Regulation of Sertoli cell behaviour has been studied using primary Sertoli
cell cultures where the extracellular environment of the Sertoli cell can be
more easily manipulated than in vivo and direct effects of steroids can
therefore be investigated. However as was described in Chapter 5 Sertoli
cells in primary culture begin to lose their normal functions including the
ability to respond to hormones between day 6 and day 10 of cell culture
(Steinberger and Jakubowiak, 1993). Low levels of germ cell and peritubular
myoid cell contamination can also complicate interpretation of results due to
the possible regulation of Sertoli cell behaviour by paracrine interactions
with these cell types. In addition investigation of the regulation of gene
expression in Sertoli cells is greatly hampered by the requirement for large
numbers of Sertoli cells to obtain replicate determinants in primary culture
systems. The number of Sertoli cells used in vitro is often limited by the
number of cells obtained at the time of cell isolation. Such problems in cell
culture can be overcome by utilising an immortalised Sertoli cell line where
sufficient numbers of identical Sertoli cells can be acquired without the need
to sacrifice additional animals.
A number of immortalised Sertoli cell lines have been generated by insertion
of immortalising genes into primary cultured Sertoli cells. However normal
cellular physiology can be altered in these cells (Ridley et al., 1988). Jat et alv
Qat et ah, 1991) generated a transgenic mouse that had stably integrated the
simian virus 40 (SV40) mutant temperature sensitive A58 (tsA58) large
tumour antigen (TAg) gene which is a conditional immortalising gene under
the control of the mouse major histocompatibility complex class 1 promoter
(H-2kb) which is active at various levels in different tissues of the body. The
tsA58 TAg gene product is functional at the permissive temperature of 33°C
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but is rapidly degraded at the non-permissive temperature of 39°C. Thus the
presence of the TAg gene results in the generation of continuously
proliferating cell lines which are capable of differentiation following
inactivation of the tsA58 TAg gene when placed at 39°C.
A number of immortalised cell lines have been obtained from H-2Kb-tsA58
transgenic mouse tissues. The cells have been reimplanted into mouse tissue
after in vitro culture and have subsequently differentiated and functioned
normally in the intact organism (Chambers et al., 1993; Morgan et al., 1994).
Walther et al., (1996) isolated Sertoli cells from testes of postnatal day 10 H-
2Kb-tsA58 transgenic mice and established a number of immortalised Sertoli
cell lines containing the H-2Kb-tsA58 TAg gene. One of the Sertoli cell lines,
SK11, was shown to display the pattern of cytoskeletal markers characteristic
for Sertoli cells in vivo. Although not all Sertoli cell morphological
characteristics had been conserved the SK11 cell line does express mRNA for
inhibin-a, SGP-2, transferrin, SF-1, aromatase, GATA-1 and AR (Walther et
al., 1996; Walther et al., 1997).
In the present chapter gene expression in the SK11 Sertoli cell line was
further investigated focusing in particular on effects of T and E on GATA-4,
Musashi-1 and inhibin-a gene expression (re: previous chapters). It was
hoped that in using an immortalised Sertoli cell line previous problems
encountered using primary Sertoli cell cultures would be removed allowing
direct effects of E and T on Sertoli cell behaviour to be assessed.
6.2. Materials and Methods
6.2.1. Immortal Mouse Sertoli cell line (SK11)
An immortal Sertoli cell-line (SK11) established from H-2Kb tsA58 transgenic
mice carrying the inducible temperature-sensitive SV-40 T antigen (Walther
et al., 1996) was a gift from Dr Walther, Hamburg. SK11 cells were
maintained in Dulbecco's modified Eagle's media (DMEM) with 4500mg
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glucose, glutamine, pyridoxine.HCl and sodium bicarbonate (Sigma)
containing 10% fetal bovine serum (Gibco-BRL), 50 Units/ml
penicillin/streptomycin (Gibco-BRL) and 2.5pg/ml amphotericin B (Sigma) at
33°C, 5% C02 and 95% humidity. When cell confluency had reached 70% at
33°C, some flasks were placed in a 39°C incubator at 5% C02 and 95%
humidity for 48 hours whilst cells growing in flasks that had remained at
33°C reached 100% confluency (approximately lxlO6 cells/75cm2 flask).
6.2.1.1. Treatments
Treatments, stock solutions and working concentrations were as given in
section 5.2.1.2. lOOpg of testosterone (Sigma, 4-androsten-17P-ol-3-one) (T)
was dissolved in 1ml absolute ethanol producing a stock solution at
lOOpg/ml and appropriate volumes were added to cell culture media to give
a final working solution of lOOng/ml. A stock solution of oestradiol
benzoate (Sigma) (E) in absolute ethanol (lOpg/ml) was added to cell culture
media such that a final working concentration of lOng/ml was produced.
Equivalent volumes of absolute ethanol were added to control media.
Forskolin (Sigma) was dissolved in DMSO to give a stock solution at lOmM.
Appropriate volumes were added to media to give a working concentration
of lOpM.
Treatments were timed from the point at which SK11 cells were placed into
the 39°C incubator such that 48 hour treatments were added at this point, 24
hour treatments were administered 24 hours later and 4 and 1 hour
treatments were carried out 44 and 47 hours after placement at the non-
permissive temperature, respectively. Therefore all SK11 cells were grown
in culture for identical amounts of time. Control cells grown at 33°C were
administered equivalent treatment regimes. Cells were harvested 48 hours
after placement in the 33°C or 39°C incubators. When steroid treatments
were added DMEM media containing 10% charcoal stripped fetal calf serum
was used in place of normal fetal calf serum.
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6.2.2. RNA extraction and separation
Total RNA was extracted from whole mouse and rat tissues as described in
Chapter 2.
6.2.2.1. Lysis of cultured SK11 cells
After 48 hours in culture at 33°C or 39°C media were aspirated and cells were
washed with PBS. 1ml of lx trypsin in DMEM (Sigma) was added to the cells
to detach them from the culture flask surface with gentle agitation. Once the
majority of cells were detached, 5mls of DMEM was added and the cell
suspension was placed in a 15ml centrifuge tube (Corning) and cells were
gently pelleted at 4°C for 10 minutes at 3000g. The supernatant was carefully
removed and the cell pellet was snap frozen prior to storing at -70°C.
6.2.2.2. RNA extraction from frozen SK11 cells
Whilst frozen SK11 cell pellets were thawing on ice, 1ml of Tri-Reagent™
was added to lyse the cells and extract RNA. RNA extraction was carried out
as described in Chapter 2 with appropriate adjustment of volumes.
6.2.2.3. RNA separation
lOpg of total RNA extracted from cultured SK11 cells and whole rat and
mouse tissues was separated on 1.5% denaturing agarose gels and blotted
onto nitrocellulose membranes as described in Sections 2.3.3. and Section 2.9,
respectively. RNA was extracted from SK11 cells in each treatment group.
Experiments were duplicated and RNA from each experiment was separated
alongside total RNA extracted from day 18 whole rat testes, rat kidney and
day 10 mouse testes which were used as control RNA samples.
6.2.3. Northern blot analysis
Northern blot analysis of total RNA was carried out as described in Section
2.9 and cDNA probes for SGP-1, inhibin-a and 18S were as described in
Chapter 3. Musashi-1 cDNA probe was amplified as described in Maguire et
al (1999) and section 3.2.1.3. except that the partial Musashi-1 cDNA was
amplified by PCR from a pool of day 10 mouse testis cDNAs prepared by RT
using oligo dT primers as described in section 2.5.2. Partial cDNAs for
GATA-4 and GATA-1 were amplified by PCR as described in section 3.2.1.4
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and 3.2.1.5, respectively. Both partial cDNAs were amplified from a pool of
SK11 cell (grown at 39°C) cDNAs prepared by RT using oligo dT primers as
described in section 2.5.2. The SK11 GATA-4 partial cDNA had 100%
sequence homology with the published mouse GATA-4 cDNA over the
region of sequence whilst the SK11 GATA-1 partial cDNA sequence had
95.8% homology with the published rat GATA-1 sequence over the region of
sequence. Radiolabelling of cDNA probes was carried out following the
protocol given in Chapter 2. Quantification of radiolabeled signals was
carried out as described in Section 2.9.
6.2.4. Immunocytochemistry
6.2.4.1. Mouse testes tissue sections
Whole mouse testes were fixed, embedded in paraffin and sectioned as
described in section 2.4. Immunocytochemistry using antibodies raised
against PCNA, SGP-1, inhibin-a, Musashi-1, GATA-1, GATA-4, AR and ER(3
was performed on fixed mouse tissue sections as described in Chapter 3.
6.2.4.2. SK11 cultured cells
SK11 cells were grown on glass chamber slides containing one or four
culture wells (Gibco). Treatment of SK11 cells was carried out as described in
section 6.2.1.1. and different timed treatments were set up on the same slide
as shown below (Figure 6.1.)
120hours 24hours 4hours 1hour
Figure 7.1: Diagram to show set up of timed treatment of SK11 cells
cultured on 4 chamber glass slides. SK11 cells were cultured in each
chamber. At appropriate time points the media in each chamber were
removed and replaced with media containing ethanol, F (10pM), F+E
(lOng/ml) or F+T (lOOng/ml).
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SK11 cells grown on glass slides were fixed and prepared for
immunocytochemical analysis as described in section 5.1.4.
Haemotoxylin and eosin (H and E)
H and E staining of control SK11 cells required a 1-3 minute incubation in
haemotoxylin followed by a wash in distilled water and a short incubation in
Scott's tap water. If the haemotoxylin staining was too intense, it was
reduced by placing the slides in 1% acid alcohol for 5-10 seconds and once the
blue haemotoxylin stain was optimal the slides were placed for 5-20 seconds
in 1% eosin, washed in tap water and quickly dehydrated in an increasing
series of alcohols as described in Chapter 2.
Sertoli cell proteins
Immunolocalisation of GATA-4 to fixed SK11 cells was performed as
described in Chapter 5. ER(1 was immunodetected in SK11 cells as stated in
Chapter 5 except that in place of permeabilising the cells with NP40 solution
a 5 minute incubation in 0.1% sodium dodecyl sulfate (SDS) in PBS was
carried out followed by 3 x 5 minute PBS washes as reported in Brown et al.,
(1996) (Brown et al., 1996). Blocking serum was then added and the
immunocytochemical procedure was continued as in Chapter 5.
6.3. Results
6.3.1. Protein expression in postnatal mouse testis
SGP-l (Fig. 6.2.a) and inhibin-a (Fig. 6.2.b) were immunolocalised to Sertoli
cell cytoplasm in postnatal day 10 mouse testes. Both Sertoli cell nuclei and
cytoplasm were immunostained for Musashi-1 protein in day 10 mouse
testes (Fig. 6.2.c). Nuclear immonostaining for Musashi-1 was of a greater
intensity than cytoplasmic Musashi-1 immunostaining, GATA-4 was
expressed in Sertoli and interstitial cell nuclei (Fig. 6.2.d). Stage specific
immunoexpression of all four Sertoli cell proteins was not observed in
mouse testes at this age.
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GATA-1 was not immunoexpressed in postnatal day 3 mouse testes
(Fig.6.3.a). In day 8 mouse testes GATA-1 protein was immunolocalised to
Sertoli cell nuclei in some seminiferous tubules where Sertoli cell nuclei were
closer to the basement membrane of the seminiferous epithelium (Fig.6.3.c).
The intensity of GATA-1 immunostaining was increased in Sertoli cell nuclei
by day 10 and day 12 (Fig. 6.3.e, g). The majority of cells, including Sertoli
cells (black arrowheads), in day 3 mouse testes were immunopositive for
PCNA (Fig.6.3.b). By day 8 a large number of spermatogonia were still
immunopositive for PCNA as were some Sertoli cell nuclei (black
arrowheads). However a number of Sertoli cell nuclei were
immunonegative for PCNA (black arrows) (Fig. 6.3.d). In day 10 mouse
testes PCNA was immunoexpressed in primary spermatocytes whilst the
majority of Sertoli cell nuclei were immunonegative for PCNA (black
arrows). A small number of immunopositive Sertoli cell nuclei were still
present in mouse testes at this age (black arrowhead) (Fig. 6.3.f). However
by day 12 all Sertoli cell nuclei were immunonegative for PCNA (black
arrows) and the number of spermatogonia and spermatocytes positively
immunostained for PCNA had increased (Fig. 6.3.h).
AR immunoexpression was restricted to interstitial cell nuclei in day 2 mouse
testes (Fig. 6.4.a). By day 8, AR was also immunolocalised to Sertoli cell
nuclei (Fig.6.4.b). The intensity of Sertoli cell and interstitial cell nuclear
immunostaining was increased in day 10 mouse testis (Fig.6.4.c). AR was
immunolocalised to Sertoli and interstitial cell nuclei from day 12 (Fig. 6.4.d-f)
and into adulthood where AR immunoexpression in Sertoli cells was stage
specific (Fig.6.4.g).
In day 2 and day 3 mouse testes ERp was immunolocalised to interstitial cells
and cells within the seminiferous tubules (Fig.6.5.a, b). The intensity of ERP
immunostaining in Sertoli cell nuclei was increased in day 10 mouse testes
and both interstitial and Sertoli cell nuclei remained positively
immunostained throughout development and into adulthood (Fig. 6.5.c-g).
Between days 10 and 12 developing spermatogonia were found to express
ERP (Fig. 6.5. c, d) and by day 16 primary spermatocytes are also
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immunopositive for ER(3 (Fig. 6.5. f). In adult mouse testes (Fig. 6.5g) round
spermatids also express ER(3. Some non-specific immunostaining was
observed in the adult mouse testes when preabsorbed antibody was used in
place of primary antibody (Fig. 6.5.h).
6.3.2. Steroid regulation of mRNA and protein
expression in SK11 cells
The nuclei of SK11 cells cultured at 33°C appeared to contain more
condensed chromatin (blue arrows) than those grown at 39°C (black
arrows). In addition more mitotic figures (black arrowheads) were observed
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Figure 6.2: Immunolocalisation of SGP-1, inhibin-oc, Musashi-1 and GATA-4 to
postnatal day 10 mouse testes. Sertoli cell proteins SGP-1 (a), inhibin-a (b),
Musashi-1 (c) and GATA-4 (d) were immunolocalised to testes of postnatal day
10 mice. Corresponding negative controls where primary antibody was replaced
with normal rabbit IgGs (a), normal mouse IgGs (b), normal rat IgGs (c) and
normal goat IgGs (d) are shown in insets. Scale bar represents 50pm.
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Figure 6.3: Immunolocalisation of GATA-1 and PCNA to postnatal mouse testis. GATA-1 (a,c,e,g)
and PCNA (b,d,f,h) were immunolocalised to testes from mice aged postnatal day3(a,b), day 8(c,d),
day 10(e,f) and day 12(g,h). Arrows point to immunonegative Sertoli cell nulcei and arrowheads
point to immunopositive Sertoli cell nulcei. Insets show negative controls where primary antibody
was replaced with normal rat IgGs (e) and normal mouse IgGs (h).Scale bar represents 50pm
Figure 6.4: Immunolocalisation of androgen receptor (AR) to postnatal mouse
testes. AR was immunolocalised to testes from mice aged postnatal day 2 (a), day
8 (b), day 10 (c), day 12 (d), day 14 (e), day 16 (f) and adult (g). A negative control
from day 10 testes is shown in (h) when primary antibody was replaced with
normal rabbit IgGs. Scale bar represents 50pm.
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Figure 6.5: Immunolocalisation of oestrogen receptor-p (ER(3) to postnatal mouse
testes. ERP was immunolocalised to testes from mice aged postnatal day 2 (a), day
3 (b), day 10 (c), day 12 (d), day 14 (e), day 16 (f) and adult (g). A negative control
on adult testes is shown in (h) when primary antibody was replaced with
preabsorbed antibody. Scale bar represents 50pm.
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Figure 6.6: Haemotoxylin and eosin (H+E) staining of control SK11 cells cultured
at both 33°C and 39°C. SK11 cells grown on glass slides at 33°C (a, b) and 39°C
(c, d) in control media were stained with H and E. Blue arrows point to nuclei
containing condensed chromatin, black arrows point to nuclei containing less
condensed chromatin and black arrowheads point to mitotic figures. Scale bar
represents 20pm.
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Figure 6.7: Northern blot analysis of inhibin-a and Musashi-1 mRNA expression
in SKll cells. Northern blot analysis detected a single 1.5kb inhibin-a mRNA
transcript!A), a single 3kb Musashi-1 mRNA transcript (D), a 2.6kb SGP-1 mRNA
transcript (B, E) and a 1.9kb 18S rRNA transcript (C, F). lOgg of total RNA was
loaded per lane and RNA was obtained from postnatal day 18 rat testes (1), rat
kidney (2), postnatal day 10 mouse testes 13), SKll 39"C; F (4), SKll 39"C; C (5),
SKll 33°C; F (6), SKll 33°C; C (7), SKll 39°C; T+F 24 hours (8), SKll 39°C; T+F 4
hours (9), SKll 39°C; T+F 1 hour (10), SKll 39°C; E+F 24 hours (11), SKll 39°C;
E+F 4 hours (12) and SKll 39°C; E+F lhour (13). C = ethanol, F = forskolin
(10|iM), E = oestradiol benzoate (lOng/ml) and T = testosterone (lOOng/ml).
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A single 1.5kb inhibin-a mRNA transcript was detected in day 18 rat testes
and day 10 mouse testes RNA samples (Fig. 6.7). The levels of inhibin-a
mRNA in all SK11 cell RNA samples were too low to be detected by
Northern blot analysis (Fig. 6.7. A). Musashi-1 cDNA hybridised to a 3 kb
mRNA transcript in day 18 rat and day 10 mouse testes RNA samples.
However levels of Musashi-1 mRNA in all SK11 cell RNA samples were too
low to be detected by Northern blot analysis (Fig. 6.7. D). All RNA samples
were reprobed with radiolabeled SGP-1 and 18S cDNA probes which
detected a 2.6kb SGP-1 mRNA transcript (Fig. 6.7.B, E) and a 1.9kb 18S rRNA























Figure 6.8: Changes in SGP-1 mRNA expression following steroid
treatment of SK11 cells. Hybridisation signals for SK11 SGP-1 mRNA levels
were normalised against corresponding 18S rRNA. The results shown are
the mean SGP-1:18S values from two separate experiments.
To determine if steroid treatment had any regulatory effect on SK11 SGP-1
expression, hybridisation signals for SGP-1 mRNA from 2 separate
experiments were normalised against corresponding 18S values. Mean SGP-
1:18S values were calculated and results are shown in Fig. 6.8. F treatment at
both 33°C and 39°C downregulated SGP-1 mRNA expression. At 39°C,
administration of E and T in the presence of F further downregulated SGP-1
gene expression and the decline in gene expression was greatest following E
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administration. The extent of downregulation in expression of SGP-1 in the
E treated SK11 cells was unchanged across timed treatments. In contrast 24
and 1 hour T administration had a greater effect on SGP-1 expression than
the 4 hour T treatment.
Using a radiolabeled GATA-4 cDNA probe, a single 3.1kb mRNA transcript
was detected in all SK11 and whole testes RNA samples analysed (Fig. 6.9.A).
A 2.6kb SGP-1 mRNA transcript (Fig. 6.9.B) and a 1.9kb 18S rRNA transcript
(Fig. 6.9.C) were also detected in all RNA samples.
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Figure 6.9: Northern blot analysis of GATA-4 mRNA expression in SK11 cells.
A single 3.1kb GATA-4 mRNA transcript (A) was hybridised to lOpg of total RNA
obtained from postnatal day 18 rat testes (1), rat kidney (2), postnatal day 10 mouse
testes (3), SK11 cells cultured at; 39°C +F (4); 39°C +C (5), 33°C +F (6); 33°C +C (7);
39°C F+T 24 hours (8); 39°C F+T 4 hours (9); 39°C F+T 1 hour (10); 39°C F+E 24
hours (11); 39°C F+E 4 hours (12) and 39°C F+E 1 hour (13). The RNA blot was
stripped and reprobed with SGP-1 and 18S cDNA probes which detected a 2.6kb
SGP-1 mRNA transcript (B) and a 1.9kb 18S rRNA transcript (C). C = ethanol,
F = forskolin (lOgM), T = testosterone (lOOng/ml) and E = oestradiol benzoate
(lOng/ml).






























Figure 6.10: Changes in GATA-4 mRNA expression following steroid
treatment of SK11 cells. GATA-4 mRNA hybridisation signals from two
separate experiments were quantified and normalised against corresponding
18S rRNA values. In (B), the T 4 hour RNA sample was missing and an 18S
value for E 1 hour sample could not be obtained.
Hybridisation signals from GATA-4 and 18S Northern blot analyses were
quantified and GATA-4 mRNA expression by SK11 cells was normalised
against corresponding 18S rRNA values. Results from two separate
duplicate experiments are shown in Fig. 6.10. In both experiments F
treatment decreased GATA-4 mRNA expression in SK11 cells cultured at
both 33°C and 39°C. There were some inconsistencies regarding the effect of
E and T treatment on SK11 cell GATA-4 gene expression. Overall it appeared
that both steroids had no real effect on GATA-4 gene expression at
a
Figure 6.11: Immunolocalisation of GATA-4 and oestrogen receptor-P (ERp)
in SK11 cells grown at 33°C. GATA-4 was immunolocalised to SK11 cells
cultured at 33°C in the presence (b) and absence (a) of forskolin (lOpM). ERp
was immunolocalised to SK11 cells grown at 33"C in the presence (d) and
absence (c) of forskolin (lOpM). Negative controls when primary antibody
was replaced with normal goat IgGs (a) and preabsorbed ERp antibody (c)
are shown in insets. Arrows point to immunonegative SK11 cell nuclei
following GATA-4 immunolocalisation. Scale bar represents 20pm.
1 * ft 9* . ■ a m oa ^'»*», a • •
• %• * m\% • •* • •• •• * * •
.
„ % a* * * k* »' •
♦ . v. I *••..■%•• ;;
*V •• • •«
a % b ♦ ' »<ic' ' d #'
. • %» !♦ », -V,#' % . ,
• • • • 5 ' " , ••'#» 9
A • » # • # # * %
.
. *, f •••«. '*V 1 ••
e f q h•9
%
•• ••• * • « % t • • "
% 9 • ^ > 0 *am'* A %
* * • -J** « * # ^ « *
, • JT A *!*«»%• • • •
' *
• * i " # pt •• • §s1 .,<• ■ '..• •. .k;i . l • -
»;. ♦ • v'i.^ "V :-k




• •« rv. • •. i<e
_ t *«••••» nm | n # o#»% < #* p _
Figure 6.12: Immunolocalisation of oestrogen receptor (ER(3) to SK11 cells. ER(3 was immunolocal-
-ised to SK11 cells grown at 39°C in the presence of ethanol (a, e, ,i, m), forskolin (F) at 10pM
(b, f, j, n), F and oestrogen benzoate (E) at lOng/ml (c, g, k, o) and F and testosterone (T) at
lOOng/ml (d, h, 1, p). SK11 cells were treated for 48 hours (a-d), 24 hours (e-h), 4 hours (i-1) and
1 hour (m-p). Negative control when primary antibody was replaced with preabsorbed ER(3
antibody is shown in inset. Scale bar represents 20pm.
Figure 6.13: Immunoiocalisation of GATA-4 to SK11 cells. GATA-4 was immunolocalised to SK11
cells grown at 39°Cin the presence of ethanol (a, e, i, m), forskolin (F) at lOuM (b, f, j, n), F and
oestradiol benzoate (E) at lOng/ml (c, g, k, o), F and testosterone (T) at lOOng/ml (d, h, 1, p). SK11
cells were treated for 48 hours (a-d), 24 hours (e-h), 4 hours (i-l) and 1 hour (m-p). Negative control
when primary antibody was replaced with normal goat IgGs is shown in inset. Scale bar represents
20p.m.
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all time points assessed apart from an increase in gene expression following
1 hour F+T treatment and 4 hour F+E treatment in one of the two
experiments.
GATA-4 and ER(3 proteins were immunolocalised to nuclei of SK11 cells
grown at 33°C (Fig. 6.11.). Following 24 hour F treatment the number of
SK11 cell nuclei positively immunostained for GATA-4 was decreased when
compared to control SK11 cells (Fig. 6.11.a, b; immunonegative SK11 nuclei
indicated by blackarrows). In contrast the number of ERp positively
immunostained SK11 nuclei was unchanged following F administration (Fig.
6.11.C, d).
At 39°C all SK11 cell nuclei were immunopositive for ER(3 protein (Fig. 6.12.).
There was no change in the level of ERp immunoexpression in SK11 cells
following F treatment when compared to control SK11 cells (Fig. 6.12. b, f, j,
n). Intensity of ERP immunostaining was greater in SK11 cells following all
F+E timed treatments (Fig. 6.12.C, g, k, o). Following F+T treatment for 48,
24 and 4 hours there was an increase in the intensity of immunostaining of
ERp in SK11 cells (Fig. 6.12.d, h, 1).
GATA-4 was specifically immunolocalised to the nuclei of SK11 cells in
culture at 39°C (Fig. 6.13.). Some SK11 cells were immunonegative for
GATA-4. No difference in intensity of GATA-4 immunostaining could be
observed between control (Fig. 6.13. a, e, i, m), F+E (Fig. 6.13. c, g, k, o) and
F+T (Fig. 6.13. d, h, 1, p) treated SK11 cells. SK11 cells treated with F alone
for 48 and 24 hours had a greater intensity of GATA-4 immunostaining
when compared to corresponding control SK11 cells (Fig. 6.13. b, f).
6.4. Discussion
In the study presented the SK11 cell line appeared morphologically similar to
SK11 cells described inWalther et al., (1996). Nucleoli were more apparent in
nuclei of cells grown at 33°C than at 39°C and more mitotic figures could be
observed at 33°C in accordance with proliferation of the cell line at the
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permissive temperature. Mitotic figures were also observed at 39°C. Thus a
very small number of SK11 cells are actually still dividing after 48 hours at
the non-permissive temperature and this was also reported by Walther et al.,
(1996) (Walther et al., 1996). However Walther et al., (1996) could not detect
proliferating SK11 cells after 96 hours of culture at the non-permissive
temperature. Following H and E staining, nuclei of SK11 cells at 39°C
appeared to contain less-condensed chromatin when compared to cells
grown at 33°C suggesting that SK11 cells undergoing differentiation at 39°C
are more transcriptionally active than proliferating cells at 33°C.
The SK11 cell line originated from Sertoli cells isolated from day 10 H-2Kb-
tsA58 transgenic mice. Analysis of GATA-1 and PCNA protein expression
during mouse testis development (shown in the present study) suggested
that mouse Sertoli cells cease proliferation between days 8 and 12 of
development. Hence by day 10, the majority of Sertoli cells have ceased
dividing and are undergoing maturation and consequently mouse Sertoli
cells at this age are the equivalent of day 18 Sertoli cells in the rat testis
(Chapter 4). Under normal conditions, day 10 mouse Sertoli cells express
SGP-1, inhibin-a, Musashi-1, GATA-1 and GATA-4 proteins. In addition both
AR and ER{3 proteins are expressed in Sertoli cell nuclei at this stage of
mouse testis development. Expression levels of inhibin-a and Musashi-1 in
SK11 cells were too low to be detected by Northern blot analysis and
immunocytochemistry, although previously the more sensitive technique of
RTPCR analysis detected inhibin-a mRNA expression in SK11 cells (Walther
et al., 1996). No previous research has been carried out to investigate
Musashi-1 expression in the SK11 cell line and therefore it is not known if
Musashi-1 expression has been lost in the immortalised cell line as has been
shown to occur with other proteins during cell culture (Angus et al., 1993;
Sutton et al., 1998) or if mRNA expression levels are just too low to be
detected using Northern blot analysis. RPAs and RTPCR will need to be
carried out to determine the answer. In rats (chapters 3 and 4) Musashi-1
protein levels in vivo were greater in Sertoli cell nuclei than cytoplasm in
Sertoli cells which had ceased dividing and were undergoing differentiation.
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In addition GATA-1 protein expression was shown to be restricted to non-
proliferating Sertoli cells. It was hoped that in the present study the
expression patterns of both Musashi-1 and GATA-1 could be investigated
and differences between levels of expression in proliferating SK11 cells at
33°C and differentiating cells at 39°C could be assessed. GATA-1 mRNA has
previously been detected in SK11 cells using RTPCR and preliminary
investigations in this study also detected GATA-1 mRNA in SK11 cells using
RTPCR techniques. However both mRNA and protein expression of GATA-
1 could not be detected in the cultured cells using Northern blot analysis or
immunocytochemistry. Moreover AR protein expression could not be
localised to SK11 cells grown at either temperature using an antibody against
AR. In previous studies AR mRNA was detected in the SK11 cell line using
RTPCR. However it is possible that AR levels in the immortalised cell line
are very low and could not be detected using immunocytochemical analysis.
Levels ofmRNA detected in immortalised Sertoli cell lines have been shown
to be lower than in primary cultured Sertoli cells of the same species
(McGuinness et al., 1994). It has been proposed that the decrease in mRNA
levels results from the expression of messages associated with cell replication
which are not expressed in Sertoli cells which have generally ceased dividing
when placed in vitro.
ER(3 protein expression was detected in the nuclei of SK11 cells grown at
both 33°C and 39°C. In agreement with the pattern of expression of ER(3
protein in primary cultures of rat Sertoli cells (Chapter 5) ERP was located to
the nuclei of SK11 Sertoli cells cultured in the presence and absence of
steroids. EB administration appeared to upregulate ERP protein levels in
SK11 cells cultured at 39°C. Levels of ERP protein also appeared to increase
in primary cultures of rat Sertoli cells following EB treatment (Chapter 5). In
contrast to observed increases in AR protein levels following T
administration thought to result from T stabilising the AR protein, Tena-
Sempere et al., (2000) observed an increase in ERP mRNA expression
following in vivo EB treatment of prepubertal rat testis. Consequently it is
proposed that in Sertoli cells EB directly upregulates ERP protein expression
at the level of gene transcription in addition to possibly stabilising the ERP
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protein. Results from the present study indicate that treatment with F+T
also increases ER(3 protein levels in SK11 cell nuclei even though AR
expression could not be detected in SK11 cells. ER(3 protein levels also
appeared to be upregulated in primary cultured rat Sertoli cells (Chapter 5)
and it was proposed that T indirectly increased ER(3 levels through
aromatisation of T into E. However previous research could only detect
aromatase mRNA in SK11 cells cultured in the presence of F and not in the
presence of F and T (Walther et ah, 1997). Therefore the mechanism by
which T upregulates ER(3 expression is unknown and requires further
investigation. Additional information on the regulation of protein levels
following steroid treatment will require Western analysis (Williams et ah,
2000).
Initially mRNA expression by SK11 cells was to be normalised against
corresponding SGP-1 mRNA levels. However due to the findings in the
previous chapter where SGP-1 mRNA expression appeared to be
upregulated by T treatment, steroid regulation of SGP-1 expression in SK11
cells was also investigated. Administration of F, E and T downregulated
SGP-1 mRNA expression in SK11 cells grown at both 33°C and 39°C and
therefore mRNA levels were normalised against 18S rRNA levels. As SK11
cells are an immortalised cell line this was deemed appropriate as cultures
were not contaminated by germ cells or peritubular cells which might have
affected evaluation of Northern blots.
The transcription factor GATA-4 was expressed in nuclei of SK11 cells grown
at both permissive and non-permissive temperatures. At 33°C GATA-4
mRNA and protein levels appear to be downregulated following 24 hour F
treatment whereas the reverse situation occurred with GATA-4 protein
levels in SK11 cells grown at 39°C. However results indicated that GATA-4
mRNA levels were downregulated in the presence of F at 39°C. It is possible
that at 39°C F increases the stability of GATA-4 mRNA transcripts or
increases the rate of GATA-4 translation in SK11 cells. Both these possibilities
would result in an increase in GATA-4 protein without altering the number
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of GATA-4 mRNA transcripts. There were inconsistencies between the two
experiments regarding the effect of timed steroid treatment on SK11 cell
GATA-4 mRNA expression. However overall it appeared that both E and T
administration had little effect on GATA-4 gene expression in SK11 cells.
This was in agreement with an absence of steroid regulation on GATA-4
protein levels in SK11 cells and similar results were obtained following
steroid treatment of primary cultured rat Sertoli cells (Chapter 5) or in vivo
treatment with DES on expression in day 18 rat testes (Chapter 4). Not all
SK11 cells were immunopositive for GATA-4 and similar findings were also
demonstrated in MSC-1 cultured Sertoli cells (Ketola et al., 1999) and in
primary cultures of rat Sertoli cells (Chapter 5). This is in contrast to GATA-4
protein expression in Sertoli cells observed in vivo where levels of
expression appear constant across all tubules and at all stages of
development (Chapter 3). The reason for the different levels of protein
expression observed in cells in both immortalised and primary cultured
Sertoli cells is unknown and requires additional research in order to establish
the causes.
In the current study it was demonstrated that the immortalised mouse
Sertoli cell line SK11, when grown at the non-permissive temperature,
maintained expression patterns of genes and proteins characteristic of mouse
and rat Sertoli cells in vivo and in vitro. ERP protein levels appeared to be
upregulated by EB and T treatment whereas GATA-4 protein levels were
increased in the presence of F but were otherwise unchanged following
steroid treatment. Disappointingly, expression levels of GATA-1 and
Musashi-1 were too low in the immortalised cell line such that regulation of
gene expression by steroids or Sertoli cell differentiation could not be
determined. In order to address these questions future work employing
RPA analysis would need to be carried out. Due to the maintenance of
GATA-4 and ERP protein expression in the SK11 cell line it is hoped that in
future investigations possible interactions between GATA-4 and ERP could
be carried out. The presence of both proteins in the cell line and the
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preservation of their normal in vivo regulatory processes demonstrates that
these cells are good candidates in which to carry out co-immunoprecipitation
experiments in order to determine if GATA transcription factors do interact
with ER{3 in the differentiating Sertoli cell.
Chapter 7.
General Discussion
The demonstration of ER expression throughout the male reproductive tract
(Fisher et al., 1997; Saunders et al., 1998; van Pelt et al., 1999) and the discovery
that oestrogenic action was essential for fertility in the male mouse(Eddy et al.,
1996; Hess et al., 1997) emphasised the need for further investigation into the
role of oestrogen in the male reproductive system, in particular during postnatal
testicular development. The hypothesis that increased levels of oestrogens and
oestrogen like chemicals in the environment were causing detrimental effects on
the male reproductive tract in particular during fetal and postnatal development
(Sharpe and Skakkebaek, 1993) further highlighted the importance of
establishing the complex mechanisms involved in the interplay between
oestrogen and testis development. The aims of this study were to carry out
investigations into the direct effects of oestrogen on postnatal Sertoli cell
differentiation. Other studies had already shown that oestrogen treatment to
pregnant rats could affect gene expression in the testes of their male fetuses
(Majdic et al., 1997; Majdic et al., 1995). An alteration in the differentiation of
Sertoli cells during postnatal development can affect the functional maturation
of the entire testis (De Franca et al., 1995). Changes in the expression patterns of
established and novel markers of Sertoli cell maturation by oestrogen and
testosterone were investigated using in vivo and in vitro methods and possible
direct effects of oestrogen on Sertoli cell function were studied.
Expression patterns of novel markers of Sertoli cell functional maturation were
investigated in Chapter 3. The RNA binding protein Musashi-1 was shown to
be a prime candidate for a marker of Sertoli cell differentiation because the
pattern of expression of Musashi-1 protein was modified as Sertoli cells switched
from proliferating undifferentiated cells into morphologically and functionally
differentiated cells. It is possible that Musashi-1 is involved in nuclear-
cytoplasmic RNA trafficking in mitotic Sertoli cells and then becomes
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predominantly involved in RNA processing within the nucleus during Sertoli
cell differentiation. Modulation of Musashi-1 expression by steroids could not
be demonstrated in this study using both in vivo and in vitro techniques which
was disappointing. Unfortunately, expression of Musashi-1 appeared to be
down regulated in primary cultures of immature rat Sertoli cells and mRNA
levels were undetectable in the transformed mouse Sertoli cell line. Further
research into regulation of Musashi-1 gene expression will require the use of
more sensitive techniques such as real-time PCR or the use of alternative culture
systems e.g. isolated seminiferous tubules (McKinnell and Sharpe, 1992;
McLaren et al., 1993). In addition investigations into which RNA transcripts bind
to Musashi-1 in Sertoli cells could be carried out using immunoprecipitation and
blot analysis although this would be technically challenging.
The transcription factors GATA-1 and GATA-4 bind to GATA motifs located in
regulatory regions of a number of factors expressed in the postnatal testis (Feng
et al., 1998; Silverman et al., 1999; Viger et al., 1998). Therefore both GATA
factors are thought to play an important role in testicular development. In this
study GATA-4 protein expression was found to be restricted to Sertoli and
Leydig cell nuclei throughout testis development. Expression patterns of
GATA-4 in Sertoli cells, granulosa cells and cardiomyocytes reported in this
study and in the published literature (Grepin et al., 1995; Heikinheimo et al., 1997;
Ketola et al., 1999), suggest that GATA-4 could act as a survival factor in these
cell types. GATA-4 expression did not change during Sertoli cell maturation and
the pattern of expression remained unchanged following delayed development
in the neonatal oestrogenised rats (Chapter 4). GATA-4 was therefore not
investigated further as a marker of Sertoli cell differentiation. Previous reports
have suggested that expression of GATA-4 in Sertoli and granulosa cells is
modulated by FSH and oestrogens respectively (Heikinheimo et al., 1997; Ketola
et al., 1999) In this study GATA-4 mRNA and protein levels remained unchanged
following treatment of isolated Sertoli cells with oestrogen, testosterone and
forskolin. Research using more sensitive quantitative techniques will need to be
carried out in the future to confirm these results. It would also be interesting to
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study possible causes of non-uniform GATA-4 immunolocalisation in cultured
Sertoli cell nuclei (see Figs 5.12 and 6.13) compared to the uniform GATA-4
protein expression observed in Sertoli cell nuclei present in intact rodent testis.
Over the course of this study, GATA-1 protein was shown to be an informative
marker of Sertoli cell functional maturation as GATA-1 protein expression was
restricted to non-proliferating Sertoli cell nuclei throughout postnatal testis
development. Consistent with this, a delay in the cessation of Sertoli cell
division induced in oestrogenised rat testis resulted in a delay in GATA-1 protein
expression. GATA-1 expression was not observed in Sertoli cells until cell
proliferation had stopped and the cells had begun to differentiate. Studies have
shown that ERoc and oestrogen complex with GATA-1 in erythroid cells (Blobel
and Orkin, 1996; Blobel et al.f 1995). The ERa-ligand-GATA-1 complex prevents
GATA-1 transactivation of genes essential for erythroid cell differentiation:
consequently the erythroid cells enter the apop topic pathway (Blobel and Orkin,
1996). It was hoped that during this study investigations into possible direct
effects of oestrogen (in conjunction with ERP) on GATA-1 transactivation of
genes expressed in Sertoli cells could be carried out. If the described interactions
in erythroid cells were also taking place in developing Sertoli cells such direct
inhibition of GATA-1 transactivation by oestrogen and ERP could result in a
delay in Sertoli cell maturation. Disappointingly expression of GATA-1 mRNA
in Sertoli cells could not be detected using Northern blot analysis or
ribonuclease protection assays in either the in vivo or the in vitro studies.
Preliminary RTPCR analysis was able to detect the presence of GATA-1 mRNA
in differentiating Sertoli cells and Sertoli cells in culture. Additional
investigations on the expression of GATA-1 will therefore need to make use of
sensitive methods such as real-time PCR.
The amount of SGP-1 mRNA in total testicular extracts has often been used as
an internal control to quantitate the amount of individual mRNAs in Sertoli cells
in the presence of germ cells. It has been previously demonstrated that SGP-1 is
constitutively expressed in Sertoli cells and that levels of expression do not
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change across spermatogenic cycles, following hormonal treatment or during
Sertoli cell development (Grima et al., 1992; Mathur et al., 1994; Sharpe et al.,
1993; Stallard and Griswold, 1990). However in the course of this study, SGP-1
mRNA and protein levels per Sertoli cell were shown to change as development
progressed. SGP-1 levels were low in neonatal Sertoli cells but the amount of
both SGP-1 mRNA and protein were upregulated as the Sertoli cells matured. It
has also been stated that SGP-1 expression in the testis is restricted to Sertoli cell
cytoplasm (Mathur et al., 1994). However in the immature testes used in this
study, SGP-1 protein was immunolocalised to macrophages and fetal type
Leydig cells. These results highlight the need for further research into changes
in SGP-1 expression during postnatal testis development. With more extensive
research being carried out into the effects of oestrogen on prepubertal testis
development, the use of SGP-1 as an internal control for Sertoli cell gene
expression needs to be re-evaluated. It was notable that in vitro studies
consistently demonstrated regulation of SGP-1 mRNA expression by
testosterone in Sertoli cells which further emphasises the need to reassess the
regulation of expression of SGP-1 in Sertoli cells. The majority of previous
research into SGP-1 expression in the testis has been carried out on mature
Sertoli cells. Work carried out during this study demonstrates additional
differences between proliferating and differentiating Sertoli cells which need to
be addressed when investigating Sertoli cell development in the future.
Expression of GATA-1, Musashi-1 and inhibin-a in cultured rat Sertoli cells and
the transformed mouse Sertoli cell line, (SK11) appeared to be low/negligible
demonstrating a problem which has been experienced during other studies
using cell culture of Sertoli cells. Removal of a cell from its normal surroundings
or transformation of the cell with a tumorigenic gene can lead to the loss of
expression of certain genes (Angus et al., 1993; Sutton et al., 1998). However in
this thesis isolation of Sertoli cells from intact rat testis was used as it provided a
system in which the direct action of oestrogen and testosterone on Sertoli cell
functional maturation could be explored without the complexities of the whole
organism. The possibility of paracrine interactions within the testis masking the
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regulation of the selected factors by oestrogen and testosterone was also
removed using the in vitro culture systems. The studies described in this thesis
were preliminary and therefore described effects of oestrogen on immature
Sertoli cells which could take place during postnatal testis development. Due to
the artificial nature of the experiments statements were not made proposing
what actually does take place within differentiating Sertoli cells.
The primary rat Sertoli cell culture system employed in this study retained
normal cellular physiological responses of Sertoli cells even after 5 days in
culture in the absence of steroids. To the best of my knowledge these results
are the first reports of immunolocalisation of ER[3 protein to cultured Sertoli
cells. Upregulation of ER(3 expression in Sertoli cells following oestrogen
administration supports previously published work where an upregulation in
ER(3 mRNA levels in neonatal and prepubertal rat testis following oestrogen
administration was also demonstrated (Tena-Sempere et ah, 2000). These results
suggest that oestrogen increases ER(3 gene transcription in differentiating Sertoli
cells leading to an increase in ER(3 protein levels. This is in contrast to the
proposed effect of testosterone on AR protein levels where testosterone
stabilises the receptor rather than actually upregulating AR expression levels
(Sar et al, 1993). Such an upregulation of ER(3 levels by oestrogen in immature
and differentiating Sertoli cells provides a direct pathway by which exogenous
oestrogens can affect Sertoli cell maturation and subsequent testis development.
In addition preliminary results in this thesis supported previous reports of a
downregulation in AR expression levels in differentiating Sertoli cells following
oestrogen administration (Sharpe et al., 1998; Tena-Sempere et al., 2000). These
observations provide an alternative pathway by which oestrogen can affect
male development through inhibition of androgen action in Sertoli cells.
It must be noted that these results are from preliminary investigations and in
most cases experiments were only performed twice, hence statistical analysis
could not be carried out. This was partly due to the problem in obtaining
sufficient numbers of Sertoli cells in the primary rat Sertoli cell cultures. Low cell
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numbers restricted the quantities of RNA and protein that could be extracted
from the cultures, which in turn limited the analysis of mRNA levels to the more
abundant RNA transcripts. The importance of obtaining equal distribution of
Sertoli cells across treatment groups and ensuring cell numbers were uniform
across experimental groups was also demonstrated during the course of this
study. It was hoped that the use of a transformed Sertoli cell line would
overcome problems with variation between cultures however in the present
study AR, GATA-1, Musashi-1 and inhibin-a expression levels were found to be
very low and were below detection levels for immunocytochemistry and
Northern blot analyses. Additional studies with these cells may therefore
require transfection with reporter constructs to restore the expression of
regulatory factors such as GATA-1.
In conclusion the studies described in this thesis have provided preliminary
results regarding the effects and mechanisms of oestrogen on differentiating
Sertoli cells. ER(3 protein levels were upregulated by oestrogen administration
and conversely AR levels were decreased with oestrogen treatment. Expression
patterns of Musashi-1 and GATA-1 in developing testes demonstrated the
potential use of these factors as markers of Sertoli cell functional maturation in
future research. Novel results regarding the regulation and changes in levels of
SGP-1 expression during Sertoli cell maturation were demonstrated. These
findings strongly suggest that further research into SGP-1 expression in the
developing testis is necessary if SGP-1 continues to be used as an internal control
in studies on Sertoli cell gene expression. A number of problems associated
with the use of in vitro systems were highlighted during these investigations
including the need for sufficient cell numbers in primary Sertoli cell cultures,
even distribution of cell numbers across treatment groups and loss of
expression of some genes in cells removed from the normal environment
within the seminiferous tubule. The overall conclusion from this work is that
more effort is required to identify mechanisms of oestrogen action on Sertoli
cells. This study demonstrated expression of ER(I in cultured Sertoli cells. In the
future in vitro Sertoli cell culture could be utilised for further investigations into
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the mechanisms of oestrogenic action on developing Sertoli cells. Future
research could focus on the proposed interplay between oestrogen, ER(3 and
GATA factors within the developing Sertoli cell. This research could provide
invaluable data necessary for the elucidation of the pathways involved in
interactions between oestrogen and Sertoli cell maturation which ultimately
affect male fertility.
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Appendix: Some commonly used agars and buffers
Agars
Soc medium Luria Bertani (LB) agar plates
20g Bacto-tryptone 15g agar
5g Bacto-yeast extract lOg Bacto-tryptone
lOmM NaCl 5g Bacto-yeast extract
2.5mM KC1 lOg NaCl [pH 7.0], in 1 litre
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